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Abstract 
A dynamic contrast-enhanced (DCE) near-infrared (NIR) method to measure 
cerebral blood flow (CBF) in the neurocritical care unit (NCU) is described.  A 
primary concern in managing patients with acquired brain injury (ABI) is 
onset of delayed ischemic injury (DII) caused by complications during the 
days to weeks following the initial insult, resulting in reduced CBF and 
impaired oxygen delivery. 
The development of a safe, portable, and quantitative DCE-NIR 
method for measuring CBF in NCU patients is addressed by focusing on four 
main areas: designing a clinically compatible instrument, developing an 
appropriate analytical framework, creating a relevant ABI animal model, and 
validating the method against CT perfusion. In Chapter 2, depth-resolved 
continuous-wave NIR recovered values of CBF in a juvenile pig show strong 
correlation with CT perfusion CBF during mild ischemia and hyperemia 
(r=0.84, p<0.001). In particular, subject-specific light propagation modeling 
reduces the variability caused by extracerebral layer contamination. In 
Chapter 3, time-resolved (TR) NIR improves the signal sensitivity to brain 
tissue, and a relative CBF index is be both sensitive and specific to flow 
changes in the brain. In particular, when compared with the change in CBF 
measured with CT perfusion during hypocapnia, the deconvolution-based 
index has an error of 0.8%, compared to 21.8% with the time-to-peak method. 
To enable measurement of absolute CBF, a method for characterizing the AIF 
is described in Chapter 4, and the theoretical basis for an advanced analytical 
framework—the kinetic deconvolution optical reconstruction (KDOR)—is 
provided in Chapter 5. Finally, a multichannel TR-NIR system is combined 
with KDOR to quantify CBF in an adult pig model of ischemia (Chapter 6). In 
this final study, measurements of CBF obtained with the DCE-NIR technique 
show strong agreement with CT perfusion measurements of CBF in mild and 
moderate ischemia (r=0.86, p<0.001). 
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The principle conclusion of this thesis is that the DCE-NIR method, 
combining multidistance TR instrumentation with the KDOR analytical 
framework, can recover CBF values that are in strong agreement with CT 
perfusion values of CBF. Ultimately, bedside CBF measurements could 
improve clinical management of ABI by detecting delayed ischemia before 
permanent brain damage occurs. 
 
Keywords 
Near-infrared spectroscopy, cerebral blood flow, time-resolved, dynamic 
contrast-enhanced, delayed ischemic injury, acquired brain injury  
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Chapter 1 
INTRODUCTION 
The objective of this introductory chapter is to provide the reader with an 
appreciation of why the topic of this doctoral thesis—the development and 
validation of near-infrared (NIR) methods to quantify cerebral blood flow 
(CBF) in the neurocritical care unit (NCU)—was studied. First, the rationale 
for this work will be provided within the context of the clinical problem: 
acquired brain injury (ABI). This will involve a description of the pathological 
mechanisms underlying some of the most common conditions treated in the 
NCU—traumatic brain injury (TBI) and nontraumatic subarachnoid 
hemorrhage (SAH). The importance of quantifying CBF for the management 
of these patients will be highlighted, and current methods for measuring CBF 
will be described. After establishing the motivation for this work, the 
theoretical basis of dynamic contrast-enhanced (DCE) NIR techniques, which 
encompasses the methods developed in this work, will be provided. In 
particular, the specific challenges of applying DCE-NIR methods to an adult 
head to measure CBF will be highlighted. This final point represents the 
main knowledge gap that this thesis will address.  
1.1. Rationale 
The neurocritical care unit (NCU) has emerged as a specialized intensive care 
unit responsible for the treatment of life-threatening neurological illnesses. 
2 
Often, patients admitted to the NCU are comatose or paralyzed and present 
with injuries to other parts of the body, making their management difficult. 
In a collaborative effort, neurointensivists, neurosurgeons, diagnosticians and 
nurses are responsible for the clinical management of NCU patients to 
ensure the best chance for survival (Diringer et al 2001). Acquired brain 
injuries—including TBI, diffuse acquired brain injury, stroke, and SAH from 
traumatic or aneurysmal origin—comprise the majority of cases for which 
patients are admitted to the NCU. For the purpose of this thesis, discussion 
will be limited entirely to ABI and principally those injuries caused by TBI 
and its sequelae, as well as SAH. 
 
Figure 1.1: Prognosis of traumatic brain injury. 
The approximate outcomes of 1.7 million TBIs that occurred annually in the United States 
during years 2002-2006. Of the 275,000 hospitalizations, 52% of individuals died or suffered 
permanent disability. (Figure adapted from Langois 2010 and Baron and Jallo 2007).  
From an epidemiological standpoint, TBI is the single most common 
cause of death and disability among children and young adults (Langlois 
2000). At least 1.7 million people sustain a TBI each year in the United 
States (figures from 2002-2006, when the US population was approximately 
300 million); 275,000 of those individuals are subsequently hospitalized and 
about 52,000 of those injuries are ultimately fatal (CDC 2010). The term 
“traumatic brain injury” reflects an etiology (i.e., a brain injury sustained in 
3 
trauma) rather than a specific pathology, which can be complex and 
multifaceted. Therefore, TBI is further stratified according to mechanism 
(blunt or closed injury versus penetrating or open injury), spatial pattern of 
disease (focal or diffuse), and severity of primary brain damage (Glasgow 
coma scale). Proper classification of TBI can help establish a prognosis, and 
provide insight into possible complications that are likely to follow. For 
example, a focal pattern of TBI is likely to result in cerebral contusions, 
hemorrhages, and hematomas (Baron and Jallo 2007). 
In addition to TBI, the NCU supports patients with non-traumatic ABI 
such as ischemic stroke and subarachnoid hemorrhage. In particular, SAH 
accounts for about 5% of strokes, but remains among the most life-
threatening neurological diseases and affects primarily adults under the age 
of 60. In fact, because SAH affects preferentially young individuals—with a 
mean age of 50 years (Nieuwkamp et al 2005)—the number of years of 
potential life lost by SAH accounts for about 25% of all stroke-related 
diseases (Johnson et al 1998; Hop et al 1997). Therefore, SAH has a societal 
impact comparable with ischemic stroke. Nontraumatic SAH—for which 85% 
of cases are secondary to the rupture of an aneurysm (Sehba et al 2012)—
occurs when blood extravasates into the CSF-filled space between the 
arachnoid membrane and pia mater known as the subarachnoid space. The 
mortality rate of SAH is 40%, and includes approximately 10-20% of patients 
who die before receiving advanced medical care (Sehba et al 2012). 
Furthermore, SAH patients are susceptible to serious complications following 
the initial injury, which will be further discussed in the subsequent section 
(van Gijn J 2001).    
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1.2. Complications in acquired brain injury 
1.2.1. Clinical presentation 
Following the primary brain injury caused by either TBI or SAH, the 
principal concern of the NCU is to minimize complications during the acute 
recovery stage that compromise the outcome of the patient. Complications 
that develop secondary to the initial injury represent the single greatest 
threat to the outcome of the patient, as a significant portion of neurological 
damage develops during the days to weeks following hospitalization, rather 
than during the primary insult. Most often, these complications result from 
impaired blood flow which prevents adequate oxygen delivery to the brain 
tissue, resulting in permanent "secondary brain injury" or “delayed ischemic 
injury” (DII) (Wartenberg 2011; Coles 2004). Although DII is the 
manifestation of a pathological cascade beginning within hours of brain 
injury, it is a target for intervention since it tends to progress gradually while 
the patient is in the NCU. Therefore, a primary concern of the NCU is to 
detect and minimize these complications, which include intracranial 
hypertension, edema, vasospasm, and other bleeding disorders (Rincon and 
Mayer 2007), before permanent brain injury results. 
 Intracranial hypertension, in which intracranial pressure (ICP) 
becomes elevated, is among the most important complications that occur in 
brain injury patients. An increase in ICP usually results from a mass effect—
either edematous or hemorrhagic in nature (Steiner and Andrews 2006). 
Since the skull acts as a closed container, ICP becomes elevated when the 
overall volume of three elements—brain parenchyma volume, blood volume, 
and cerebrospinal fluid (CSF)—increases. To some degree, slight variations in 
one element can be compensated by the other two according to the Monro-
Kellie doctrine (Mokri 2001). Figure 1.2 shows a schematic of this 
compensatory mechanism. 
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Figure 1.2: Compensatory mechanism  
In a normal state, the intracranial pressure (ICP) is tightly regulated. When a mass effect 
occurs due to some underlying pathology, a small increase in volume can be accommodated 
by reductions in blood volume and cerebral spinal fluid (CSF). Larger increases overwhelm 
the compensatory mechanisms and brain tissue expansion causes elevated ICP leading to 
herniation and distortion.  
Compensation occurs as either blood volume, or more often CSF, is reduced to 
accommodate the expanding lesion. In the latter case, CSF is reabsorbed and 
the production of new CSF is reduced in the presence of slightly elevated ICP 
(Cutler et al 1968). Continued expansion of the mass will result in 
progression through four stages of intracranial hypertension: total 
compensation, partial compensation, decompensation, and vasomotor 
paralysis (Barlow and Stewart 2007).  
A principle cause of intracranial hypertension is brain edema, which 
increases the brain parenchymal volume. Defined as the swelling of brain 
tissue, brain edema can be vasogenic or cytotoxic in origin (Ropper 1984). In 
vasogenic edema, the blood-brain barrier is disrupted by the primary or 
secondary injury, allowing the extravasation of fluid and proteins across the 
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otherwise tightly regulated endothelium and into the interstitial space of the 
brain parenchyma. As a result, an osmotic gradient is created, drawing water 
into the interstitum. In cytotoxic edema, the primary insult causes a 
disruption in brain energy metabolism, resulting in a depletion of energy 
stores needed to maintain ion homeostasis (Liang et al 2007). The resulting 
increase in interstitial osmolality draws water across the blood-brain barrier 
and causes a subsequent increase in intracranial pressure. Edema of the 
brain can result in secondary brain injury if the increase in parenchyma 
volume overwhelms the compensatory mechanisms described in the previous 
paragraph.  
An additional cause of intracranial hypertension is the development of 
a hematoma, a localized collection of blood outside of the vessels, which can 
pool between the dura mater and the skull (i.e., epidural hematoma) or 
between the dura mater and the arachnoid mater (i.e., subdural hematoma). 
Epidural and subdural hematomas are examples of extra-axial hemorrhage 
(Wilberger et al 1991)―bleeding that occurs outside of the brain tissue but 
within the skull. In addition to extra-axial hemorrhage, intra-axial or 
cerebral hemorrhage can also occur. When cerebral hemorrhage occurs 
secondary to brain injury, it is usually due to penetrating head trauma or 
acceleration-deceleration trauma (Udstuen and Claar 2001). In all of these 
examples, elevated ICP is a principle concern. In some circumstances, this 
can be mitigated by early evacuation of the hematoma (Wilberger et al 1991). 
 Delayed ischemic injury is also a primary concern in SAH, and 
develops in approximately one third of patients within the first two weeks. 
The main cause of DII in SAH patients is the development of vasospasms—
spontaneous spasms in cerebral blood vessels leading to vasoconstriction—
which have a high rate of mortality and must be treated aggressively 
(Crowley et al 2011). The risk of developing vasospasm following aneurysmal 
SAH appears to be related to blood clot burden, and is likely triggered by an 
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inflammatory response within the blood-vessel wall that manifests sometime 
between days 4 and 12 post-SAH. The fact that the amount of blood seen on 
the initial CT scan is the best predictor of the occurrence of vasospasm in 
aneurysmal SAH (Hijdra et al 1988) also suggests that vasospasm induction 
is blood-mediated. Cerebral vasospasm can also occur in TBI, and while the 
importance of vasospasm in aneurysmal SAH has been well-studied, 
considerable controversy surrounds the exact relationship between TBI and 
vasospasm (Werner and Engelhard 2007). Unlike in SAH, where vasospasm 
seems to be directly related to factors released by the blood clot, TBI-related 
vasospasms are frequently detected in patents without CT evidence of 
bleeding (Taneda et al 1996). This calls into question whether all vasospasms 
share the same pathophysiology, and underlines the challenge in managing 
patients for whom vasospasm-related complications may not be easily 
predicted based on CT imaging. 
1.2.2. Clinical management 
There is a growing body of evidence that suggests that the NCU has 
improved both survival and outcome in patients with ABI (English et al 2012; 
Varelas et al 2006). For example, a reduced mortality rate following 
intracerebral hemorrhage was observed in patients admitted to NCUs 
compared to general intensive care units (Diringer and Edwards 2001). 
Improvements in patient recovery has been principally due to the NCU’s 
ability to manage the complications associated with secondary brain injury, 
which combine standard clinical practice of intensive care medicine with 
interventions that target specific complications such as elevated ICP, reduced 
CBF, and hemorrhage. 
 Osmotherapy is considered the first-line method for managing raised 
ICP and involves the rapid infusion of mannitol or hypertonic saline. 
Mannitol, a crystalline sugar alcohol, creates an osmolar gradient in the 
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brain, drawing water across the blood-brain barrier (Muizelaar et al 1984). A 
similar ICP-lowering effect is achieved by the infusion of hypertonic saline. 
When administered repeatedly, osmotherapy can be an effective means to 
manage raised ICP, notwithstanding the additional risks that require careful 
monitoring of electrolyte status and serum osmolarity. In addition to 
osmotherapy, decompressive craniectomy can be used to reduce ICP. 
Decompressive craniectomy involves removing part of the skull to allow the 
expansion of the brain parenchyma in the presence of uncontrollable elevated 
ICP. Despite being used for more than a century to manage brain swelling 
and ICP, its current use is controversial. Several previous studies (Hofmeijer 
et al 2009; Vahedi et al 2007; Jüttler et al 2007) reported neutral findings, 
and while a meta-analysis of these studies suggests a benefit to craniectomy 
in certain patient subgroups, further research is needed before routine 
decompression craniectomy can be recommended (Mitchell et al 2009). 
 While there is no general consensus on the treatment or prevention of 
DII following SAH, current treatment recommendations include prophylactic 
nimodipine (Barker et al 1996), along with the so-called "triple H" therapy 
(hypervolemia, hypertension, and hemodilution) (Weyer et al 2006). The 
motivation behind these treatments is to prevent contraction of cerebral 
arterial smooth muscle cells and/or to counter the effects of increased 
vascular resistance by increasing cerebral perfusion pressure and reducing 
blood viscosity. For instance, nimodipine, a dihydropyridine-type calcium 
channel blocker, inhibits the influx of extracellular calcium which acts on 
smooth muscle cells to effect vasoconstriction. As a standard-of-care, the only 
proven therapy for vasospasm is nimodipine (Weyer et al 2006); however, 
"triple-H" therapy may be indicated for individual patients on a case-by-case 
basis. 
 In addition to the management of DII, best evidence-based practices 
generally indicated for intensive care patients remain important for 
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neurotrauma patients. These include ensuring optimal oxygenation through 
proper ventilation, maintaining appropriate levels of glucose and nutrition, 
and monitoring temperature homeostasis. In particular, the injured brain is 
thought to have low tolerance to hypoglycemia, and is a concern unique to 
neurocritical care (Vespa et al 2006). 
1.3. Assessing delayed ischemic injury 
1.3.1.  Current clinical methods 
While many of the management options discussed in the previous section are 
effective in alleviating some of the deleterious complications that develop 
during recovery, a principle challenge is detecting the onset of DII in NCU 
patients. First, it is often difficult to differentiate between clinical features 
resulting from the primary injury and those symptoms that develop 
subsequently. Early signs of DII present as general neurological defects or 
reduced consciousness, which can also be attributed to other causes (e.g., 
effect of sedatives, hypotension, heart failure). In addition, many NCU 
patients are comatose or heavily sedated, and clinical features are unreliable 
for these individuals (Vergouwen et al 2010). 
 Electroencephalography (EEG) is used to monitor cerebral electrical 
activity (i.e., voltage fluctuations that result from neuronal activation in the 
cortex). Several studies have investigated the use of EEG to detect DII in 
SAH patients (Vespa et al 1997; Claassen et al 2004a) and TBI (Claasen et al 
2004b), in part by identifying clinical features associated with energy failure. 
In particular, epileptic activity, which can be accurately detected using EEG, 
could exacerbate brain energy impairments and increase glutamate-mediated 
excitotoxicity (Vespa et al 1998). As well, a relationship between increased 
seizure activity and cerebral hyperglycolysis has been documented in several 
studies (Engel et al 1983; Evans et al 1984; Theodore et al 1983). 
Hyperglycolysis, which occurs acutely after severe TBI, is indicative of 
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impaired oxygen metabolism and can also occur during a major reduction in 
CBF (Bergsneider et al 1997). In general, SAH and TBI produce a wide 
variety of EEG abnormalities, some of which may be predictive of DII 
(Rivierez et al 1991; Claassen et al 2004). However, in all cases, large sets of 
EEG data must be interpreted by an expert, which is time consuming and 
subjective, making general clinical thresholds for directing patient therapy 
unlikely. 
 Intracranial pressure monitoring has become a mainstay of the NCU 
as a standard surrogate of CBF. Because these methods are invasive, their 
use is generally limited to poor-grade SAH (Wartenberg 2011) and severe TBI 
(Brain Trauma Foundation 2008). Being a surrogate of CBF, there is 
considerable controversy surrounding its use in directing patient therapy, 
since large variations in optimal thresholds are likely to exist due to 
differences in cerebral autoregulation (Jaeger et al 2007). Four randomized 
clinical trials reported no significant relationship between ICP monitoring 
and survival in TBI patients (Mauritz et al 2007; Mauritz et al 2008; 
Thompson et al 2008; Griesdale et al 2010), and two additional studies 
demonstrated conflicting results (Lane et al 2000; Shafi et al 2008). A 
sytematic review of these studies found that the benefit of routine ICP 
monitoring in severe TBI is not established and further research is needed 
(Mendelson et al 2012).  
The gold standard in the diagnosis of vasospasm is cerebral 
angiography, despite having a specificity of only 50% (Uterberg et al 2001). In 
addition to angiography, vasospasm is monitored using transcranial Doppler 
(TCD), which can detect elevated blood flow velocities that occur with vessel 
narrowing (Sloan et al 1989). However, like in the case of ICP monitoring, 
vessel narrowing is only a surrogate of CBF, and not all patients with 
vasospasm develop DII (Vergouwen 2011). Furthermore, DII can occur in 
regions where large-vessel narrowing was not observed, but regional 
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hypoperfusion and oligemia were nevertheless present (Dhar et al 2012). 
Taken together, these studies suggest that vessel narrowing detected by 
angiography, or the resulting elevated blood flow velocity detected with TCD, 
are not reliable markers of DII, especially when neurological assessment is 
unavailable (Vajkoczy et al 2003). 
 Recently, thermal diffusion flowmetry (TDF) has been described as a 
potential method to measure absolute CBF and has been validated against 
XeCT in adult sheep. (Vajkoczy et al 2000). While the ability of TDF to 
measure CBF in absolute units is a positive step, the TDF technique is 
invasive, requiring microprobes to be inserted directly into the cortical 
parenchyma. The degree to which this might result in complications, such as 
intracerebral hemorrhage or infection, is not yet known. Another limitation of 
this technique is that it is only able to provide local CBF measurements from 
a very small region of tissue. As such, a single microprobe placed in the 
region of brain most susceptible to SAH-related vasospasm could miss up to 
20% of cases (Vajkoczy et al 2003), likely requiring the placement of multiple 
microprobes with additional patient risk.   
 Finally, xenon-enhanced computed tomography (XeCT) has emerged as 
a promising method of measuring CBF in NCU patients (Yonas et al 1996), in 
part due to the advent of portable CT units that can be used at the patient 
bedside (Kim et al 2009). Like other CT perfusion methods, XeCT provides 
only a single snapshot of CBF and the use of ionizing radiation, as well as the 
expensive nature of inhaled xenon gas, precludes its use for frequent serial 
measurements. 
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1.3.2.  Clinical value of measuring cerebral blood flow 
In a normal, healthy adult, CBF is maintained by autoregulation at 
approximately 50 ml min-1 100g-1. However, in pathological conditions, 
autoregulation is disrupted or overwhelmed and CBF can decrease to critical 
levels. When this occurs, depletion of high-energy phosphates—the brain’s 
energy stores—occurs rapidly. If CBF falls below about 17 ml min-1 100g-1, 
electrocortical activity is lost, as evinced by EEG, and increased anaerobic 
metabolism occurs (Sharbrough et al 1973). Further reduction of blood flow 
below 10 ml min-1 100g-1 results in the loss of ion homeostasis (due to failed 
membrane integrity) and leads to an efflux of potassium from neurons. 
Cytotoxic edema and subsequent cell death follow quickly (Astrup et al 1981). 
In addition, the progression of tissue state from ischemia to infarction 
depends on the duration of the insult. For example, extremely low CBF (less 
than 5 ml min 100g) can result in an infarction within minutes. On the other 
hand, when CBF is held at around 18 ml min-1 100g-1, permanent damage 
occurs only after several hours (Astrup et al 1981). This dependency of 
infarction on insult duration has been well established in the treatment of 
acute stroke, where tissue is salvaged by prompt recanalization.  
  As highlighted in the previous section, complications that occur 
following ABI―including elevated ICP from edema, hemorrhage or 
hematoma, and SAH-induced vasospasm―can severely reduce CBF and 
result in DII and poor patient outcome (Rincon and Mayer 2007). Current 
clinical methods to detect DII are limited, and involve monitoring surrogates 
of CBF (e.g., ICP, CPP, blood velocity, etc.). A cursory review of literature 
supports two principle conclusions. First, each of these methods may be 
indicated for certain patients on a case-by-case basis; however, the systematic 
use of any of these techniques is not supported by current evidence. Second, 
emerging evidence supports the use of guideline-driven management of 
severe TBI patents (who present with heterogeneous features that are 
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unreliable for steering intervention) which has been shown to improve 
patient outcome (Griesdale et al 2012). Presumably, measurements of CBF, 
for which well-defined thresholds exist, have the potential of informing these 
clinical guidelines.  
 In an early study by Yonas and colleagues, CBF measurements by 
XeCT were acquired in fourteen SAH patients exhibiting symptoms of 
vasospasm (Yonas et al 1989). Regions of CBF above 18 ml min-1 100g-1 did 
not progress to infarction, whereas areas with CBF lower than 12 ml min-1 
100g-1 resulted in conversion to infarction. For regions between 12 - 18 ml 
min-1 100g-1, infarct conversion was variable. Although the sample size of the 
study was too small to accurately determine optimal thresholds for CBF 
predictive of infarct conversion, the determination of such a threshold could 
enable more individualized treatment to the patients with the most to gain 
(i.e., with CBF values close to the threshold for which infarct conversion is 
variable).  
 Thermal-diffusion flowmetry was used to evaluate regional CBF in 
fourteen patients with high-grade SAH. In each patient, two TDF 
microprobes were inserted into the white matter of regions of the brain 
supplied by the artery that was affected by the aneurysm (which included the 
internal carotid artery, the anterior communicating artery, and the middle 
cerebral artery). Thermal-diffusion flowmetry values of CBF predicted 
symptomatic vasospasm in these patients with 85% sensitivity and 97% 
specificity when a threshold of 10 ml min-1 100 g-1 was used. While the 
threshold used in this study was lower than loss of neuron function 
thresholds (i.e., 18 ml min-1 100g-1)―likely due to the lower blood flow in 
white matter where the probes were implanted―the reliability of TDF 
measurements was greater than TCD. 
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   Most recently, CT perfusion was acquired in 85 SAH patients to 
determine a diagnostic threshold value with optimal sensitivity and 
specificity to DII (Dankbaar et al 2010). Values of CBF and mean transit time 
(MTT) were able to distinguish DII with greater than 70% accuracy. 
However, since imaging was only performed at a single time-point, more 
transient instances of vasospasm may have gone undetected. 
 The handful of studies investigating the ability of CBF measurements 
to predict subsequent development of DII in high-risk SAH patients suggests 
a CBF diagnostic threshold exists, and that a direct assessment of CBF can 
confirm vasospasm and enable aggressive treatment (Powers et al 1985; 
Soucy et al 1990). For this reason, the ability to directly measure CBF in 
patients with SAH has been highly sought by clinicians (Vajkoczy et al 2003). 
While the role of CBF measurements in TBI is less clear, it is well 
established that CBF less than 18 ml min-1 100g-1 is present in about one 
third of TBI cases, and is correlated with poor outcome and early mortality 
(Bouma and Muizelaar 1995). Given the importance of proper stratification of 
patients in the randomized clinical trials of future therapies for ABI, CBF 
thresholds are likely to have an important role. The limitations of current 
methods highlight the need for a non-invasive bedside technique to measure 
CBF in NCU patients. Dynamic contrast-enhanced NIR techniques are well 
suited to this goal, and the remainder of this chapter will provide the 
necessary background on DCE methods in general, and in particular, on the 
DCE-NIR method that was developed for NCU applications.  
1.4. Dynamic contrast-enhanced measurement of 
cerebral blood flow 
1.4.1. History in humans 
The pioneering work in the field of quantitative CBF measurement was 
accomplished largely by Kety and Schmidt, who in 1945 described a method 
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of measuring CBF based on the Fick principle (Kety and Schmidt 1945). This 
method utilized the highly diffusible gas nitrous oxide as a blood flow tracer. 
Cerebral blood flow was calculated by measuring the time-varying 
concentration of nitrous oxide in arterial blood and venous blood samples 
from the jugular bulb. A significant advancement in CBF measurements was 
achieved using radiolabeled 85Kr instead of nitrous oxide, as this provided a 
means of assessing regional CBF by placing scintillation counting devices at 
various locations on the scalp (Lassen and Munck 1955). This approach was 
further improved by the use of radioactive 133Xe, and through the work of 
Obrist who modified the Kety-Schmidt equation to account for three tissue 
compartments: extracerebral tissue, gray matter (which has a higher blood 
flow (BF)), and white matter (which has a lower BF) (Obrist et al 1967). 
Furthermore, the arterial input function (AIF) could be determined non-
invasively from end-tidal 133Xe measurements instead of requiring carotid 
artery catheterization, making the technique more desirable clinically. 
Diffusible tracer methods proved very popular in subsequent imaging 
approaches, including the first truly tomographic method of quantifying 
cerebral blood flow achieved using positron emission tomography (PET) and 
H215O (Frackowiak et al 1980). 
 Around the same time, Axel published the theoretical groundwork for 
DCE CT that implemented a sequence of scans following an intravenous 
bolus injection of contrast to determine CBF (Axel 1980). Unfortunately, the 
method required ultrafast acquisition times with little inter-scan delay 
times―something the CT scanners at the time were unable to accomplish. As 
well, the proposed method for analyzing the dynamic CT data relied on a 
number of assumptions and was prone to subject-dependent effects (such as 
the tissue hematocrit level) (Gobbel et al 1990). Nevertheless, the 
groundwork by Axel laid the foundation for CT perfusion, which would 
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receive considerable attention as CT technology and analytical methods 
improved over the next decade. 
1.4.2. Current techniques  
During the 1990s, CT scanners were developed with the capability of 
performing repeat scans with acquisition times of about 100 milliseconds and 
interscan delays of about 1-2 seconds, so that quantitative CBF 
measurements with dynamic CT imaging became feasible (Brix et al 1999). 
As a result, CT perfusion has emerged as a robust, reliable, and accurate tool 
to quantify CBF and is capable of providing parametric maps of CBF as well 
as cerebral blood volume (Cenic et al 2000), mean transit time (Eastwood et 
al 2002), and bolus arrival time (Eastwood et al 2002; Mayer et al 2000). 
Current CT perfusion techniques can be considered variations on the 
methodology outlined by Axel: CT slices are acquired at a high temporal 
resolution during the injection of a bolus injection of contrast agent. The 
analysis consists of reconstructing the time-series of images, defining the AIF 
and voxel or region-of-interest (ROI) specific tissue concentration curves, and 
performing kinetic analysis on these curves to recover kinetic parameter 
maps. Most techniques differ by the manner in which they perform the final 
step of kinetic analysis: mainly, whether they use a compartment-based 
approach (Miles 1991; Mullani and Gould 1983) or deconvolution approach 
(Cenic et al 2000; Eastwood et al 2002). The latter approach will be discussed 
in following section. In addition to CT perfusion, CBF measurements can be 
made using XeCT, DCE magnetic resonance imaging (MRI) (typically in 
conjunction with a gadolinium-based tracer) or with the MRI arterial spin 
labeling (ASL) technique (Wintermark et al 2005). In recent years, there has 
been a rekindled interest in XeCT due to the development of portable and 
intraoperative CT devices (Kim et al 2010). However, limitations of the device 
include the high costs of xenon gas and the use of ionizing radiation (120 
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mGy CTDIw), which makes it unsuitable for bedside measurements of CBF on 
a continual basis.   
1.4.3. Tracer kinetic modeling 
The DCE NIR techniques presented in this thesis, in addition to CT 
perfusion, rely on a bolus injection of a contrast agent to provide 
hemodynamic information about a tissue region-of-interest (ROI). In this 
context, the contrast agent acts as a blood flow tracer, which by definition is a 
substance that behaves in the same manner as blood as it travels through the 
tissue of interest (Lassen and Perl 1979). The transport of the tracer through 
the microvasculature of the tissue can be described by constructing a kinetic 
model and applying it to time-dependent measurements of the tracer 
concentration. For example, the blood flow (F) to an organ can be determined 
using the Fick principle if the time-dependent concentration of tracer in the 
organ, Q(t), in the arterial blood, Ca(t), and the venous blood draining the 
organ, Cv(t), are measured. In this case, the following expression describes 
the dynamic behaviour of the tracer: 
 ).()(
)(
tFCtFC
dt
tdQ
va    (1.1) 
The most common type of model used in kinetic analysis is the Kety model, 
which describes the behaviour of a highly diffusible tracer in a single tissue 
compartment. Compartment models form the basis of the radioactive and 
stable Xenon CT techniques and the radioactive H2O PET methods described 
in the previous section.  
 There is a fundamental problem with applying compartmental models 
to non-diffusible, intravascular tracers (e.g., iodine-based CT contrast agents, 
and optical tracers such as indocyanine green (ICG) that bind to vascular 
proteins) because the intravascular space (IVS) dynamics are much faster 
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than the minimal extravascular space (EVS) component. Therefore, the tissue 
cannot be treated as a single, well-mixed compartment. Instead, it is more 
appropriate to consider the tissue vascular bed as a mesh of microvessels 
supplied by a single input and draining to a single output (Fig. 1.3), where 
each possible path from the artery to the vein has a specific transit time. In 
this case, the concentration of tracer in the tissue at a given time point is a 
function of its collective path through the capillary bed, as well as the AIF.  
 
Figure 1.3: Blood flow through a capillary bed. 
The convolution theory of kinetics treats the capillary bed as a black box, with an arterial 
input, a venous output, and a transfer function based on the distribution of transit times 
required by possible paths through the mesh. 
The path that a particular tracer molecule takes is nondeterministic, 
but a distribution of transit times, h(t), can be described for a bulk set of 
tracer molecules (Meier 1954). This distribution describes the effect of a time-
invariant linear system on the input, Ca(t), such that the venous output can 
be modeled as: 
 ,)()()(
0
 
t
av duuthuCtC   (1.2) 
where u is a dummy variable in the convolution. Equation 1.2 provides a 
definition for Cv(t) that is not dependent on any modeling assumptions, such 
as instantaneous equilibrium, and by substitution, Eq. 1.1 becomes: 
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where * represents the convolution operator. To simplify Eq. 1.3, a more 
convenient and closely related function, R(t), called the impulse residue 
function is used to describe the dynamics of the system. R(t) is defined as the 
fraction of dye remaining in the system at time, t, following the injection of 
an idealized bolus (i.e., a Dirac delta function), and is given by: 
 ,)(1)(
0

t
duuhtR   (1.4)  
Substituting R(t) for h(t), Eq. 1.3 becomes 
 ).()()( tFRtCtQ a    (1.5) 
A deconvolution method (also called nonparametric analysis) is used to solve 
Eq. 1.5, and does not require any explicit assumptions regarding the 
underlying behaviour of the tracer beyond that required by the definition of a 
linear time-invariant system. In other words, knowledge of the number 
compartments and their distribution volumes are not necessary. However, 
deconvolution is a mathematically difficult problem from the perspective of 
real data analysis. In particular, even small amounts of noise in the 
measured functions Ca(t) and Q(t) are amplified during linear inversion due 
to the ill-conditioned nature of the inverse problem. Consider the matrix form 
of Eq. 1.5 following discretization: 
    RCQ AF   (1.7) 
where the arterial input function, Ca(t), is now represented by the Toeplitz 
matrix: 
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The function FR(t) can be solved in a least squares sense by optimizing: 
  2minarg QRCA
R
F
F
  (1.9) 
where is the Euclidean norm. Because of the redundancy of information in 
CA, the problem is ill-conditioned, and minimization of Eq. 1.9 is highly 
susceptible to experimental noise. A complete discussion of rank-deficient and 
ill-posed problems is outside the scope of this thesis, but the reader is invited 
to refer to (Hansen 1987) for more information. To stabilize the minimization 
of Eq. 1.9, a number of options exist including truncated singular value 
decomposition, Tikhonov regularization, and mathematical constraints based 
on a priori knowledge (Dehghani et al 2007). All three methods have benefits 
and limitations depending on the information that is desired. Since this 
thesis is mainly concerned with the measurement of blood flow, it is assumed 
that the principle parameter of interest is F. As previously mentioned, the 
nonparametric method is useful when an explicit mathematical model of R(t) 
is unavailable. However, there are some basic assumptions about the shape 
of R(t) that can be inferred from an understanding of the basic physiology of 
microcirculation that are unlikely to be violated even under pathological 
conditions, and these form the basis for mathematical constraints that help 
stabilize the deconvolution (Lee 2005). These assumptions are: 
(i)  Tracer injected into a periphery vein will require a minimum 
amount of time to travel to the heart and be pumped to the 
tissue region-of-interrogation. 
.
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(ii)  R(t) represents the residue function of a Dirac delta function; in 
this unique case, the entire bolus of dye would reach the tissue 
at a single instant in time.  
(iii)   In addition to (ii), there would be a finite amount of time before 
the first molecule of dye left the region of interrogation. 
(iv)  The dye must enter the tissue via an artery and exit via a vein 
(i.e., no retrograde flow will occur). 
These assumptions, which are all derived from a basic understanding of 
physiology, will be satisfied under almost any clinically relevant condition; 
however, from a mathematical point-of-view, they can be used to construct 
rigid and powerful constraints that provide stability to the deconvolution. 
Assumption (i) defines a finite delay between the injection and appearance of 
dye, called the lag time, L, during which Q = 0. Assumptions (ii) and (iii) 
defines a plateau equal to unity that begins after L time, and lasts for a finite 
period of time called the minimum transit time, M. These provide the 
equality constraints for R(t), mainly   
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Assumption (iv) essentially implies that R(t) must be monotonically 
decreasing, that is 
 MLt
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  (1.11) 
Finally, since there is no physical representation of negative tracer amount, 
R(t) must be non-negative for all t. This final constraint enables the use of 
the non-negative least-squares (NNLS) numerical method (Lawson and 
Hanson 1974). The nonparametric method described above has been 
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validated in CT perfusion using microspheres (Cenic et al 1999). For the 
studies in this thesis, MATLAB was used to minimize Eq. 1.9 subject to the 
inequality and equality constraints outlined above. 
To a large degree, the use of DCE methods to measure CBF—and 
tracer kinetics in general—have been confined to more established medical 
imaging modalities such as CT, PET and MRI. However, in recent years, 
kinetic modeling has been increasingly used in optics in combination with 
light absorbing dyes. A major benefit of most optical techniques is that data 
can be collected at high temporal resolution and with a high signal-to-noise 
ratio (SNR). As a result, DCE methods are well suited to applications in 
optics, and recent studies have established biomedical optics as fertile ground 
for the advancement of new tracer kinetic methods and applications. In 
particular, the deconvolution method has been used to measure CBF in 
piglets (Brown et al 2002, Tichauer et al 2006, Diop et al 2010) and 
premature newborns (Arora et al 2013) and it provides a foundation for the  
analytical approaches used in Chapters 2-6 of this thesis. 
1.5. Theoretical basis of near-infrared methods 
1.5.1. Near-infrared scatter 
Light scatter, (i.e. the deviation of light from a straight trajectory), is the 
dominant interaction with tissue in the near-infrared range between 700 - 
1000 nm. The main causes of scatter in this range are Mie scatter and 
Fresnel reflection. A third type, Rayleigh scatter, represents interaction 
between light and very small particles, and is increasingly important at 
shorter wavelengths of light; therefore, it is outside the scope of this thesis. 
As light propagates through tissue, it interacts with cell membranes, tissue 
boundaries, and organelles; at each interface, light is reflected and refracted 
by these objects, and therefore experiences a deviation in trajectory. The 
majority of scattering in mammalian cells is thought to arise from structures 
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within the cell, i.e. organelles (Mourant et al 1998). Mie scatter characterizes 
the interaction of light with spherical particles of size similar to its 
wavelength, and is described by the Mie solution to Maxwell's equations (Mie 
1908). Most organelles such as nuclei (3-10 μm) and mitochondria (1 μm) can 
be approximated as spheres or ellipsoids, and can therefore be described by 
Mie scatter. 
 A significant portion of scatter in brain tissue occurs by cell 
membranes, which are comprised of lipoproteins (Cope 1991). Since cells are 
significantly larger than the wavelength of NIR light, it is best to consider 
them as a set of randomly oriented flat, dielectric reflecting films (Cope 
1991). The reflection and transmission of an incident plane wave of light as it 
moves between two media of differing refractive indices is described by the 
Fresnel equations. For a single, well defined interface, the amplitude and 
phase of the transmitted and reflected light can be readily determined if the 
angle of incidence and indices of refraction of the two media are known. 
However, it would be impossible to produce an analytical solution for the 
interaction of light between the roughly 1 x 108 cellular interfaces and 
organelles that typically exist within 1 mm3 of tissue (estimated from 
Norazmi et al 1990 and Loud 1968). Instead, the scattering of light is 
described statistically using probability functions and empirically derived 
approximations.  
 The scatter of light in tissue is typically discussed in terms of the angle 
of scatter and the distance between scattering events. The scattering angle is 
most commonly described by the Heyney-Greenstein phase function, which 
was originally developed to describe the angular dependence of light 
scattering by small particles in interstellar dust clouds (Heyney and 
Greenstein 1941). The function describes the probability of a particular 
scattering elevation angle, θ, given the tissue’s anisotropy factor, g:    
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The anisotropy factor, g, is the mean cosine of the scattering angle, and in 
biological tissue, typically varies from 0 to 1. Such probability functions can 
be used to sample the bulk behaviour of light, and form the basis of modeling 
approaches collectively called Monte Carlo methods, which will be further 
discussed in subsection 1.5.4.  
 The average distance between scattering events is described in terms 
of the mean scattering length, ls, of a medium, usually in units of mm. More 
commonly, the scattering property of tissue is defined by the scattering 
coefficient, μs, which is equal to 1 / ls. For a medium with high scatter, such 
as tissue, after a sufficient number of scattering events, a photon has lost any 
knowledge of its incidence angle and can be considered effectively isotropic. 
In this case, the scatter of light can be approximated by a single parameter, 
the reduced scattering coefficient, μs′, which is defined as: 
 ss g  )1(   (1.13) 
In addition, the wavelength dependence of μs′ is well approximated by the so-
called power law: 
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where A and b are constants either empirically determined or predicted by 
Mie theory, depending on the application (Wang 2000). A good understanding 
of the principles of light scatter is essential to any quantitative biomedical 
optical techniques. In particular, the probability function in Eq. 1.12 and the 
description of absorption in the next section form the basis for Monte Carlo 
methods. 
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1.5.2. Near-infrared absorption 
As light propagates through a medium, energy from the incident field is 
transferred to particles in the medium, which are in turn excited to a higher 
energy state. While this excited state is short-lived, the resulting collisions 
that occur between these particles and neighbouring ones results in a 
transfers of energy—for example, by increasing the vibrational mode of the 
particle and therefore the kinetic energy of the system, or by re-emitting the 
light in a different color. This process is known as absorption, and causes a 
reduction in the intensity of a light beam as it travels through the medium. 
The first mathematical description of this process was given by Pierre 
Bouguer in 1729, and later extended by August Beer to include the 
dependency of light absorption not only on the pathlength through the 
medium, but also on the concentration of light absorbing molecules, or 
chromophores, in the medium. The resulting Beer-Lambert-Bouguer Law is a 
given by: 
 ,ln 0 LC
I
I
A     (1.15) 
where I0 is the incident intensity, I is the transmitted intensity, (the log ratio 
of which is A, is the attenuation of light), C is the chromophore concentration, 
L is the pathlength of light through the medium, and ε is the specific 
extinction coefficient. 
Within the NIR range of 700-1000 nm, there are three main 
endogenous absorbers of light: water, hemoglobin, and deoxyhemoglobin. 
Water is arguably the most important, since it is prevalent in biological 
tissue. Although the absorption of NIR light by water is relatively weak 
(about 50 times less than hemoglobin), because of its abundance in human 
tissue it has a significant effect. In particular, the specific absorption of water 
rapidly increases with wavelength after about 920 nm, effectively forming the 
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upper-limit on what is termed the "optical window" of NIR. The concentration 
of water in the adult brain is tightly regulated to a value of 80% by mass 
(Woodard and White 1986).  
Since the pioneering work of Jobsis in the 1970s, hemoglobin and 
deoxyhemoglobin quantification has been a principle focus of many NIR 
techniques. This can be attributed to the unique spectral features of both of 
these chromophores in the NIR, and the clinical importance of hemoglobin in 
being the molecule responsible for the transport of oxygen from the lungs to 
the various tissues in the body. Structurally, hemoglobin is comprised of four 
subunits which are each able to bind a single O2 molecule. Binding of oxygen 
occurs at the heme group—an iron ion held in a porphyrin ring (Caughey et 
al 1975) and induces a conformational change in its tertiary structure, 
resulting in a dramatic change in absorption characteristics. The effect of this 
change can be observed in the difference in specific absorption of deoxy- and 
oxy-hemoglobin depicted in Figure 1.4. In addition to marked differences in 
features at 760 nm and 900 nm, oxy- and deoxy-hemoglobin share an 
isobsetic point at 800 nm (i.e., their specific extinction is equal at this 
wavelength). The difference in absorption spectra between the two 
hemoglobins forms the basis for the ability to determine oxygen saturation, 
for example, in pulse oximetry (Aoyagi 2003).  
 
 
27 
 
Figure 1.4: Specific absorption spectra of H20, Hb, HbO2 and ICG in the NIR range. 
Values for H2O and ICG are adjusted by a factor of 101 and 10-2, respectively, for illustrative 
purposes. Spectra were obtained from (Oregon Medical Laser Clinic 2013). 
1.5.3. Light propagation in tissue 
Light transport, like any propagation of electromagnetic radiation, is 
governed by Maxwell’s equations. In this paradigm, a beam of light interacts 
with an object resulting in elastic scattering (i.e., the spreading of energy in 
all directions at the frequency of the incident beam), as well as absorption 
(i.e., the conversion of incident energy to other forms such as heat). The 
resulting scattered field can undergo subsequent interactions with other 
objects. In a highly complex, multiple scattering regime, analytical solutions 
to Maxwell’s equations become intractable (Wilson and Jacques 1990). 
Furthermore, to determine the superposition of multiple scattered fields, it is 
necessary to know the exact location of each scatterer. In tissue, due to 
Brownian motion, the scatterers exist in randomized positions. Therefore, it 
is more appropriate to consider light as comprised of individual photons that 
are absorbed or scattered by discrete random particles. This description of 
light is governed by the radiative transfer equation (RTE), which is given by: 
28 
 
              stSdssPstLstLstLsstL
t
ssa ˆ,,ˆ,ˆˆ,,ˆ,,ˆ,,ˆˆ,,
1
4
rrrrr 






 
   (1.16) 
and describes the propagation of radiance  stL ˆ,,r  in the medium as a 
function of the position r, moving in direction , at time t. Other parameters 
include υ, the velocity of light in the medium, μa and μs, (the absorption and 
scattering coefficients, respectively),  ssP ˆ,ˆ , the scattering phase function,  
 stS ˆ,,r , the source term, and ,d  the solid angle around sˆ . 
 To obtain analytical solutions specific to a particular problem, 
boundary conditions are applied to the RTE. The most common solution in 
the field of tissue optics is the diffusion approximation (DA). In the DA, it is 
assumed that the source of light is an isotropic point source, and that 
scattering within the medium is isotropic. This greatly simplifies Eq. 1.16, by 
eliminating the dependency on , and by reducing the phase function to a 
constant (1/4π). However, for short source-detector distances, and for complex 
arbitrary media, the diffusion approximation can be inaccurate. A statistical 
approach, rather than an analytical solution, can provide a powerful means of 
sampling the RTE while incorporating effects of anisotropy. These solutions 
are known as Monte Carlo methods.  
1.5.4. Monte Carlo modeling 
Monte Carlo simulations are a ubiquitous statistical approach used in a 
variety of applications―e.g. nuclear physics (Anderson 1986), computational 
biology (Huelsenbeck and Ronquist 2001), pricing financial derivatives 
(Glasserman 2003)―when a closed-form expression is unavailable or 
prohibitively difficult to formulate. Monte Carlo methods to model light-
tissue interactions were introduced in 1983 by Wilson and Adam, and 
sˆ
sˆ
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modifications were made by various groups, before the publication of the 
Monte Carlo modeling of photon transport in multi-layered tissues (MCML) 
which forms the foundation of almost all modern Monte Carlo light 
propagation models (Wang et al 1995). Monte Carlo methods define 
probability functions that describe the expected values of parameters—i.e., 
length between scattering events, direction of scatter and absorption—that 
describe the interaction of light with tissue. For a simulated photon of light, 
these probability functions are repeatedly sampled until the photon is either 
detected by a hypothetical photodetector, or absorbed by the medium. Then, 
the process is repeated for a large number of photons, typically 108, to 
describe the fluence and flux of light in terms of spatially and/or temporally 
dependent functions. To increase computational efficiency, some 
simplifications are made that are not believed to affect the overall outcome of 
the simulation. For example, photons are considered as "packets" which loose 
a portion of their energy with each scatter event, and following each scatter 
event, a photon continues, or is "killed"—with an increased likelihood of 
being killed as its energy diminishes. Another implicit assumption is that 
photons are independent of each other, and therefore, do not interact.  
 The MCML algorithm is divided into a series of decisions representing 
physical interactions. For example, a photon packet is launched from a source 
at a position and direction specified by the user. The first calculation 
determines the photons step size (i.e., the distance from source to the first 
scattering event). To understand how this is done, recall the definition of the 
scattering coefficient from the previous section, which describes the expected 
number of scattering events per unit length. Since each unit length is 
expected to interact with a constant fraction of photons, a series of successive 
unit lengths will result in an exponentially decaying number of photons that 
have not been deviated from their trajectory. The probability of a photon 
having a step-size, s, is given by 
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This non-uniform probability function can be sampled with a computer-
generated pseudorandom number using the following relationship (Wang and 
Wu 2007): 
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where ξ is a pseudorandom number in the interval 0 to 1. Substituting the 
probability function from Eq. 1.17 into Eq. 1.18, integrating, and replacing (1- 
ξ) with ξ on the basis that ξ is symmetrical about 0.5, yields  
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This provides a sampling function for the step-size of a photon packet moving 
through a semi-infinite turbid medium (Wang et al 1995). In addition to the 
photon step size, the direction of scatter must be determined by sampling the 
azimuth angle, , and the elevation angle . The manner in 
which Monte Carlo treats the directionality of scatter differentiates it from 
the DA and produces more accurate solutions in cases where the DA 
assumptions are invalid. The azimuth angle is sampled uniformly over the 
defined interval, but the elevation angle is determined by sampling the 
Henyey-Greenstein function that was introduced in subsection 1.5.1. 
Applying Eq. 1.18 to the phase function in Eq. 1.12,  
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Each successive scattering event causes a reduction in the weight, W, or 
energy of the photon packet, represented by a fraction of its initial weight. 
The reduction in weight, ΔW, is calculated by  
 WW
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By sampling these three functions, Monte Carlo methods allow the user to 
provide the optical properties (μa, μs, and g) of the tissue, and calculate the 
fluence distribution (spatially or temporally) in the medium. In addition, the 
pathlength of light can be summed for each photon packet and the mean 
partial pathlength (MPP)—i.e., the average pathlength of light in each 
region, or tissue type—can be recorded.  
 Small differences exist in between Monte Carlo methods in terms of 
how they handle reflection at boundaries (Fresnel reflection), layers or 
arbitrary geometries, detection of photons by a virtual photodetector, and 
parallelization or scalability. In Chapter 2, the Monte Carlo method used in 
the reported study was based upon the MCML code, and was written in 
house using the C++ programming language, so that it could be run on a high 
performance computing architecture called SHARCNet. In subsequent 
chapters, the Monte Carlo eXtreme (MCX) method by Fang is used. This 
algorithm is based on the earlier tMCimg algorithm by Boas and colleagues, 
which advanced the MCML algorithm to allow modeling of photon 
propagation in 3D segmented image volumes. The MCX method is essentially 
tMCimg written in such a way that enables the use of graphics processing 
units (GPUs) to run multiple instances of Monte Carlo in parallel. Because 
each simulated photon packet is treated as an independent event, the Monte 
Carlo problem is highly parallelizable; the first report of MCX demonstrated 
an acceleration of about 300 times on a GPU capable of 500 GFLOPS. The 
performance of GPUs has increased at a rate much greater than that of 
32 
central processing units, and at the time of the writing of this thesis, 
commercially available GPUs for personal computing use are capable of 2000-
4000 GFLOPS. For a typical MCX simulation on an MRI human head atlas 
(Fang and Boas 2009), 108 photon packets could be simulated in 47.5 − 95 
seconds. 
1.6. Near-infrared measurements in adults 
1.6.1. Extracerebral contamination  
Near-infrared methods of measuring CBF have been successful, especially in 
neonatal applications (Arora et al 2013; Brown et al 2008; Edwards et al 
1988; Tichauer et al 2009), where the scalp and skull is negligible and the 
head can be thought of as a homogenous region comprised mostly of brain 
tissue. However, when applied to adult subjects, these same methods 
measure signal that is comprised of multiple tissue layers including brain 
and scalp (Fig. 1.5). In some cases, the signal arising from the extra-cerebral 
layers (ECL) can account for more than half the overall signal.  
 
Figure 1.5: Interrogation of adult head with NIR light 
Illustration of the underlying structure of the human head and the typical region of 
interrogation by a NIR optode pair spaced about 30 mm apart. Note the large contribution to 
light absorption by the extracerebral layer. 
Both the scalp and skull are metabolically inactive and therefore poorly 
perfused tissues. For example, the blood flow in the scalp is about 1/10th that 
of the brain (approximately 5 ml min-1 100g-1). As a result, single-probe NIR 
measurements acquired on the surface head, without accounting for 
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contamination from the ECL, produce CBF values that are significantly 
underestimated (Gora et al 2002). Figure 1.6 demonstrates the relationship 
between extracerebral thickness and brain signal percentage, determined 
using Monte Carlo simulations. To minimize the errors caused by ECL 
contamination, it is necessary to increase cerebral signal sensitivity and 
remove ECL signal contributions through some type of reconstruction 
method. 
 
Figure 1.6: Effect of extracerebral layer thickness on brain sensitivity. 
The effect of increasing ECL thickness on the percent contribution of brain tissue to the total 
differential pathlength for a 30 mm source-detector distance, as determined by two-layer 
Monte Carlo simulation. The ECL was assumed to comprise 60% scalp, 30% skull, and 10% 
CSF, and optical properties were taken from Strangman et al 2003. 
1.6.2. Increasing cerebral sensitivity 
Increasing the sensitivity to changes occurring in cerebral tissue reduces the 
amount of ECL contamination, thereby helping to differentiate signals from 
the ECL and the brain. This can be achieved through a combination of 
instrumentation improvements and more sophisticated analytical methods, 
which will both be discussed in this section. These advancements form the 
crux of this thesis, as detailed in the research objectives presented in Section 
1.7. 
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Instrument-based solutions 
The penetration depth of light increases as a function of source-detector 
distance; therefore, the easiest method of increasing sensitivity to the brain is 
by moving the detector optode further from the source. However, the flux of 
photons across the surface of the head rapidly decreases with source-detector 
distance representing an important trade-off that must be considered (Fig. 
1.7) 
 
Figure 1.7: Effect of source-detector distance on brain sensitivity and photon count. 
The effect of increasing source-detector distance on the percent contribution of brain tissue to 
the total differential pathlength assuming an ECL thickness of 10 mm. The flux of photons 
exiting the surface decreases almost 5 orders of magnitude over the range of source-detector 
distances. 
Practically, a source-detector upper-limit of 40 mm is imposed by 
signal-to-noise considerations for most current systems that use emission and 
detection optodes comprised of fiber bundles with an active area on the order 
of 400 um in diameter. However, a recent study avoided the substantial loss 
of signal that occurs during fiber transmission by placing a photodetector 
directly on the surface of the head (Liebert et al 2011). In addition to 
minimizing fiber loss, this had the effect of increasing the active area 
diameter of the optode from 400 um to 8 mm, the diameter of the 
photocathode.  
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 A logical extension to the single channel approaches that have been 
discussed is to deploy multiple optodes and collect data from these channels, 
simultaneously. This multi-distance, multichannel or depth-resolved 
approach allows the separation of information into superficial and deep 
components on the basis that light penetration increases with source-detector 
distance. It is important to note, however, that due to the diffuse nature of 
light, large source-detector distances only increase the proportion of signal 
from the brain and don't eliminate the ECL contribution all together. 
Nevertheless, by collecting information at multiple distances simultaneously, 
it is possible to separate out information in terms of tissue layers, using an 
optical reconstruction approach. 
 The development of time-resolved methods have greatly improved the 
amount of information that can be acquired with a small number of optodes 
and have opened up new avenues of exploration in terms of data analysis 
(Diop et al 2010; Diop and St. Lawrence 2012). Time-resolved NIR methods 
are photon counting techniques that use a laser light source to emit pulses of 
monochromatic light and fast detectors to measure the time-of-flight of each 
detected photon (i.e., the time required for a photon to travel from the laser to 
the photomultiplier tube). This process is repeated, typically at a frequency of 
around 80 MHz until about 107 photons are measured, and a histogram 
called the distribution of times-of-flight (DTOF) is generated. Figure 1.8 
shows a representative example of a DTOF collected on the surface of an 
adult pig head. A series of DTOFs, resolved to typically 1024 time-bins, can 
be collected continuously during the injection of a contrast agent at a rate of 
about 2.4 Hz across multiple detectors simultaneously, representing a 
staggering amount of information. Furthermore, because photons with longer 
times-of-flight are more likely to have visited deeper tissue than those with 
very short times-of-flight, selecting later time-bins has the effect of increasing 
brain sensitivity. Combining some or all of these technologies results in a rich 
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dataset full of information about the hemodynamics of the underlying brain 
tissue. However, only with well-developed analytical tools can this 
information be processed to yield accurate and quantitative measurements of 
CBF. The closely related concept of frequency-domain (FD) NIR provides 
analogous information to time-resolved NIR if measurements are collected 
across a range of modulation frequencies Mei et al, 2013). However, 
commercial FD systems typically use only a single modulation frequency. 
 
Figure 1.8: Distribution of time-of-flight and instrument response function. 
The DTOF and IRF for measurements acquired with a 20 mm source-detector distance on an 
adult pig with an ECL thickness of 10.5 mm. Note the presence of an after-pulse in the IRF, 
defined as an increased probability of a photon being detected after an initial detection event, 
and is observed in almost all conventional PMTs.  
Analytic-based solutions 
Perhaps the simplest approach to incorporating multi-distance NIR 
information was proposed by Schytz and colleagues, in a technique that 
exploits the different amounts of ECL and brain signal contribution present 
in short (10 mm) and long (30 mm) source-detector distances (Schytz et al 
2009). In this approach, the change in optical density in the brain was 
calculated by scaled subtraction of the short source-detector distance signal 
from the long source-detector distance signal. While the approach represents 
a good first step in trying to use multi-distance NIR measurements to isolate 
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the brain signal, the scaling factor was based on an assumed value and 
applied to the group as a whole. Therefore, the amount of intra-subject 
variability likely impacted the results of the study, which did not show 
sensitivity of NIR measurements to changes in CBF. A more robust approach 
is to properly model the light propagation in the head for each subject 
separately. This approach was used in the study highlighted in Chapter 2 of 
this thesis. While collection of CW NIR information at multiple distances can 
provide a limited ability to separate out the brain contribution to the signal, 
TR NIR offers an exquisite amount of information even in a single or few-
channel approach. However, the main problem with TR NIR data is that the 
experimental DTOFs represent the convolution between the instrument 
response function (IRF) and the tissue impulse function (TIF). Although the 
IRF can be measured independently, the recovery of a TIF from the DTOF 
requires deconvolution of the signal; a challenging mathematical problem 
that has only recently been addressed successfully (Diop and St. Lawrence 
2012). Therefore, the proper analysis of DTOFs to exploit the sensitivity of 
late-arriving time-bins has been challenging. An elegant approach was 
proposed by Liebert and colleagues, and involves determining the statistical 
moments of DTOFs―intensity, mean time-of-flight, and variance―effectively 
reducing the large dataset into three "principle components" (Liebert et al 
2004). The kth order moment of the DTOF, N(t), is defined as 
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where t1 and t2 are temporal integration limits. In addition to reducing the 
size of the problem set, the influence of the IRF can be removed by using the 
change in the normalized moments: 
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The change in attenuation, ΔA, change in mean time-of-flight, , and the 
change in variance, ΔV, are the principle moments used in moments-based 
TR NIR methods. Theoretically, there is no limit to the number of moments 
that can be used, however, noise increases significantly with order of 
moment. Conceptually, the relationship between moment order and brain 
sensitivity is not as straightforward as when considering the time bins of the 
DTOF. However, in general, the sensitivity of brain tissue is highest in 
higher order moments because changes in the tail of the TPSF have a more 
dramatic effect on the width and skewness of the distribution. Figure 1.9 
shows the sensitivity of attenuation and variance to layers located at depths 
of 1, 5 and 9 mm. Note, the sharp increase in the sensitivity of variance to the 
9 mm layer for source-detector distances greater than 30 mm.  
 
Figure 1.9: Moment sensitivity factors as a function of source-detector distance 
(A) The relationship between source-detector distance and mean partial pathlength, the 
sensitivity factor for attenuation, and (B) the relationship between source-detector distance 
and variance sensitivity factor, corresponding to depths of 1 mm (solid black line), 5 mm 
(solid grey line) and 9 mm (dashed black line). Reproduced from Liebert et al 2004.  
t
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The sensitivity of a particular moment to a particular tissue region below the 
surface of the head is represented by its sensitivity factor. Sensitivity factors 
can be readily calculated using Monte Carlo simulations (Liebert et al 2004).  
1.6.3. Multilayer reconstruction 
The previous section described a variety of instrument-based and analytical 
approaches to increasing the sensitivity of the detected signal to brain tissue. 
However, proper isolation of the brain tissue signal requires the use of optical 
reconstruction: a general term that describes the recovery of local changes in 
tissue optical properties at a predefined region from a measured signal 
containing contributions from multiple regions. Optical reconstruction forms 
the basis for imaging methods including diffuse optical tomography (DOT) 
and fluorescence molecular tomography (FMT), and is analogous in some 
ways to CT and PET reconstruction. The optical reconstruction forward 
problem is given generally by 
  

 
JN
J
JJJAS
1
,  (1.27) 
where μJ represents the collective optical properties defined for NJ spatial 
regions, and J  is the local variations in optical properties responsible for 
the variation S  in the detected signal  associated with the background 
properties J . The transformation between these two variations is given by 
AJ, also called the Jacobian. Optical reconstruction is performed by 
minimizing the difference between the experimental measurements of , 
and the predictions of the model based on the update equation (Eq. 1.27). 
Essentially, all optical reconstruction methods can be broken down into four 
considerations: (i) selection of linear or nonlinear solver, (ii) definition of the 
signal domain, (iii) calculation of the Jacobian, and (iv) availability of a priori 
knowledge or "priors". 
S
S
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 Typically, DOT involving large variations in μa and μs must be solved 
with nonlinear iterative solvers. However, in the DCE-NIR methods 
described in this thesis, an assumption of linearity is made between the 
measured signal and the change in absorption caused by the introduction of 
tracer. This assumption is valid under the concentrations used in DCE 
methods, based on the fact that ICG has a negligible effect on scattering 
(Kuebler et al 1998) and its effect on the optical pathlength is negligible. The 
signal domain is defined primarily according to the spatial location of source 
and detector pairs used to construct the signal data. In DCE measurements 
acquired on the surface of the head, spatial information is typically simplified 
by using source-detector distance, ρ. The signal domain can be further 
divided into dimensions that are specific to the type of instrumentation used. 
For example, in broadband NIRS, signal can be defined according to 
wavelength, λ, as in DOT methods that employ spectral constraints (Corlu et 
al 2005). In the case of TR-NIR, the signal domain can be labeled according to 
time-of-flight, t, or when used in conjunction with a moments-based 
approach, moment order, k. Regardless of how the signal domain, Ω, is 
defined, the Jacobian must be defined accordingly, in addition to being 
defined for each region, J. In optical reconstruction, the Jacobian is 
essentially a matrix comprised of partial derivatives of fluence and flux taken 
with respect to μa and μs′. Therefore, to compute the Jacobian, light 
propagation models are needed. The two principle models―Monte Carlo and 
diffusion approximation, typically formulated as a finite element method 
(FEM) are used. The FEM approach has the benefit of being fast, flexible, 
and accurate under most conditions. As a result, it is the most widely used 
method for FMT reconstruction. Monte Carlo is computationally demanding, 
but more accurate, and calculation of TR DTOF functions is very 
straightforward. Furthermore, Monte Carlo methods for calculating the 
moments-based Jacobians are published (Liebert et al 2004). 
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 The incorporation of priors into optical reconstruction is perhaps the 
most fertile ground for advances in quantitative DOT and FMT methods 
(Pogue et al 2011). The importance of priors can be understood from an 
algebraic perspective, in that optical reconstruction is an ill-posed and often 
underdetermined problem. Therefore, regularization (which is itself, 
fundamentally a prior in that it forces a solution with predetermined 
qualities―i.e. smoothness) and prior-based constraints are essential for 
converging to a unique solution. In recent years, a number of priors have 
been described and each has been implemented in a variety of different ways. 
For example, anatomical priors—information provided by an alternate 
imaging modality such as CT or MRI—can be implemented into the 
reconstruction process as a soft prior using Laplace regularization (Davis et 
al 2007). Another common approach is to use spectral priors to constrain the 
reconstruction of broadband data (Corlu et al 2005). Chapter 5, which is 
based on a paper published in Optics Letters, describes a previously 
unexploited prior based on temporal changes in absorption caused by the 
injection of tracer. This "kinetic prior" was incorporated directly into the 
optical reconstruction problem, in an approach referred to as kinetic 
deconvolution optical reconstruction (KDOR). The standard approach to 
extracting physiological measurements from DCE data is a two-step method 
of first performing image reconstruction and then recovering kinetic 
parameters with subsequent modeling. The use of KDOR mitigated much of 
the loss-of-information that occurs due to the ill-posed nature of 
unconstrained optical reconstruction (Elliott et al 2012). The KDOR approach 
is highlighted in Chapters 5 and 6, and Appendix A. 
1.7. Research objectives 
The goal of this doctoral work is to develop a reliable bedside optical 
technique capable of quantifying CBF in adult patients. It was hypothesized 
that CBF can be measured accurately by correcting for inter-subject 
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variability in tissue anatomy and optical properties. With this in mind, the 
following four objectives were addressed: 
(i) Designing and optimizing a clinically-compatible instrument 
(ii) Developing an analytical framework 
(iii) Developing a clinically relevant ABI animal model 
(iv) Validating the technique against CT perfusion 
Each chapter in this thesis represents a progression toward the central goal, 
by advancing one or more of these objectives. A secondary goal of this thesis 
is to provide the reader with an appreciation for the way in which this 
research has unfolded, by which each study provided an important "piece to 
the puzzle". 
1.8. Thesis outline 
The reminder of the thesis is divided into five chapters outlining published or 
completed studies, and a final concluding chapter. 
1.8.1.  Measuring quantitative cerebral blood flow in a juvenile 
porcine model using multidistance continuous-wave near-
infrared spectroscopy (Chapter 2) 
Advancing CW-NIRS methods from neonatal applications to a juvenile pig 
model with a non-negligible ECL can be achieved by employing multi-
distance measurements. This chapter summarizes the work presented in the 
paper “Quantification of CBF in a juvenile porcine model by depth-resolved 
near-infrared spectroscopy,” published in the Journal of Biomedical Optics in 
2010 by Elliott JT, Diop M, Tichauer KM, Lee T-Y, and St. Lawrence K. The 
proposed depth-resolved approach, which uses an algebraic approach to 
separate signals by depth, is presented alongside with a comparison to a 
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simple-subtraction approach and the single-channel method used in neonatal 
studies. These optical methods are compared to CT perfusion measurements 
as a clinical gold standard.  
1.8.2. Measuring cerebral blood flow changes in adult pigs with 
statistical moments of time-resolved near-infrared 
measurements (Chapter 3) 
A single-channel time-resolved method to measure changes in blood flow 
using statistical moments of the time-of-flight distribution (DTOF) is 
presented. Previous DCE methods using moments have examined the time-
to-peak of the dye concentration curve; a more robust method is presented 
that takes into account variations in the AIF. This method has the benefit of 
being relatively insensitive to uncertainties in optical properties and ECL 
thickness, but provides only a measure of the change in CBF. The work in 
this chapter is based on the paper entitled “Variance of time-of-flight 
distribution is sensitive to cerebral flow dynamics of indocyanine green as 
confirmed by comparing scalp and brain measurements in adult pigs” 
published in Biomedical Optics Express in 2013, by Elliott JT, Milej D, 
Gerega A, Weigl W, Diop M, Morrison LB, Lee T-Y, and St. Lawrence K. The 
work presents a series of animal experiments investigating the influence of 
extracerebral and cerebral blood flow on the proposed blood flow index, and 
represents a straightforward means of tracking CBF changes in a clinical 
setting. 
1.8.3.  Measuring the arterial input function with a standard pulse 
oximeter to facilitate the clinical implementation of DCE 
optical methods (Chapter 4) 
All of the DCE methods described in this thesis require the measurement of 
the AIF—the time-dependent arterial concentration of dye. Currently, this 
can only be measured noninvasively by a pulse dye densitometer, which is a 
specialized device designed to measure arterial blood concentration of 
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indocyanine green. In this chapter, an alternative method is described which 
was first published in “Arterial input function of an optical tracer for dynamic 
contrast enhanced imaging can be determined from pulse oximetry oxygen 
saturation measurements” by Elliott JT, Wright EA, Tichauer KM, Diop M, 
Morrison LB, Pogue BW, Lee T-Y and St. Lawrence K, published in Physics 
in Medicine and Biology in 2012. The proposed method involves using a 
standard pulse oximeter device to measure the AIF, with the goal of 
overcoming practical obstacles to enable the use of DCE optical techniques in 
clinical settings.  
1.8.4. Kinetic deconvolution optical reconstruction: theoretical 
basis and numerical simulations (Chapter 5) 
To leverage the advances in instrumentation described in Chapter 3, a 
completely novel analytical approach was developed to combine the optical 
reconstruction of time-resolved multi-distance data with nonparametric 
kinetic analysis, or deconvolution, used in previous DCE NIR methods. The 
chapter is based largely on the published paper “Model-dependent constraint 
to improve the optical reconstruction of regional kinetic parameters” 
published in Optics Letters in 2012 by Elliott JT, Diop M, Lee T-Y, and St. 
Lawrence K. This paper presents the theoretical derivation of the KDOR 
concept, and demonstrates improved accuracy and precision in simulated 
blood flow measurements in the human head. The KDOR methodology is 
fully described in this chapter, and numerical simulations have been 
expanded for completeness.  
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1.8.5.  Measuring cerebral hemodynamics in an adult pig model of 
ischemia with time-resolved near infrared and kinetic 
deconvolution optical reconstruction (Chapter 6). 
The culmination of instrumentation and analytical advances is presented in 
this chapter, where the DCE TR-NIR method is used in combination with the 
KDOR approach to quantify CBF in adult pigs before and during cerebral 
ischemia. This work, which will be submitted to a peer-reviewed journal in 
the near future, establishes NIR as a potential tool to measure CBF in under 
ischemic conditions. In addition to multidistance time-resolved data collected 
before injection of ICG, segmented anatomical CT images are incorporated 
into an optimization framework to determine the subject-specific Jacobian 
used in KDOR. 
1.8.6. Conclusions and future work (Chapter 7) 
In the final chapter, the most significant findings from the previous five 
chapters are summarized within the context of the stated objectives in 
Section 1.7. In addition, areas of future work are discussed based on the 
findings and limitations determined in the studies. Finally, the principle 
conclusions of the thesis are presented. 
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Chapter 2 
MEASURING QUANTITATIVE CEREBRAL 
BLOOD FLOW IN A JUVENILE PORCINE 
MODEL USING MULTIDISTANCE 
CONTINUOUS-WAVE NEAR-INFRARED 
SPECTROSCOPY 
This chapter is adapted from the work entitled “Quantitative measurement of 
cerebral blood flow in a juvenile porcine model by depth-resolved near-
infrared spectroscopy” by Elliott JT, Diop M, Tichauer KM, Lee T-Y, and St. 
Lawrence K, published in the Journal of Biomedical Optics in 2010. The focus 
of this paper is to extend the quantitative continuous-wave (CW) near-
infrared spectroscopy (NIRS) methods of measuring blood flow to a scenario 
where the extracerebral layer (ECL) is non-negligible: the juvenile pig model. 
The original journal article from which this chapter was adapted can be 
found at http://biomedicaloptics.spiedigitallibrary.org/article.aspx?articleid= 
1103440. 
2.1. Introduction 
The rationale for measuring cerebral blood flow (CBF) at the intensive care 
bedside was explained in Chapter 1. In particular, the ideal monitoring tool 
should be noninvasive, portable, quantitative, and fully compatible with the 
clinical environment. Although dynamic contrast-enhanced (DCE) near-
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infrared (NIR) methods require the injection of indocyanine green (ICG), this 
procedure is considered minimally invasive since intravenous access is 
ubiquitous in the context of intensive care. Furthermore, the dye is extremely 
safe as reflected in the low incidence of adverse reaction (approximately 1 in 
250 000 (Garski et al 1978)). The portability of NIR is attractive, since 
current methods of quantifying blood flow (e.g., CT, MRI, PET) are of limited 
use in intensive care since patients are often unstable and not easily 
transported to imaging suites. In fact, it is estimated that adverse effects 
occur in up to 70% of transfers involving critically-ill patients (Waydhas 
1999). 
 Continuous-wave, broadband, NIRS is a particularly robust technique 
that is compatible with the intensive care environment as it is relatively 
insensitive to ambient light. Dynamic contrast-enhanced NIRS capable of 
measuring CBF employs either a change in arterial oxygenation or a bolus 
injection of the light absorbing ICG. Both methods have been shown to 
provide accurate CBF measurements in animal models and neonates 
(Themelis et al 2007; Tachtsidis et al 2009; Brown et al 2002; Tichauer et al 
2006; Springett et al 2001; Patel et al 1998). However, when applied to 
juvenile or adult subjects, measuring CBF accurately has proven difficult. 
The main reason for the reduced accuracy is the non-negligible effects on the 
near-infrared signal of the ECL, as discussed in the previous chapter. 
Because of the ECL, CBF is substantially underestimated (Owen-Reece et al 
1996; Gora et al 2002; Rothoerl et al 2003). As such, NIRS has yet to develop 
into a clinically feasible method for patients older than a few weeks of age, 
and intensivists continue to rely on invasive subdural CBF techniques or 
intracranial pressure (ICP) probes to infer changes in cerebral 
hemodynamics. Not only do these techniques carry a risk of infection and 
bleeding, evidence suggests that adhering to a set ICP threshold does not 
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always ensure adequate oxygen delivery owing to differences in intracranial 
compliance between patients (Wright 2007; Stiefel et al 2006).  
  This chapter describes a multidistance continuous-wave NIRS method 
enabling depth-resolved measurements to quantify CBF in the presence of 
significant ECL signal contamination. The approach is partly based on a 
previous method for measuring CBF in neonates (Brown et al 2002), but 
depth sensitivity is improved by collecting NIR signal from two detection 
probes placed at different distances from the source. The relationship 
between the depth of light penetration and source-detector distance forms the 
basis for the separation of intra- and extra-cerebral signals (Hongo et al 
1995). Monte Carlo simulations of a two-layer medium were performed using 
subject-specific optical properties and ECL thickness parameters optimized 
from CT anatomical priors and second-derivative spectroscopy measurements 
of water, which was assumed to have a concentration of 80% in the brain. 
Monte Carlo simulation results were then used to determine the mean partial 
pathlengths (MPPs) for each layer and source-detector pair, which were used 
to reconstruct the time-dependent concentration of ICG in brain. The brain 
tissue concentration curve, in addition to the arterial input function, was 
used to recover CBF using a nonparametric model (Cenic et al 1999).  
The set of experiments highlighted in this chapter validates the 
multidistance CW NIRS technique by collecting measurements of CBF with 
NIRS and CT perfusion (Cenic et al 1999) over a range of hemodynamic 
states in juvenile pigs. These results are compared with two other analytical 
approaches: the single-probe method identical to that used in the previous 
neonatal studies (Brown et al 2002), and a simple-subtraction method 
whereby MPP values are assumed for the entire group (Schytz et al 2009). 
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2.2. Materials and methods 
2.2.1. Animal experiment 
The study was approved by the Animal Use Subcommittee of the Canadian 
Council on Animal Care at the University of Western Ontario (AUP #2007-
050-06). Eight juvenile Duroc x Landrace crossbred pigs were delivered from 
a local supplier on the morning of the experiment. The pigs were 
tracheotomized and mechanically ventilated while anaesthetized by 3% 
isoflurane. Cannulae were inserted into each ear for injection of the NIRS 
and CT contrast agents. An additional cannula was inserted into a femoral 
artery for continuous monitoring of arterial blood pressure and to allow blood 
samples to be collected for gas and glucose analysis. Following the surgical 
procedure, isoflurane was reduced to 1.75% and the animals were allowed to 
stabilize for 1 hour before measurements were collected. 
Near-infrared spectroscopy and CT measurements of CBF were 
collected concomitantly over a range of blood flow values. The range was 
achieved by adjusting the respiratory rate in each animal to produce distinct 
levels of arterial blood CO2 tension (PaCO2): hypocapnia (PaCO2 < 28 mm 
Hg), normocapnia (PaCO2 ≈ 40 mm Hg) and hypercapnia (PaCO2 > 50 mm 
Hg). 
2.2.2. Instrumentation  
An in-house developed continuous-wave spectrometer was used to collect 
broadband, near-infrared intensity data (Diop et al 2009). The main 
components of the system included an illumination unit, a multiplexer, and a 
spectrometer consisting of a holographic grating and a cooled charge-coupled 
device. The illumination unit was a 50-W quartz halogen light bulb that was 
bandpass filtered to remove light outside the 600 to 1000 nm range. The 
filtered light was coupled to a 2-m fiber-optic bundle (emission optode) with a 
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numerical aperture of 0.55 and a 3.5-mm diameter active area. The opposite 
end of the emission optode was placed on the scalp of the animal and held in 
position by a specially designed probe holder. Two optical fiber bundles 
(detection optodes) with the same specifications as the emission optode were 
positioned at 10 and 30 mm distances from the emitter to collect light having 
traveled through the multi-layered tissue. Light collected by the detection 
probes was sequentially recorded at intervals of 200 ms using a multiplexer 
as described in detail elsewhere (Diop et al 2009).  
2.2.3  Near-infrared spectroscopic measurements of cerebral blood 
flow 
Cerebral blood flow was measured using a bolus-tracking method that 
requires an intravenous bolus injection of ICG (0.1 mg/kg in 1 ml of sterile 
water), followed by continuous measurements of the time-varying 
concentrations of ICG in arterial blood and brain tissue (Brown et al 2002). 
The arterial concentration, Ca(t),  was measured by a pulse dye densitometer 
(PDD) (DDG-2001 A/K, Nihon Kohden, Tokyo, Japan) and the tissue 
concentration, C(t), was measured by NIRS. Recall from Chapter 1 that the 
two concentration curves are related by the following equation: 
 )()()( tFRtCtC a    (2.1) 
where FR(t) is the flow-scaled impulse residue function and * represents the 
convolution operator. A necessary assumption is that blood flow remains 
constant during the bolus-tracking experiment, which typically lasts about 70 
seconds. An in-house developed deconvolution routine was used to calculate 
FR(t) from the measured arterial and tissue concentration curves (Cenic et al 
1999). 
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2.2.4. Single-probe near-infrared spectroscopy 
If it is assumed that the head is a homogeneous medium—i.e., the 
contribution from the ECL is negligible—then the modified Beer-Lambert 
Law can be used to determine time-dependent changes in the concentrations 
of chromophores in brain from the change in light attenuation, ΔA(λ,t), 
measured from a detector: 
        
n
nn DPLtCtA ,  (2.2)  
In this equation, λ represents wavelength, εn(λ) is the wavelength-dependent 
extinction coefficient of each chromophore (corrected for the wavelength 
dependence of the pathlength  (Cope et al 1991)), ΔCn(t) is the concentration 
change in the ith chromophore, and DPL is the total differential pathlength in 
the medium, averaged across the fitting range 800−880 nm.  Without 
attempting to remove ECL signal contamination, the absolute change in the 
tissue concentration of ICG, C(t), following an injection of the dye can be 
determined from ΔA(λ,t) data acquired at a source-detection distance of 30 
mm. By collecting broadband NIRS spectra, the DPL can be determined by 
second differential analysis using the spectral features of water absorption, 
which are distinct at 740 nm and 830 nm, and assuming a water 
concentration in the brain of 80% (Matcher et al 1994). This single-probe 
homogenous approach is referred to as single-probe (SP) NIRS. 
2.2.5.  Depth-resolved near-infrared spectroscopy  
If the ECL is non-negligible, brain signal can potentially be resolved with 
NIRS by modeling the head as a two-layered medium and simultaneously 
collecting ICG tissue concentration curves from two detection optodes placed 
at different source-detector distances. The modified Beer-Lambert Law can 
be generalized for this collection geometry as follows (Hiraoka et al 1993): 
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       
n j
njnn MPPtCtA ,,   (2.3) 
where ΔA(λ,t) is the wavelength-dependant change in attenuation measured 
by the detector at time t, ΔCn,j is the concentration of the nth chromophore in 
the jth layer, MPPn is the mean partial pathlength of light in the jth layer.  
Depth-resolved measurements can be obtained by collecting signal at 
multiple source-detector distances. Assuming that all other chromophore 
concentrations remain constant during the time that the bolus is measured, 
the concentration of ICG in the jth layer, Cj(t) is related to the change in 
attenuation measured at the ith source-detector distance by: 
       
j
jijicgi MPPtCtA ,,   (2.4) 
Note that this expression is a specialized version of the optical reconstruction 
forward problem (Eq. 1.27). Recovering the layer-specific ICG concentration, 
Cj(t), is achieved by optimizing the following expression:  
     .0subject to minarg
2
,  jjijicgi
C
CMPPCA
j
  (2.5) 
To solve Eq. 2.5, MPPs were estimated from a look-up table generated from 
Monte Carlo simulations for various ECL thicknesses and various ECL 
component (skull, scalp, and CSF) ratios (see subsection 2.2.7). First, the 
thickness of the ECL was measured from a CT anatomical image of the 
subject’s head. Second, a set of potential MPPs were selected from the library 
from simulations that employed ECL thicknesses within 20% of the 
measured value. Third, for each potential set of MPPs, second derivative 
spectroscopy was applied to baseline attenuation data (i.e., attenuation data 
acquired prior to ICG injection) to calculate the concentration of water in the 
brain, CH2O,brain. Finally, the set of MPP values that resulted in a water 
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concentration closest to the assumed value of 80% was selected.  Equation 2.5 
was solved using these MPP values to recover Cj(t). The brain concentration 
curve, C2(t), along with the arterial input function, Ca(t), were deconvolved to 
recover FR(t) from Eq. 2.1. The deconvolution procedure used in this study is 
explained in depth in subsection 1.4.3. This multistep procedure is referred to 
as depth-resolved (DR) NIRS. 
2.2.6.  Simple-subtraction technique  
If anatomical priors are unavailable, it has been proposed that ECL 
contamination can be reduced by calculating a weighted difference in 
attenuation measurements from the two optodes (Schytz et al 2009). In a 
two-distance approach, if the light collected by an optode placed at 10 mm is 
assumed to have interrogated only the ECL and the mean partial pathlength 
of light through the ECL is assumed to be the same for light collected at both 
distances, Eq. 2.4 can be simplified to 
 
   
  DPLr
tAtA
tC
icg
brain




 ,,
)( 12   (2.6) 
where ΔA1 and ΔA1 are change in attenuation measured at 10 mm and 30 mm 
source-detector distances. Values for DPL and r were estimated from the 
literature (Owen-Reece et al 1996); a pathlength factor of 5.9 was chosen (van 
der Zee et al 1992) (corresponding to a DPL of 177 mm for a source-detector 
distance of 30 mm) and the fraction of the DPL through the brain, r, was 
assumed to be 0.35. This value represents the group average determined 
from the Monte Carlo simulations presented in the following section. The 
same values of DPL and r were used to analyze all data sets, irrespective of 
the animal’s ECL thickness. This simple subtraction technique is referred to 
as simple subtraction (SS) NIRS. 
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Table 2.1: Optical properties used in the Monte Carlo simulations 
Medium µs' (mm−1)  µa (mm−1) 
760 nm 830 nm  760 nm 830 nm 
Scalp 0.73 0.66  0.0177 0.0191 
Skull 0.93 0.86  0.0125 0.0136 
CSF 0.01 0.01  0.0021 0.0026 
Brain 1.18 1.11  0.0195 0.0106 
Values are taken from literature (Strangman et al 2003). 
2.2.7.  Monte Carlo Library Generation 
Monte Carlo simulations have been extensively used to model light 
propagation in multi-layered media (Hiraoka et al 1993). To generate the 
MPPs required for equations 2.3-2.5, a Monte Carlo code in C++ was 
programed based on the code first published by Wang and colleagues (1995), 
using the optical properties listed in Table 2.1. A library of MPP values was 
generated for combinations of different ECL thickness (5 to 20 mm in steps of 
1 mm) and relative scalp-to-bone ratios (3:7, 4:6, 5:5, 6:4, and 7:3; effectively 
varying the bulk optical properties of the ECL) at two wavelengths (760 and 
830 nm).  
The use of only two wavelengths to characterize MPP over the fitting 
range was necessary because central processing unit (CPU)-based Monte 
Carlo simulations are time consuming—n.b., graphics processing unit (GPU)-
based solutions (Fang and Boas 2009) were not published at the time this 
study was conducted. These particular wavelengths were used because their 
optical properties for the various extra- and intra-cerebral tissues are well 
documented, and they are also close to a distinct water feature at 740 nm and 
enclose the peak absorption of ICG at 805 nm. Small discrepancies between 
wavelengths was accounted for by correcting ε(λ) for the wavelength 
dependency of pathlength (Cope 1991). 
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 Simulations were performed in parallel on the Shared Hierarchical 
Academic Research Computing Network (SHARCNet) system, a high 
performance computer cluster, and required 4-6 CPU hours per simulation on 
average for 108 photons on a 2.2 GHz CPU core. 
2.2.8.  Computed tomography perfusion imaging 
Computed tomography images of CBF were acquired using a LightSpeed QXi 
multislice CT scanner (GE Healthcare, Milwaukee, WI). Eight 5 mm-thick 
coronal slice scans (80 kVp, 190 mA) were collected at 1 s intervals for 40 s 
upon injection of 1.0 ml/kg of the iodinated contrast agent iohexol (300 mg/ml; 
Omnipaque™, GE Healthcare); the injection rate was 1 ml/s.  
 
Figure 2.1: CT anatomical and perfusion images 
(A) CT anatomical image showing the region of interest (yellow outline) directly below the 
optical probe holder (white arrow). Red dashed lines on probe holder indicate position of the 
optode. (B) Corresponding cerebral blood flow map determined by CT perfusion. 
Parametric maps of CBF were generated from the cine images using CT 
Perfusion 3 software (GE Healthcare). Regions of interest were defined on the 
CBF images that corresponded to the brain volume interrogated by the NIRS 
probes (Figure 2.1A). The thickness of the ECL was measured using 
anatomical CT images acquired at the start of the experiment. Since the 
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probe-holder was visible on the CT image, ECL thickness could be measured 
directly below the location of the optodes (Figure 2.1B). 
2.2.9.  Statistical Analysis 
All data are presented as mean ± SE unless otherwise stated. SPSS 16.0 
(SPSS, Chicago, IL) was used for all statistical analyses and statistical 
significance was defined as p < 0.05. Physiological parameters were analyzed 
using one-way ANOVAs and a Tukey’s test for post-hoc analyses. 
Correlations between CT and NIRS CBF were analyzed using parametric 
linear regression. Non-parametric analysis was used to analyze the 
relationship between the errors in the NIRS CBF measurements and ECL 
thickness. 
2.3. Results 
Cerebral blood flow measurements were acquired in eight juvenile pigs. All 
pigs were between one and two months of age with a mean weight of 16.2 ± 
0.5 kg. The thickness of the ECL, as determined from anatomical CT images, 
ranged from 7.5 to 14.5 mm, with a mean value of 10.4 ± 0.6 mm. In total, 25 
ICG runs were completed; however, four NIRS measurements could not be 
analyzed. In three cases the concentration of ICG injected was below the 
threshold required for accurate PDD analysis and in one case the CT contrast 
agent concentration was too low.  
The results of the physiological parameters for the eight pigs at the 
three different conditions are summarized in Table 2.2. As expected, average 
PaCO2 and pH values were significantly different between hypo-, normo- and 
hyper- capnia groups (p < 0.05). No statistically significant differences were 
observed for any of the other physiological parameters. 
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Table 2.2:  Physiological parameters during the three conditions. 
 Hypocapnia 
(nx=6)†† 
Normocapnia 
(nx=13) 
Hypercapnia 
(nx=6) 
Heart Rate, beats/min 122 ± 5 132 ± 5 159 ± 15* 
Mean arterial pressure, 
mmHg 
54.5 ± 2.0 57.8 ± 1.9 63.2 ± 1.9* 
Arterial PCO2, torr 22.6 ± 1.3 38.9 ± 1.2* 57.4 ± 4.4*† 
Arterial PO2, torr 238.7 ± 21.0 227.1 ± 15.8 212.9 ± 22.1 
Arterial pH 7.58 ± 0.02 7.43 ± 0.01* 7.30 ± 0.03*† 
Values are mean ± SE. *p < 0.05 compared with hypocapnia. †p < 0.05 compared with 
normocapnia. ††nx refers to the number of ICG runs acquired at each capnic level. 
 
To determine the error caused by ignoring the ECL, the SP-NIRS approach 
was applied to ICG tissue concentration curves acquired with a source-
detection distance of 30 mm and the resulting CBF estimates were compared 
with CBF measured by CT perfusion. Figure 2.2A depicts an example of the 
time-dependent change in optical density measured at both optode distances 
following ICG injection.  
 
Figure 2.2: Measured optical signals and recovered tissue dye concentration curves. 
(A) The change in optical density following ICG injection at 1 cm and 3 cm detector probes 
measured at 800 nm, and (B) the corresponding change in ICG concentration in the ECL and 
brain following data processing by the DR-NIRS method. Data are from the same ICG run in 
an animal with an ECL thickness of 14 mm. 
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Figure 2.3 shows the SP-NIRS CBF measurements plotted as a 
function of the corresponding CBF measurements acquired with CT 
perfusion. The SP-NIRS technique consistently underestimated CBF and no 
significant correlation was observed between CBF measurements from the 
two techniques. The mean CBF determined by SP-NIRS was 18.17 ± 3.26 ml 
min−1 100g−1, which was significantly different from the mean CBF value 
determined by CT perfusion (69.91 ± 3.25 ml min−1 100g−1, p < 0.001). 
 
Figure 2.3: Comparison of SP-NIRS CBF and CT perfusion CBF 
Correlation plot comparing CBF measurements acquired by CT perfusion and single-probe 
NIRS. Symbols represent the data grouped according to ECL thickness: less than or equal to 
8 mm (solid diamonds), between 8 and 12 mm (shaded triangles), and greater than or equal 
to 12 mm (open circles). No significant correlation between CBF measurements from the two 
techniques was detected. The line of unity (dashed line) is shown for comparison. 
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Figure 2.4 shows CBF values derived from the SS-NIRS technique 
plotted as a function of the corresponding CBF values determined from CT 
perfusion. Similar to the SP-NIRS results, no significant correlation was 
observed between CBF measurements from the two techniques. The mean 
CBF calculated by SS-NIRS (42.80 ± 7.58 ml min−1 100g−1) was greater than 
that determined using SP-NIRS, but still underestimated the mean CBF 
calculated from the CT perfusion data set. 
 
Figure 2.4: Comparison of SS-NIRS CBF and CT perfusion CBF 
Correlation plot comparing CT and SS-NIRS measurements of CBF. Symbols represent three 
ECL groups described in figure 2.3. No significant correlation between the two 
measurements was detected. The dashed line indicates the line of unity. 
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The correlation between CBF measurements from DR-NIRS and CT 
perfusion is shown in Figure 2.5. In this case, a strong, statistically 
significant correlation was revealed (r2 = 0.714, slope = 0.92, p < 0.001). The 
mean CBF measured using the DR-NIRS approach was 64.93 ± 3.47 ml min−1 
100g−1, which was not significantly different from that measured by CT 
perfusion.  
 
Figure 2.5: Comparison of DR-NIRS CBF and CT perfusion CBF 
Correlation plot comparing the CT and DR-NIRS measurements of CBF. Symbols represent 
three ECL groups described in figure 4. The solid line represents the line of regression (r2 = 
0.714, slope = 0.92, intercept = 2.7, p < 0.001), and the line of unity (dashed line) is shown for 
comparison. 
A Bland-Altman plot was used to investigate the existence of any bias 
in the CBF measurements and to determine the variability in the 
measurements (Figure 2.6). The mean difference between the two techniques 
was −2.83 ml min−1 100g−1. The limits of agreement, i.e., the region in which 
95% of the differences lay, were −19.63 ml min−1 100g−1 and 14.00 ml min−1 
100g−1. No discernible CBF-dependent errors were observed. 
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Figure 2.6: Bland-Altman plot of DR-NIRS and CT perfusion CBF 
Bland-Altman plot comparing CT and DR-NIRS measurements of CBF. Symbols represent 
three ECL groups, as described in figure 4. The mean difference between the two 
measurements (solid line) is −2.83 ml min−1 100g−1. The limits of agreement (dashed lines), 
within which 95% of the differences reside, are 13.97 and −19.63 ml min−1 100g−1. 
Non-parametric regression analysis was performed to further investigate the 
relationship between ECL thickness and the percent difference between CT 
perfusion and CBF values obtained with each of the NIRS techniques. 
Significant correlations were observed for both SP-NIRS (ρ = -0.884, p < 
0.001) and SS-NIRS (ρ = -0.861, p < 0.001). In contrast, there was no 
correlation between ECL thickness and percent difference in CBF values for 
DR-NIRS. 
2.4. Discussion 
An integral part of critical care management of ABI patients is the 
maintenance of adequate CBF to avoid secondary brain injury. Near-infrared 
spectroscopy has long been recognized for its potential as a non-invasive 
bedside cerebral monitor due to its portability and sensitivity to cerebral 
hemodynamics (McCormick et al 1991). However, its application to adult 
patients has been challenged by the significant signal contamination from the 
76 
scalp and skull. Previous studies have reported that CBF collected using 
traditional NIRS approaches can be underestimated by more than a factor of 
3, due primarily to the increase in optical pathlength through extra-cerebral 
tissue (Owen-Reece et al 1996). Moreover, not only does ECL contamination 
affect the accuracy of the CBF measurements, studies using ICG bolus 
tracking methods have found that NIRS is also insensitive to changes in 
CBF, which questions if NIRS can even be used to monitor relative CBF 
(Schytz et al 2009; McCormick et al 1991).  To overcome this major hurtle, a 
multidistance NIRS approach was developed to resolve depth-specific 
information. Monte Carlo simulations were used in conjunction with the two-
layer modified Beer-Lambert law to extract the cerebral ICG concentration 
curve from multi-distance NIRS data. The use of subject-individualized 
Monte Carlo simulations to model depth-resolved NIRS has been proposed 
previously in neural activation studies (Boas et al 2002; Custo et al 2010; 
Yamada et al 2009). Selection of the appropriate simulation parameters for 
each animal was based on its specific ECL geometry (i.e., thickness and 
relative scalp-to-skull ratio) determined from anatomical CT images. A fixed 
cerebral water concentration provided an additional constraint in the 
selection process. The main finding of this paper was that CBF 
measurements obtained with our Monte-Carlo driven, depth-resolved NIRS 
technique correlated well with CT perfusion data (a clinically validated and 
widely used technique for measuring CBF in humans (Konstas et al 2009a, 
2009b)). As a corollary, we found that the more simplistic SP-NIRS and SS-
NIRS techniques did not provide reliable measurements of CBF. 
It was expected from previous studies (Owen-Reece et al 1996; Gora et 
al 2002) that the SP-NIRS technique would be inadequate for measuring CBF 
in the intact adult head since the cerebral NIR signal comprises only about 
30% of the total signal at a source-detector distance of 30 mm (see subsection 
1.6.1). Qualitatively, this effect can be seen in the attenuation signal shown 
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in Figure 1.2A. Signal collected by the 30 mm detector probe demonstrates a 
relatively slow washout, typical of ECL tissue and attributable to its lower 
blood flow. The effect of the significant ECL MPP was evident by the large 
underestimations of CBF, calculated from the long-distance NIRS data 
compared to the measurements acquired with CT perfusion. Furthermore, no 
correlation between the two techniques was observed over a range of CBF 
from 35 to 90 ml min−1 100g−1. These results agree with previous studies 
conducted in humans (Gora et al 2002; Rothoerl et al 2003) and clearly 
demonstrate that SP-NIRS is unsuitable for measuring CBF in adults.  
Marginal improvements were observed for SS-NIRS, which relied upon 
an assumed value of the mean partial pathlength in brain, over the SP-NIRS 
approach; however, it also performed poorly relative to DR-NIRS. It might be 
anticipated that even if SS-NIRS cannot accurately measure absolute CBF, a 
correlation with CT perfusion could be expected, but this was not observed. 
The most likely explanation for this discrepancy is that the relative 
contributions of brain and ECL varied substantially from experiment to 
experiment, as suggested by the dependency of SS-NIRS error on the ECL 
thickness revealed by non-parametric analysis. Further analysis of the data 
revealed that assuming the ECL MPPs are the same for both distances 
introduced an error. The difference in the actual ratio compared to the 
assumed ratio of unity was correlated with the error in SS-NIRS measured 
CBF (r = −0.76, p < 0.01), suggesting that the large variability in the SS-
NIRS data has its source in the error of MPP values used in this approach. 
Since the calculation of CBF is heavily dependent on the height of the ICG 
curve, which in turn is dependent on the chosen value of brain MPP, any 
discrepancy between the assumed MPP and the true value will lead to 
considerable variance in the CBF estimate. These findings suggest that in 
order to measure CBF precisely, a case-by-case method of calculating the 
MPP values is prerequisite. These results also provide a plausible reason for 
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the failure of SS-NIRS to detect changes in CBF in healthy human subjects, 
as reported in a recent study (Schytz et al 2009), and may help to explain 
some of the contamination issues observed in studies measuring cerebral 
blood saturation by spatially resolved NIRS (Muehlschlegel and Lobato 
2006). 
The approach presented in the current study is based on a previously 
validated technique using broadband continuous-wave NIRS to measure CBF 
in neonates (Brown et al 2002). In contrast to the simpler techniques 
presented above, the DR-NIRS technique attempted to correct for the 
primary sources of inter-subject variability. By using independent Monte 
Carlo simulations, with a priori information of the ECL thickness, MPP 
values can be defined on a subject-by-subject basis. Furthermore, by using a 
continuous-wave broadband NIRS system, second derivative spectroscopy can 
assist with selecting the appropriate MPP values. By virtue of the fact that 
the water concentration in brain is known (80%) and relatively stable 
(Matcher et al 1994), the MPP selection process was constrained to only those 
choices that met this criterion. Finally, our system uses a shutter 
multiplexing system that allows for rapid collection of NIR signals from 
multiple probes with high fidelity (Diop et al 2009). It is likely that these 
characteristics contributed to the strong correlation that was observed 
between CBF measurements from CT perfusion and DR-NIRS (Figure 2.5) 
and also resulted in the small bias revealed by the Bland-Altman method 
(Figure 2.6). When compared with the previous validation study published by 
our group for the neonatal pig model which also used CT perfusion (Brown et 
al 2002), the 95% confidence intervals shown in the Bland-Altman plot were 
only slightly larger (±16.8 ml min−1 100g−1 compared to ±12.7 ml min−1 100g−1  
in the previous study). Given the sources of uncertainty introduced by the 
depth-resolved approach, as well as the decreased signal-to-contrast ratio, it 
is encouraging to note that the difference in precision was only marginal. 
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There are a few significant limitations in this study which should be 
addressed. The first concern pertains to the reliance on a priori knowledge of 
the ECL geometry from anatomical imaging. Certainly, a completely 
independent technique would be more attractive and may potentially emerge 
in the future. However, given that standard procedure for head trauma 
neurological assessment upon admittance includes CT or MRI scanning, the 
requirement of this additional information for subsequent NIRS 
measurements does not represent a significant burden. A second concern is 
the possibility that the two-layer Beer-Lambert model used to characterize 
light propagation through the pig head may not adequately represent the 
human head. Similarly, this approach relied on assumed optical properties 
for the ECL. While the selected brain MPP value was constrained by the 
known water concentration—a benefit of using broadband NIRS—
uncertainties in the assumed scattering and absorption coefficients for the 
different extra-cerebral layers (scalp, skull and CSF) are likely to affect the 
accuracy of the CBF measurements. More complex instrumentation, such as 
frequency-domain and time-resolved NIRS have the ability to calculate the 
optical properties directly from reflection measurements either by employing 
an analytical model (Kienle and Patterson 1997) or fitting to Monte Carlo 
simulations (Elliott et al 2011). In particular, multi-distance time-resolved 
NIR methods have the benefit of also being more sensitive to deeper tissue 
structures, and for this reason, the work presented in subsequent chapters 
will explore this instrumentation.  
A final limitation with this study pertains to the animal model that 
was used. First, the mean thickness of the ECL in these animals was 10 mm 
and, consequently, was more representative of a juvenile patient group than 
an adult one. Second, the thick temporalis muscles originating in the 
temperoparietal region have evolved in the pig to allow powerful mastication 
are more metabolically demanding than the human scalp (Ström et al 1986). 
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As a result, the blood flow values are significantly higher than what is 
expected in the human (on the order of 3-4 times higher). Furthermore, hypo- 
and hyper-capnia conditions are likely to elicit a global vascular response. 
These factors combined result in an animal model that is likely more 
favourable than the clinical scenario in terms of measuring CBF accurately. 
All of these issues will be addressed in subsequent chapters, and ultimately 
culminate with the validation of the kinetic deconvolution optical 
reconstruction (KDOR) method of analyzing multidistance time-resolved DCE 
NIR measurements (Chapter 6). 
2.5. Conclusion 
The salient finding of the present study is that, in contrast to the SP- and SS-
NIRS methods, the DR-NIRS technique demonstrated for the first time that 
accurate measurements of CBF can be acquired with NIRS despite the 
presence of a significant ECL. These results highlight the promise of using 
NIRS for acquiring bedside measurements of CBF in neurological intensive 
care patients, demonstrating the potential of NIRS to greatly improve clinical 
management of these individuals. 
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Chapter 3 
MEASURING CEREBRAL BLOOD FLOW 
CHANGES IN ADULT PIGS WITH STATISTICAL 
MOMENTS OF TIME-RESOLVED NEAR-
INFRARED MEASUREMENTS 
This chapter is adapted from the work entitled “Variance of time-of-flight 
distribution is sensitive to cerebral blood flow as demonstrated by ICG bolus-
tracking measurements in adult pigs” by Elliott JT, Milej D, Gerega A, Weigl 
W, Diop M, Morrison LB, Lee T-Y, Liebert A and St. Lawrence K, published 
in Biomedical Optics Express in 2013. The focus of this paper is two-fold: to 
investigate the specificity of time-resolved measurements to cerebral blood 
flow (CBF) effects by sequential acquisition on the intact and ischemic scalp, 
the skull, and directly on the dura matter; and, to determine the sensitivity of 
time-resolved measurements acquired on the surface of the head to 
hypocapnic decrease in CBF. Furthermore, this chapter describes a method 
using more advanced instrumentation than in the previous continuous-wave 
(CW) near-infrared spectroscopy (NIRS) study, as well as a more accurate 
animal model of the adult neurotrauma patient, but highlights an analytical 
approach that is only able to determine relative changes in CBF. The original 
journal article from which this chapter was adapted can be found at 
http://www.opticsinfobase.org/boe/abstract.cfm?uri=boe-4-2-206 
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3.1. Introduction 
In the previous chapter, a broadband CW-NIRS method of quantifying CBF 
was presented. The salient finding of this study was that reconstruction of 
brain-specific optical changes is possible using a multi-distance 
reconstruction technique stabilized with anatomical (i.e., CT or MRI imaging 
data) and physiological/spectral (i.e., assumed water concentration of 80%) 
priors. However, this approach was applied to smaller animals whose 
anatomy more closely approximates the juvenile patient. Furthermore, it is 
likely that the higher blood flow observed in the scalp of pigs compared with 
humans limits the conclusions that can be drawn regarding the performance 
of the method in adult subjects. To this end, the work presented in Chapter 3 
describes the application of the more sensitive time-resolved (TR) NIR 
instrumentation to investigate the influence of extracerebral hemodynamics 
and optical properties (by systematically removing the scalp and skull) on the 
measured signal. In addition, measurements acquired directly on the brain 
were compared with contralateral measurements acquired on the head 
surface during normo- and hypo-capnia. In this way, both the sensitivity—
i.e., the ability to reliably detect changes in CBF or hemoglobin 
concentrations—as well as the specificity—i.e., the confidence that a change 
in signal reflects only the brain and not the extracerebral tissue—were 
investigated. 
 Dynamic contrast-enhanced (DCE) methods based on analysis of the 
statistical moments of measured distributions of times-of-flight of photons 
(DTOF) have been proposed as a way to increase the sensitivity to signal 
changes occurring in the brain over conventional CW NIRS methods (Liebert 
et al 2004). Following an injection of the vascular tracer indocyanine (ICG), it 
is possible to record the concentration-dependent changes in three statistical 
moments of DTOFs: total number of photons, N, mean time-of-flight, <t>, and 
variance, V. To date, the moments-based technique has been applied to 
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healthy volunteers (Liebert et al 2004, Jelzow et al 2012), stroke patients 
(Steinkellner et al 2010; Liebert et al 2005), and other neurotrauma patients 
(Liebert et al 2012), and qualitative analysis strongly suggests that the time-
dependent change in variance of the DTOF shows good sensitivity to 
absorption changes occurring in the brain. However, these previous studies 
employed qualitative methods, or attempted to quantify changes in CBF 
using the time-to-peak (TTP) method, a relatively straightfoward but indirect 
method of measuring change in CBF (Steinkellner et al 2010; Kuebler et al 
1998; Terborg et al 2003), that is also dependent on cerebral blood volume 
(CBV) and variations in the arterial input function (AIF). 
 To further investigate the potential pitfalls associated with the TTP 
method limitation, an error analysis was conducted. In particular, the 
dependency of TTP accuracy on the CBV and the TTP of the arterial input 
function is highlighted. As an alternative to this method, a nonparametric 
deconvolution-based method is introduced (Cenic et al 1999; Brown et al 
2002; Elliott et al 2012) that enables the recovery of a relative blood flow 
index, dBF. While this method differs from the quantitative deconvolution 
method used in the previous chapter (since only a relative blood flow index is 
recovered), the advantage of this approach compared to TTP measurements is 
that confounding effects due to the AIF and CBV are removed. 
 In this study, an adult pig model is used to conduct a within-subject 
comparison of moments collected on the surface of the scalp and moments 
collected directly on the brain. In Part A (subsection 3.4.1), the experiments 
involved manipulating the extracerebral layer to cause perturbations in both 
scalp blood flow and the extracerebral optical properties (by surgically 
altering the ECL composition). In Part B (subsection 3.4.2), DCE-NIR 
measurements are acquired directly on the brain and contralaterally on the 
scalp during normocapnia and hypocapnia—the latter causes CBF to 
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decrease. Concomitant measurements were acquired by CT perfusion (CTP) 
for comparison. 
3.2. Theory 
3.2.1.  Statistical moments of distributions of times-of-flight 
Time-resolved NIR techniques measure the times-of-flight of individual 
photons at each detector over a few hundred milliseconds, building a 
histogram that approximates a distribution function. It has been 
demonstrated theoretically (Zaccanti et al 1995) and experimentally 
(Steinbrink et al 2001) that later time-bins correspond to a group of photons 
are statistically more likely to have interrogated deeper tissue structures. 
Therefore, changes in absorption of light in brain tissue, for example 
following the injection of dye, will differentially affect certain time bins in the 
DTOF. A transformation can be written as follows: 
  
j
jajii AN ,,,    (3.1) 
where ΔNi is the change in the number of photons occurring in the ith time-
bin of the DTOF, Δμa,j is the change in absorption coefficient in the jth layer, 
and Ai,j is the sensitivity matrix describing the transformation between these 
two functions. Since the experimentally measured DTOF is in reality a 
convolution between ΔNi and the instrument response function (IRF), direct 
analysis of the DTOF is challenging (Diop et al 2012). A simpler approach is 
to use statistical moments, mk, of the DTOF: 
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where k is the order of the moment, and t1 and t2 are temporal integration 
limits. This approach reduces the dimension of the problem in Eq. 3.1, and 
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the change in normalized moments is independent of the IRF (Liebert et al 
2004). Furthermore, it has been demonstrated previously that higher-order 
moments are more sensitive to changes occurring in deeper tissues (Liebert et 
al 2004). A similar transformation to Eq. 3.1 can be written: 
 ,,
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where Ak,j is the sensitivity matrix describing transformation between a 
change in the kth moment and the change in absorption coefficient occurring 
in the jth layer. The changes in three moments are used to describe the time-
dependent changes that occur in the head following a bolus injection of dye: 
attenuation, A, which is related to the zeroth moment, mean time of flight, 
<t>, and variance of the DTOF, V. The mathematical definitions of these 
moments and the sensitivity factors corresponding to the change in these 
moments are given in Table 3.1. Sensitivity factors can be determined with 
analytical (Kacprzak et al 2007) or Monte Carlo based methods (Steinbrink et 
al 2001; Liebert et al 2003); the latter was used for this study. 
Table 3.1: Definitions of statistical moments 
Name Related moment Formula Sensitivity 
factor 
Attenuation 
zeroth moment (area 
under the curve) 
)ln( 0mA   MPP 
Mean time of 
flight 
first normalized 
moment 
01 mmt   MTSF 
Variance 
second centralized 
moment 
 20102 mmmmV   VSF 
The three moments used in DTOF analysis, along with their formulae and the abbreviations 
for their sensitivity factors. MPP, mean partial pathlength; MTSF, mean time-of-flight 
sensitivity factor; VSF, variance sensitivity factor. 
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3.2.2.  Indicator dilution theory 
The previous section provides the mathematical basis for understanding how 
a change in the absorption coefficient of underlying tissues will produce a 
change in the measured moments. With dynamic contrast-enhanced 
techniques, this change in absorption is caused by the injection of an 
exogenous dye. If all other chromophores are assumed constant for the period 
of time required to collect a measurement, then the change in absorption 
coefficient in a tissue of interest as a function of time, T, is related to the 
tissue dye concentration, C, by 
 ),10ln()()(   TCTa   (3.4) 
where ε is the wavelength-dependent extinction coefficient of the dye. 
Following a bolus injection into a peripheral vein, the dye is delivered first to 
the heart, where it is subsequently pumped though the arterial circulatory 
system to all tissues of the body. According to the convolution theorem (Meier 
and Zierler 1954), the time-dependent tissue dye concentration is given by: 
 ,)()()(
0
duuTRuCFTC
T
a     (3.5) 
where F is blood flow, Ca(T) is the time-dependent arterial concentration of 
dye (i.e., the AIF), and R(T) is referred to as the impulse residue function. 
R(t) represents the fraction of dye remaining in the tissue at time, T, 
following an idealized bolus injection. The convolution theorem can be 
derived from the Fick Principle and a previous publication provides 
additional details of this derivation (Elliott et al 2011). The function Ca(T) is 
common to all tissue regions in the body, while in contrast, R(T) and F are 
specific to each tissue region. Therefore, if C(T) is characterized from signal 
containing information from multiple regions of tissue, F and R(T) are in 
reality a weighted average of the tissue-specific functions represented in the 
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probed region. In the case that the region-of-interrogation contains multiple 
layers of tissue, a more rigorous expression is found by combining Eqs. 3.3 
and 3.4 with the convolution in Eq. 3.5, yielding the moment-specific solution: 
 .)()()10ln()(
0
,  
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T
ajkjk duuTRuCAFTm    (3.6) 
This convolution describes the fundamental relationship between the 
behavior of contrast agent in the tissue and the measured change in DTOF 
moments.  
3.2.3. Quantification of blood flow changes 
In this paper, we investigated two different approaches of measuring change 
in CBF: the time-to-peak method and the relative deconvolution method. The 
time-to-peak of the tissue function, TTPC, is defined as the time elapsed 
between the first appearance of dye, T0, and the peak concentration of dye, 
Tmax (Fig. 3.1). 
 
Figure 3.1: Time-to-peak analysis  
A depiction of the time-to-peak (TTP) method. Hypothetical tissue and arterial concentration 
curves including the effects of dye recirculation are shown by the solid black lines, along with 
their corresponding TTP values (TTPC and TTPCa, respectively). The solid grey lines 
represent the first moments of the concentration curves without the effects of recirculation. 
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The time-to-peak can be related to CBF using the first moments of the 
tissue and arterial concentration curves. A property of a convolution is that 
the first moments are additive (Jaynes 2003) and, therefore, Eq. 3.5 can be 
written as: 
 .MTTtt
CaC
   (3.7) 
The mean transit time (MTT), which is the first moment of the flow-scaled 
R(t), is equal to CBF/CBV  by the central volume principle (Meier and Zierler 
1954). Typically, tissue and arterial functions can be approximated by 
gamma variate functions (Thompson et al 1964). However, over the interval 
T0 < t ≤ Tmax, these functions can be approximated by a symmetrical function, 
such as a Gaussian. In this case, the first moment equals the time-to-peak: 
C
t  = TTPC and  
Ca
t  = TTPCa. Eq. 3.7 can be rewritten as: 
 .
CBF
CBV
TTPTTP CaC    (3.8) 
Note that TTPC not only depends on CBF, but also on CBV and TTPCa. 
Therefore, the influence of initial values of these two parameters must be 
considered when interpreting the relative change in TTPC.  
An alternative approach to characterizing the DCE curves is to 
perform a deconvolution to recover a relative blood flow index, dBF, 
representing the scalar quantity defined by the summation in Eq. 3.6. 
Generally, dBF for the kth moment is 
 .)10ln( , 
j
jkjk AFdBF    (3.9) 
It has been suggested that the variance of measurements acquired on the 
scalp has greater sensitivity to brain tissue and the influence of the extra-
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cerebral layers is relatively small (Liebert et al 2004). If this is the case, the 
variance sensitivity factors for the extracerebral layers are approximately 
zero and the summation in Eq. 3.9 collapses to: 
 ,)10ln( VSFCBFdBF V     (3.10) 
where VSF is the sensitivity factor for the brain layer. If VSF remains 
constant between measurements, the change in dBF equals the true change 
in CBF (ΔCBF). To recover dBF, an algorithm incorporating physiologically 
derived constraints was used to stabilize the deconvolution, which is an 
inherently unstable process. This algorithm has been described and validated 
previously, both for CT perfusion (Cenic et al 1999), and near-infrared 
techniques in neonatal models (Brown et al 2002; Diop et al 2010b) as well as 
in more complex multi-regional scenarios (Elliott et al 2010; Elliott et al 
2012). 
3.2.4. Influence of CBV and AIF on time-to-peak measurements  
A series of numerical simulations were performed to determine the effect of 
CBV and AIF on the relationship between ΔTTPC and ΔCBF. To investigate 
the effect of CBV, cerebral blood volume was related to cerebral blood flow 
according to the Grubb relationship (Grubb et al 1974): 
 .CBFgCBV    (3.11) 
where g and γ are empirically derived parameters. Values for g and γ are 
described in the rhesus monkey as 0.8 and 0.38 (Grubb et al 1974), and 
similar CBV values have been measured in humans (Grubb et al 1977). For 
the simulations, g was set to 0.8 and γ varied between 0.2 and 0.6 to 
investigate how the relationship between ΔTTPC and ΔCBF (Eq. 3.8) was 
affected by changes in CBV. In these simulations, TTPCa was set to zero, 
which represents the ideal case where the arterial input function is a Dirac 
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delta function. The results are summarized in Fig. 3.2A. Similarly, the effect 
of TTPCa on Eq. 3.8 was performed by setting γ = 0.38 and varying TTPCa 
from 0 to 6 seconds. These results are summarized in Fig. 3.2B. 
 
Figure 3.2: Effect of CBV and AIF on TTP analysis. 
The relationship between changes in tissue-curve TTP (ΔTTPC) and changes in CBF (ΔCBF) 
(grey lines). (A) The effect of varying the relationship between CBV and CBF, which was 
performed using the Grubb relationship for γ = 0.2, 0.4 and 0.6, and setting TTPCa = 0. (B) 
The effect of varying the arterial TTP (TTPCa) from 0 to 6 s with γ set to 0.38. The solid lines 
show the negative unity slope for comparison.  
The results of the simulations illustrated in Fig. 3.2 predict that the 
relationship between ΔTTPC and ΔCBF can be strongly influenced by how 
CBV and CBF are related, and by the finite width of the AIF (i.e., TTPCa). 
3.3.  Materials and methods 
3.3.1. Instrumentation 
A time-resolved near-infrared system, assembled in-house, was used for all 
optical measurements. A detailed description of this system and its 
characterization can be found in (Diop et al 2010b). Briefly, a picosecond 
diode laser light source (LDH-P-C-810, PicoQuant, Germany) emitting at 802 
nm, close to the peak absorption wavelength of ICG, was used. The laser 
output was attenuated by a neutral density filter to below ANSI safety limits 
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for skin exposure (52.2 mW/cm2 measured at fiber output compared to limit of 
317 mW/cm2 for 800 nm), and a pulse repetition rate of 80 MHz was used. 
The beam was coupled into a 1.5-m long multimode fiber (core = 400 μm and 
N.A. = 0.22; Fiberoptics Technology, Pomfret, CT) and directed onto the scalp. 
Photons exiting the tissue were collected by a fibre bundle 1.5 m long. The 
proximal end of the bundle was placed on scalp to provide measurements at a 
source-detector distance of 30 mm. The source and detector light-guides were 
held in place using a probe holder, constructed from black polychloroprene 
rubber. The distal end of the collection optode was secured in front of an 
electromechanical shutter (SM05, Thorlabs, Newton, NJ). Light transmitted 
through the shutter was passed through a bandpass filter (FEB800-10, 
Thorlabs) to remove fluorescence emission, before being collected by a Peltier-
cooled photomultiplier tube (PMT). A photon count rate corresponding to 
roughly 1% of the laser repetition rate was used. 
3.3.2.  Animal experiments 
All animal experiments were conducted following the guidelines of the 
Canadian Council on Animal Care and approved by the Animal Use 
Subcommittee at the University of Western Ontario (AUP #2007-050-06). 
Duroc x Landrace crossbred pigs (n = 4) were acquired from a local supplier 
on the morning of the experiment. Animals were anesthetized with 1.75-3% 
isofluorane, tracheotomized and mechanically ventilated on an 
oxygen/medical air mixture. A femoral artery was catheterized to monitor 
heart rate and blood pressure and to collect blood gas samples. Body 
temperature was maintained between 37.5 and 38.5°C throughout the 
experiment. 
Following a 1-h stabilization period, the rubber probe holder was 
placed on the head and fixed in place with tissue glue (Vetbond™ 1469SB, 
3M Health Care, St. Paul, MN). The respiration rate, anesthetic levels and 
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glucose levels were closely monitored and adjusted to ensure that 
physiological parameters remained stable throughout the experiment.  
All four animals were included in Part A (i.e., the manipulation of the 
extracerebral layers) and two animals were included in Part B (i.e., the 
manipulation of CBF). In Part A, two sets of time-resolved measurements 
during inflow and washout of ICG (0.1 mg/kg, Cardiogreen, Sigma-Aldrich, 
St. Louis, MO) were acquired on the surface of the head. All measurements 
were separated by a delay of 20 min to allow sufficient time for clearance of 
the dye. After these scalp measurements, three incisions were made around 
the probe holder to reduce scalp blood flow. The tissue medial to the probe 
holder was left intact and the three incisions were cauterized to stop 
bleeding. Two sets of measurements were acquired under this ischemic scalp 
condition. After the exact position of the probe holder was marked, the 
underlying scalp was removed using the probe holder as a guide. Two 
measurements were acquired directly on the skull of the animals at 
approximately the same location as the previous measurements. Following 
the skull measurements, holes were carefully drilled through the skull in the 
same locations. Probes were inserted into the holes until they rested directly 
on the dura matter. In this way, two sets of time-resolved measurements 
were acquired on the brain. 
In Part B, time-resolved measurements were acquired directly on the 
brain and then concomitantly on the contralateral scalp during normocapnia 
and hypocapnia. Hypocapnia was achieved by adjusting the respiration rate 
on the mechanical ventilator until blood CO2 concentration reached 25 
mmHg.  Computed tomography perfusion measurements were acquired using 
a CT scanner (LightSpeed QXi, GE Healthcare, Milwakee, WI) during 
normocapnia and hypocapnia. Each cine scan (80 kVp, 190 mA) was acquired 
for 40 s following injection of the contrast agent (1.0 ml/kg of 300 mg/ml 300-
Isovue, Bracco Diagnostics Inc., Princeton, NJ) at an injection rate of 1 ml/s. 
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Eight coronal slices (5 mm thick, temporal resolution of 1 s) were used to 
generate CBF maps using CT Perfusion 4 software (GE Healthcare). Region-
of-interests were drawn encompassing the cortical tissue of each hemisphere 
which approximate the region interrogated by the NIR light.  
3.3.3.  Data processing 
Data processing was performed in the MATLAB programming environment 
(MathWorks, Natick, MA). Prior to the analysis, the DTOFs of diffusely 
reflected photons were denoised using a three-step method which uses an 
Anscombe transformation, followed by wavelet denoising and then 
subsequent inverse Anscombe transformation, as described previously (Diop 
et al 2012). Denoising was done to reduce the susceptibility of higher 
moments to noise-related artifacts. Statistical moments were calculated from 
the denoised datasets using a previously described approach (Liebert et al 
2003). For calculating the moments, the upper integration limit was defined 
on the level of 5% of the maximum of the DTOF in order to reduce the 
influence of any remaining noise. Following subtraction of IRF contribution, 
moments were smoothed using the Savitzky-Golay algorithm (11.6 second 
window span, 6th order polynomial) to remove high-frequency components not 
related to dye kinetics. 
Attenuation and variance of the DTOFs were analyzed using the time-
to-peak method and the kinetic deconvolution method. When presenting the 
percent change in TTP, values were multiplied by −1 to facilitate comparison 
with the other indices. These four values were obtained for all time-resolved 
measurements. For Part A, analysis of differences between groups was 
performed using SPSS 17.0 (IBM, Armonk, NY). Statistical significance was 
considered to be p < 0.05. 
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3.4.  Results 
3.4.1.  Part A: Extracerebral manipulations 
During these experiments, the extracerebral environment was manipulated 
in several ways to demonstrate the sensitivity of the measured parameters to 
perfusion changes in the different layers. Blood flow indices were determined 
under four conditions: (i) baseline, (ii) following partial scalp ischemia, (iii) 
probes placed on the skull, and (iv) probes placed directly on the brain (17 
datasets were collected from 4 animals). The shape of the tissue 
concentration curves acquired on the scalp showed large differences between 
the different moments of DTOFs (A, <t> and V). Furthermore, the higher 
order moments showed less variability when the extracerebral layer was 
manipulated compared to attenuation. Figure 3.3 shows the attenuation ICG 
curves and the variance ICG curves for one animal under the four conditions. 
This representative example was typical of all animals. Figure 3.3C shows 
the similarity between the ICG curves derived from the scalp variance 
measurements and the brain attenuation measurements.  
 
Figure 3.3: Dynamic contrast-enhanced curves during ECL manipulation  
Representative curves from one animal (pig #2) under the four conditions. In this case, the 
thickness of the extracerebral layer was 10.2 mm. (A) Change in attenuation (ΔA) for 
measurements made on intact scalp (solid grey), ischemic scalp (dashed grey), skull (dashed 
black) and brain (solid black). (B) Change in variance (ΔV) for the same conditions. (C) ΔA 
measured on the brain (solid black) compared with ΔV measured on the scalp (dashed black). 
Curves are normalized to brain curve. 
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In terms of the qualitative blood flow indices (TTP and dBF) calculated 
from changes in attenuation (ΔA) and variance (ΔV) of the DTOF, Figure 3.4 
summarizes the percent difference between the measurements under the 
three extracerebral manipulations and the measurement directly on the 
brain. From the ΔA measurements, the average difference was −47.9 ± 7.8% 
for dBF and −8.0 ± 6.31% for TTP. From the ΔV measurements, the average 
difference was −0.2 ± 2.43% for dBF and by −3.5 ± 2.22% for TTP. The values 
for ΔV TTP, ΔV dBF, and ΔA TTP were not significantly different, but ΔA 
dBF was significantly lower than the other three parameters (p < 0.001). 
 
Figure 3.4: Variations in blood flow indices during ECL manipulation.  
Box-and-whisker plot of the difference in measured blood flow indices during the 
extracerebral manipulations compared to measurements acquired on the brain. Each 
parameter was evaluated from seventeen measurements acquired in four pigs. Boxes are 
bound by 1st and 3rd quartiles, with the center line indicating the median. Error bars 
represent the range of the data, and crosses signify outliers. Only ΔA dBF was significantly 
different from the expected change of zero (p < 0.001). Additionally, none of ΔA TTP, ΔV TTP, 
or ΔV dBF differed significantly from each another, as measured by a paired t-test. 
3.4.2.  Part B: Hypocapnic challenge 
To augment the results of Part A, we further analyzed the sensitivity of the 
attenuation and variance TTP and dBF measurements to reductions in CBF 
caused by hypocapnia. Sequential bilateral measurements were made in two 
animals during normocapnia and hypocapnia. On the ipsilateral side, 
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measurements were made directly on the brain and on the contralaterial 
side, measurements were made on the scalp. A reduction in CBF was 
observed during hypocapnia as depicted by the CBF maps generated by CT 
perfusion (Fig. 3.5). 
 
Figure 3.5: CT perfusion maps during normocapnia and hypocapnia 
CT perfusion images of the brain from one animal during normocapnia and hypocapnia. The 
mean reduction in global CBF during hypocapnia was 43% in this case. 
Qualitatively, a large reduction of amplitude was also observed in ΔV 
from the DTOFs measured on the contralateral site that reflected ΔA 
measured directly on the brain. There was also a decrease in ΔA measured on 
the scalp; however, it was less marked. Figure 3.6 provides a representative 
example of the ΔA and ΔV ICG curves during normo- and hypo- capnia. 
 
Fig. 3.6: Dynamic contrast-enhanced curves during hypocapnia 
Representative curves from one animal under normocapnia (solid lines) and hypocapnia 
(dashed lines). (A) The change in attenuation (ΔA) made on intact scalp for the two 
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conditions. (B) The change in variance (ΔV) made on intact scalp for the two conditions. (C) 
ΔA measured directly on the brain for the two conditions. Note: curves have been normalized 
to the maximum of the normocapnia curve. 
Table 3.2 summarizes the hypocapnic changes CBF and scalp blood 
flow measured by CT perfusion and the corresponding quantitative NIRS 
blood flow indices from the two animals. As a reference, the values obtained 
with the NIRS indices were compared to CBF values obtained by CT 
perfusion—the current clinical standard-of-care. 
Table 3.2: Comparison of  TTP and dBF changes during hypocapnia  
 Animal #1  Animal #2 
Percent 
Change 
Error  Percent 
Change 
Error 
Ipsilateral (brain) 
CTP brain −32.0% -  −44.4% - 
CTP scalp - -  - - 
ΔA TTP −16.7% 15.3%  10.5% 54.9% 
ΔV TTP −21.1% 10.9%  4.5% 48.9% 
ΔA dBF −28.0% 3.9%  −45.5% −1.1% 
ΔV dBF −31.6% 0.4%  −42.3% 2.1% 
Contralateral (scalp) 
CTP brain −31.7% -  −42.2% - 
CTP scalp −19.1% -  −29.3% - 
ΔA TTP −16.7% 15.1%  −22.2% 20.0% 
ΔV TTP −20.0% 11.7%  −26.3% 15.9% 
ΔA dBF −20.9% 10.9%  −27.4% 14.8% 
ΔV dBF −31.6% 0.1%  −42.7% −0.5% 
Percent change in the blood flow indices (TTP and dBF) obtained by analysis of attenuation 
(A) and variance (ΔV) of DTOF during hypocapnia. Measurements were obtained directly on 
the brain and on the contralateral scalp. The error values are relative to the CBF change 
measured by CT perfusion (CTP). The thickness of the extracerebral layer was 10.2 mm and 
11.2 mm for animal 1 and 2, respectively. 
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3.5.  Discussion 
A number of recent studies have suggested that the DTOF variance signal 
collected on the scalp is sensitive to decreased CBF in neurological disorders 
such as stroke (Steinkellner et al 2010; Liebert et al 2005). The principle 
objective of this study was to verify these findings in an adult pig model in 
which scalp and cerebral blood flow could be manipulated. The results of Part 
A indicated that the ΔV signal was less sensitive to the extracerebral layer 
than the corresponding ΔA signal, as demonstrated by the greater variability 
in the shape of the ΔA ICG concentration curves over the different 
manipulations of the extracerebral layers. In general, the dynamics of the ΔA 
ICG curves reflected flow contributions from both scalp and brain. The curves 
shown in Fig. 3.3 illustrate that the ΔA signal acquired under the ischemic 
scalp condition resulted in the slowest kinetics, whereas the ΔA signal 
acquired directly on the brain have the fastest. The ΔA signals collected on 
the skull and the intact scalp demonstrated intermediate kinetics. The 
former was the most similar to the brain ICG curve since the thickness of the 
skull in this animal was only about 5 mm. Interestingly, the shape of the ΔA 
ICG curve acquired on the intact scalp was more similar to the ΔA signal 
collected on the skull rather than the signal acquired from ischemic scalp, 
despite the fact that the thickness of the extracerebral layer approximately 
doubled.  
The influence of the extracerebral layer on the shape of the ΔA ICG 
curve is also reflected in the TTP and dBF measurements shown in Figure 
3.4. In both cases, the increased variability was not due to increased 
measurement error, but rather, it was attributed to the different flow 
contributions under the four conditions. The dBF measurements determined 
from the ΔA ICG curves that included an extracerebral layer were also 
consistently lower than the value determined from the brain ICG curve. This 
is because ΔA dBF represents a weighted average of the blood flow in each 
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layer scaled by its mean partial pathlength. Therefore, the addition of each 
extracerebral layer resulted in a reduction in average blood flow within the 
region of interrogation 
The faster ICG dynamics for the ΔA signal collected on the intact scalp 
would appear to be at odds with previous studies involving human subjects, 
in which a large difference in the shape of the ΔA and ΔV ICG curves was 
reported (Liebert et al 2004; Steinkellner et al 2010; Liebert et al 2006). This 
apparent discrepancy can be attributed to differences in head anatomy 
between pigs and humans. We found that the pig’s scalp was highly 
vascularized and well perfused, likely to supply the thick temporalis muscles 
that originate at the temporoparietal region of the head. This observation 
was confirmed by CT perfusion, which revealed an average scalp blood flow of 
approximately 25 ml min-1 100g-1. In contrast, scalp blood flow in the human 
head, as determined by a radioactive xenon clearance technique, was only 
about 5 ml min-1 100g-1 (Friberg et al 1986). Given this difference, the 
ischemic scalp condition in Part A more closely reflects the intact human 
scalp. 
In contrast to the ΔA signals, the ΔV ICG curves shown in Fig. 3.3B 
exhibited less sensitivity to the extracerebral tissue. In this case, there was a 
noticeable improvement in the similarity of the ICG curves acquired under 
the two extremes—i.e., on the brain and on the ischemic scalp—compared to 
the ICG curves obtained from the ΔA signal.  This insensitivity to the top 
layers was also reflected in the lower variability observed in the ΔV TTP and 
dBF values across the four conditions, as shown in Fig. 3.4. As well, the 
underestimation of CBF by ΔA dBF was not observed when dBF was 
determined from the ΔV signals. 
A secondary objective of this study was to compare two analytical 
methods of tracking change in CBF from the measured DTOF moments. The 
106 
metric of choice in these studies has been time-to-peak, since it is relatively 
easy to calculate, and can be applied to normalized signals of variance of the 
DTOF. The ability to use the normalized signal makes TTP a robust 
longitudinal tool because it will be relatively insensitive to small changes in 
the signal amplitude, for example, from light coupling issues. This is a major 
benefit when using time-resolved equipment that is sensitive to light 
coupling and noise; however, time-to-peak also has some drawbacks that may 
not always be appreciated. In particular, a limitation of the TTP method is 
the implicit assumption that the AIF is consistent from measurement to 
measurement. In a clinical environment, it may be difficult to achieve an AIF 
of reproducible shape, since bolus injections are operator dependent, and the 
AIF depends on the cardiac output of the patient. For example, in the 
ipsilateral measurements acquired from animal #2 (Table 3.2), TTP 
measurements did not correctly identify the large decrease in CBF. Further 
investigation revealed that the arterial TTP changed in the opposite direction 
by 30%, obscuring the expected change in tissue TTP caused by hypocapnia. 
After adjusting the tissue TTP value to account for the unexpected change in 
arterial TTP, the change in ΔV TTP was −13.6% instead of 4.5%. In certain 
applications, such as inter-hemisphere comparisons in stroke patients, the 
absolute change in TTP (as opposed to the percent change in TTP) is 
independent of the arterial input function (Steinkellner et al 2010). However, 
when percent change in TTP is used as a surrogate of percent change in CBF 
across serial injections of ICG, any variability in the arterial input function, 
including systemic physiological changes, will have a dramatic effect on the 
accuracy of the measurement. 
Another important consideration with using the time-to-peak method 
as a surrogate CBF is that it also depends on CBV and the time-to-peak of 
the AIF (Eq. 3.8). Therefore, it exhibits a non-linear relationship with CBF. 
The numerical simulations depicted in Fig. 3.2 demonstrate how the 
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relationship between ΔCBF and ΔTTP can be altered by both the relationship 
between CBV and CBF (the Grubb relationship) and the finite width of the 
AIF. In these simulations, both effects cause the measured ΔTTP to be 
underestimated relative to the true change in CBF. Interestingly, when CBF 
decreases by about 80%, which would be similar to the expected perfusion 
reduction during clinical ischemia, this error is not as severe. 
An alternative method to analyzing DCE data is derived from the 
convolution theory of tracer kinetics. If the AIF is measured, a deconvolution 
method can be used to recover the blood flow index, dBF, which is equal to 
the average blood flow in the region of interrogation weighted by the layer-
specific sensitivity factor (Eq. 3.9). In addition to accounting for variability in 
the AIF, the deconvolution method also decouples the effects of blood flow, 
blood volume and mean transit time. When ΔA is measured in the intact 
head, the acquired signal is highly sensitive to extracerebral tissue, and the 
average blood flow recovered by deconvolution will represent a weighted 
average of scalp and cerebral blood flow as shown in Fig. 3.4. In contrast, the 
region of interrogation represented in the ΔV signal has greater sensitivity to 
brain tissue and, therefore, the change in dBF better reflects the true change 
in CBF. Note that this relative approach is in contrast to previous methods 
that recover absolute CBF from time-resolved measurements acquired 
directly from the brain, or in a scenario where the scalp contribution is 
negligible. In these special cases, deconvolution of the ΔA signal permits 
recovery of absolute CBF in units of ml min-1100g-1, since the differential 
pathlength can be measured directly from the time-resolved data (Diop et al 
2010a). 
In Part B, concomitant measurements were acquired on the ipsilateral 
brain and the contralateral scalp during normocapnia and hypocapnia in two 
animals. In addition, CT perfusion measurements were acquired under the 
two conditions to measure scalp and cerebral blood flow. Table 3.2 
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summarizes the percent change in TTP and dBF caused by hypocapnia for 
both animals. Despite a small sample size, three observations can be made 
about these results. First, all four ΔV dBF values and the two ΔA dBF values 
derived from ispilateral measurements exhibited good agreement with the 
CBF values from CT perfusion. Second, contralateral ΔA dBF measurements 
were almost identical to the scalp blood flow values from CT perfusion. When 
considered along with the results of Part A, this suggests that ΔA is mainly 
interrogating the extracerebral layer, while ΔV is sensitive to the brain. 
Finally, all eight TTP measurements (when the corrected TTP measurement 
for animal #2 as described above is substituted), showed a consistent 
underestimation of the CBF change measured by CT perfusion. This 
underestimation occurred whether the measurements were acquired on the 
scalp or directly on the brain. The numerical simulations presented in 
subsection 3.2.4 provide insight into this underestimation: the average 
arterial TTP in the animal experiments was about 4 seconds and the Grubb 
exponent, γ, was about 0.4 (determined from the CT perfusion data). For this 
combination, a 40% decrease in CBF is predicted to result in a roughly 20% 
change in TTP. 
3.6. Conclusions 
The salient finding of this study was that the variance of the DTOF 
was relatively insensitive to changes in extracerebral blood flow and optical 
properties caused by physically manipulating the extracerebral layers in the 
pig. A corollary finding was that the variance signal measured on the scalp 
was sensitive to changes in CBF. Finally, while both TTP and dBF obtained 
from the variance signal showed similar robustness in the presence of 
extracerebral variability, dBF had better sensitivity to hypocapnic CBF 
changes when compared to CT perfusion. This improvement suggests a 
benefit to measuring the AIF during acquisition of DCE time-resolved data. 
Despite differences in scalp blood flow in this animal model compared to 
109 
humans, the methods presented in this study for measuring CBF changes are 
translatable to the human adult. 
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Chapter 4 
MEASURING THE ARTERIAL INPUT 
FUNCTION WITH A STANDARD PULSE 
OXIMETER TO FACILITATE THE CLINICAL 
IMPLEMENTATION OF DCE OPTICAL 
METHODS  
The contents of this chapter have been adapted from the journal article 
published in 2012, entitled “Arterial input function of an optical tracer for 
dynamic contrast enhanced imaging can be determined from pulse oximetry 
oxygen saturation measurements” by Elliott JT, Wright EA, Tichauer KM, 
Diop M, Morrison LB, Pogue BW, Lee T-Y, and St. Lawrence K in Physics in 
Medicine and Biology. All of the dynamic contrast enhanced (DCE) near 
infrared (NIR) methods presented in this thesis (including the DCE 
fluorescence molecular tomography (FMT) and diffuse optical tomography 
(DOT) methods in Appendix A) require the proper characterization of the 
arterial input function (AIF). This chapter presents a practical solution to 
characterizing the AIF using a standard pulse oximeter (PO), offering an 
alternative to the current pulse dye densitometer (PDD) devices that are 
specialized and not typically compatible with small animal imaging. The 
original journal article from which this chapter is adapted can be found at 
http://iopscience.iop.org/0031-9155/57/24/8285   
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4.1. Introduction 
In Chapters 2 and 3, nonparametric kinetic analysis was used to quantify 
CBF and to provide a meaningful relative blood flow index, respectively. Both 
these methods, (and additionally, the method highlighted in the next two 
chapters) require that the AIF—the time-dependent change in arterial dye 
concentration—be characterized. This is a common requirement not just in 
DCE optical methods, but in medical imaging in general where tracer kinetic 
modeling is commonly used to characterize physiological processes (Sourbron 
and Buckley 2012). Extracting quantitative measurements from kinetic data 
requires that the AIF be measured, because it describes the delivery of tracer 
to the tissue. Therefore, proper characterization of the AIF is an important 
goal in many modalities, including optical imaging. In this thesis, as well as 
in many other optical applications, the tracer indocyanine green (ICG) is 
used. Indocyanine green acts as an intravascular tracer in most tissues due 
to its binding with plasma proteins (e.g., albumin). Since ICG is FDA 
approved (United States Food and Drug Administration 2012), it has been 
used in clinical settings to assess neurological function (Steinkellner et al 
2010; Liebert et al 2005) and to characterize breast tumours (Schneider et al  
2011), in addition to measuring cerebral blood flow (CBF) in Chapter 2 and 
elsewhere (Brown et al 2002; Diop et al 2010; Springett et al 2001). The 
principles of tracer kinetic modeling can also be applied to targeted optical 
contrast agents that are conjugated with ligands to study receptor binding 
potential and drug delivery mechanisms (Becker et al 2001). 
To properly measure the AIF of an optical dye, a device known as a 
PDD is usually needed (Iijima et al 1997). However, these units are 
specialized pieces of equipment that are not commonly found and are only 
optimized for determining the AIF of ICG. Furthermore, in preclinical small 
animal studies, no PDD is available that functions at the high heart rates of 
these animals. Because of these obstacles, more simplistic kinetic models are 
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used that do not correct for AIF-dependent effects. For example, dynamic 
contrast-enhanced MRI techniques will perform kinetic analysis on tissue 
measurements with the assumption that the AIF is constant across 
measurements or patients, but these assumptions can be problematic and 
lead to errors in the recovered parameters (Parker et al 2006). The wider 
application of kinetic modeling to quantify important parameters such as 
blood flow, vascular leakage and receptor binding potential requires a more 
accessible method of measuring the AIF.  
 The methodology presented in this chapter enables the conversion of 
an off-the-shelf pulse oximeter (PO) into a PDD. This is accomplished by 
deriving a mathematical relationship between the arterial concentration of 
dye and the negative change in apparent SaO2 measured by the pulse 
oximeter, which occurs because the increase in absorption due to the dye is 
interpreted as an increase in deoxyhemoglobin. While this interference has 
been previously observed (Sidi et al 1987), this study is the first time it has 
been used to actually quantify the AIF. Validation experiments were 
conducted in rabbits using a small animal oximetry device (MouseOx, STARR 
Life Sciences, Oakmont, PA), but the approach is translatable to the clinic, 
capitalizing on the ubiquity of pulse oximeters. 
4.2. Theory 
4.2.1.  Pulse oximetry 
Pulse oximeters record oscillations in light attenuation (ΔA1 and ΔA2) at two 
wavelengths (λ1 and λ2) that results from oscillations in arterial blood vessel 
diameter, ΔD, in response to the beating heart (Aoyagi 2003). Oxyhemoglobin 
and deoxyhemoglobin are the dominant light-absorbing molecules in the 
blood for the wavelengths selected by pulse oximeters. In this case, the 
changes in attenuation can be approximated using the Beer-Lambert Law: 
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  DCCA bbaa  1,1,1   (4.1a) 
  
  ,2,2,2 DCCA bbaa    (4.1b) 
where Ca and Cb are the concentrations of oxyhemoglobin and 
deoxyhemoglobin, respectively, and εa,i and εb,i are their corresponding 
extinction coefficients defined for i = (λ1, λ2). In pulse oximetry, equations 
4.1a and 4.1b are rearranged to determine SaO2 as follows: 
    DtHbSaOtHbSaOA ba  )1( 21,21,1   (4.2a) 
    ,)1( 22,22,2 DtHbSaOtHbSaOA ba    (4.2b) 
where SaO2 is the oxygen saturation ratio, defined as CHbO2 / tHb, and tHb, 
the total hemoglobin concentration, equals Ca + Cb. In practice, scattering 
and partial volume errors arising from the expansion of non-blood media 
create systematic errors in the measured signal. To overcome many of the 
subject-dependent errors, the channel-dependent information is converted to 
a ratio: 
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Small errors that still remain in this expression are generally calibrated by 
adjusting the intensity and gains of the electronics until the actual SaO2 
measured by hemoximetery matches the SaO2 recovered by solving Eq. 4.3. 
Alternatively, a calibration curve can be used to generate a linear 
approximation: 
  
,2 ss bSaOM    (4.4) 
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where Ms and bs are the calibration factors determined by the manufacture, 
typically obtained from healthy subjects (Mendelson 1992), to convert the 
measured change in light absorption SaO2. 
The addition of another chromophore (such as an intravenously 
injected optical dye) will not appreciably alter the calibration process 
described above if it does not cause an appreciable change in the scattering 
properties of the tissue and does not substantially accumulate in the non-
blood media within the region of interrogation. The relationship between the 
apparent SaO2 (aSaO2) reported by the pulse oximeter and the concentration 
of injected dye can be given by 
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  (4.5) 
where Ci represents the concentration of the additional chromophore and εi,j 
represents the extinction coefficient of the ith chromophore at the jth 
wavelength that is normally used by the system. Extinction coefficents, εi,j*, 
represent the extinction coefficient of the ith chromophore at the jth 
wavelength that is actually used to acquire the measurement. If the native 
probes are used to acquire the signal, then εi,j* is equal to εi,j. However, if a 
customized probe is used to modify the emission wavelength of the probe, εi,j* 
must be adjusted for the difference in absorption at the new wavelength. This 
additional parameter allows the use of a different wavelength of light in 
order to increase the sensitivity of the system to the desired optical dye, as 
was done in the validation experiments. The variable aSaO2 represents the 
apparent SaO2 that is reported by the instrument, whereas the variable SaO2 
represents the actual SaO2. The latter can be measured before the injection 
and assumed to be constant during the period that the AIF is measured. 
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Finally, the total haemoglobin concentration, tHb, is determined from a 
venous blood sample. To obtain Ci, Eq. 4.5 is solved using the fminsearch 
function in MATLAB (The MathWorks, Natick, MA). 
4.2.2.  Tracer kinetic modeling 
In tracer kinetic modeling, the time-dependent concentration of contrast 
agent in tissue, Ct(t), is related to the AIF by the convolution in Eq. 1.5 
(Meier and Zierler 1954). The specific definition of the impulse residue 
function, R(t), will change depending on the behaviour of the contrast agent 
in the tissue region of interest. For the purpose of this validation paper, the 
adiabatic approximation to the tissue homogeneity model (AATH), which 
characterizes blood flow and tracer leakage into the surrounding tissue, was 
used to simulate tissue concentration curves (St Lawrence and Lee 1998). 
The impulse residue function, R(t), derived from the AATH model is given by: 
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where Θ(t) is the Heaviside step function, Tc is the transit time through the 
capillary, E is the extraction fraction of the dye from the IVS to the EVS, Ve 
is the distribution of tracer in the EVS and F is blood flow.  The tracer kinetic 
portion of the error analysis in the next section was conducted for an 
untargeted tracer using the input summarized in Table 4.1. 
Table 4.1: Input parameters 
Parameter Units Input value 
Blood flow, F ml min-1 100g-1 15.0 
Capillary transit time, Tc s 6.5 
EVS distribution volume, Ve ml 100g-1 75.0 
Permeability-surface area 
product, PS 
ml min-1 100g-1 10.4 
Input parameters for the AATH forward model (Eq. 4.6) used in the validation experiment. 
124 
4.3. Methods 
4.3.1.  Validation of arterial input functions measured by pulse 
oximetry 
An error analysis based on simulated data was conducted to better 
understand the effect of certain variables on the ability to recover the AIF 
accurately. First, the measurement resolution of the recovered dye 
concentration was characterized since it depends on the resolution of the 
pulse oximeter SaO2 channel, the absorption properties of the dye, and tHb. 
For this analysis, tHb was fixed at 12 g/dl, the true SaO2 was set to 95%, and 
the apparent SaO2 was decreased from 95% to 75% in steps of 0.1%, which is 
the resolution of the SaO2 data stored by the MouseOx system. The 
concentration of dye at each SaO2 level was recovered from Eq. 4.5 using the 
extinction coefficients of indocyanine green. This was repeated for different 
“red channel” wavelengths from 600 to 900 nm to determine the relationship 
between the selected wavelength and the resolution of the measured dye 
concentration. Next, the effect of total haemoglobin concentration on the 
measurement resolution of the recovered dye concentration was investigated. 
The “red channel” wavelength was fixed at 760 nm, the true SaO2 was set to 
95%, and the apparent SaO2 was decreased from 95% to 75% in steps of 0.1%. 
The concentration of dye at each SaO2 level was recovered, and this process 
was repeated for tHb values from 5 to 25 g/dl. 
 In the second part of the experiment, the relationship between the 
PDD measured dye concentration and the dye curves extracted with the PO 
method were investigated in a rabbit model (see subsection 4.3.3). Regression 
plots were generated for each set of ICG curves, and a meta-analysis was 
performed to determine the mean and 95% confidence interval of the 
regression slopes. Theoretical tissue curves were generated by the AATH 
model using the measured AIF from the pulse oximeter and from the PDD to 
further understand how differences between the two AIFs would affect the 
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accuracy of the derived model parameters. The ‘true’ Ct(t) was generated 
using the PDD-measured AIF and the values of the model parameters given 
in Table 4.1. The AIF derived from pulse oximetry was then used to recover 
best-fit estimates of the model parameters from the theoretical Ct(t) curve by 
the fminsearch minimization function. The percent difference between the 
recovered and input F and PS values were determined.  
4.3.2. Instrumentation 
For the validation experiments, a small animal pulse oximeter (MouseOx, 
STARR Life Sciences, Oakmont, PA) was used. This unit is sensitive to fast 
heart rates, making it suitable for mouse and rat experiments, in addition to 
animals with slower heart rates such as rabbits. Custom-made probes with a 
“red channel” wavelength of 753 nm were used to improve the sensitivity of 
the pulse oximeter to ICG (see Fig. 4.1). The extinction coefficients for the left 
side of Eq. 4.5 were provided by the engineering team at STARR Life 
Sciences, whereas the modified extinction coefficients for the right side of Eq. 
4.5 were determined in two steps: first, the light source spectrum was 
characterized with an off-the-shelf broadband spectrometer (QEE65000, 
Ocean Optics, Dunedin, FL). Second, this reference spectrum was used as a 
probability density function to sample from the extinction spectra of the three 
chromophores, which have been previously measured (Landsman et al 1976). 
Finally, a pulse-dye densitometer (DDM2000, Nihon Koden, Japan) capable 
of measuring the AIF in rabbits, which have a normal heart rate range of 
190-310 bpm (Murphy et al 2011), was used to validate the AIF obtained from 
pulse oximetry. This instrument has been previously validated by comparison 
to serial blood sampling (Iijima et al 1998). 
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4.3.3.  Animal experiments 
All animal experiments were approved by the animal use committee at 
Western University (AUP #2009-087). Measurements using the PO and PDD 
were acquired in four New Zealand white rabbits (Oryctolagus cuniculus), 
approximately 6 months old (weight = 2.8 ± 0.3 kg). Animals were induced 
and maintained with isofluorane gas anaesthesia at 4% and 2.5% 
concentration, respectively. A mixture of 2:1 oxygen and medical air was 
maintained for the duration of the experiment, and blood gases, glucose, and 
rectal temperature were monitored frequently. The pulse oximeter and PDD 
probes were placed on separate hind limbs, and adequate signal strength was 
verified in both instruments before proceeding with tracer injection. Animals 
were allowed to rest for 30 minutes to stabilize before the experiment was 
started. 
 For each animal experiment, a solution of ICG (Cardiogreen, Sigma-
Aldrich, St. Louis, MO; 0.3 mg kg-1 ml-1 dissolved in 0.5 ml of sterile water) 
was prepared. A total of two bolus injections were administered by 
intravenously with approximately 40 min between injections to allow the ICG 
to clear the system. Boli were rapidly injected, resulting in a first-pass full 
width half maximum of approximately 5 seconds. During each injection, data 
were acquired by the PO and PDD simultaneously, and downloaded to a 
laptop for subsequent analysis. The sampling rate of the pulse oximeter was 
15 Hz; the PPD records each measurement at systole (equivalent to 
approximately 5 Hz in these animals) to a maximum of approximately 6 Hz. 
Heart rate, arterial oxygen saturation, and total haemoglobin were also 
measured and recorded, with the latter being measured by hemoximetry 
(ABL 80 FLEX CO-OX, Radiometer, Copenhagen, Denmark). 
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4.4. Results and discussion 
4.4.1.  Error analysis 
Measurement resolution is defined as the minimum change in dye 
concentration that produces a detectable instrument response. The recorded 
SaO2 channel used to calculate the dye concentration has a measurement 
resolution of 0.1%. Additionally, the degree to which a change in dye 
concentration causes a response in the SaO2 channel depends on the 
absorption properties of that dye. These two factors ultimately determine the 
AIF measurement resolution. For error analysis, simulations were performed 
by varying the “red channel” of the dye from 600 to 900 nm (step size: 5 nm), 
while fixing SaO2 at 95% and tHb at 12 g/dL. Fig 4.1 depicts the 
measurement resolution as a function of the wavelength of the “red” channel, 
which is the numerator in Eq. 4.5, when ICG is used as the optical dye. The 
absorption spectrum of ICG is shown for comparison. Note that the resolution 
function is not a perfect mirror of the ICG spectrum due to the additional 
influence of the other chromophores. 
 
Figure 4.1: Influence of “red” channel wavelength on measurement resolution  
The measurement resolution of the dye concentration extracted from the pulse oximeter 
SaO2 channel plotted on a log scale (black line), and the corresponding ICG absorption 
spectrum in plasma (gray line) plotted on an arbitrary linear scale. 
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As expected, the highest measurement resolution is achieved when a “red 
channel” wavelength is used that corresponds to the absorption peak of the 
dye (802 nm for ICG in plasma). If a light source is used that corresponds to 
the absorption peak of ICG, then a pulse oximeter that has a measurement 
resolution of 0.1% is capable of resolving 0.01 mM changes in dye 
concentration. A standard pulse oximeter, which employs a light source of 
around 650 nm would be able to resolve submilimolar (~0.5 mM) 
concentrations. 
 The amount of endogenous light absorption depends on the total 
haemoglobin concentration, tHb. Therefore, the relative effect of the dye on 
the overall signal change will depend on this parameter, which ultimately 
will affect the measurement resolution. An error analysis was performed by 
varying tHb from 5 to 25 g/dL (step size: 0.25 g/dL). A “red channel” 
wavelength of 760 nm was used, and SaO2 was set to 95%.  
             
Figure 4.2: Influence of hemoglobin concentration variations on measurement  
resolution 
The measurement resolution of the dye concentration extracted from the pulse oximeter 
SaO2 channel plotted on a log scale (black line) versus the total haemoglobin (tHb). A forest 
plot of tHb reference ranges are shown to provide context (London Laboratory Services 
Group 2012; Abbassi-Ghanavati et al 2009). *Values obtained from animals used in this 
experiment. 
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Figure 4.2 summarizes the relationship between tHb and dye measurement 
resolution, and normal haemoglobin ranges are highlighted for several 
patient groups by a forest plot. The error analysis suggests two distinct 
resolution levels within the range of normal human haemoglobin 
concentration, which may reduce the performance of the technique in a 
certain subjects such as healthy adult men, by a factor of approximately 5. It 
is important to note that the abrupt changes in measurement resolution are 
not artificial, but represent an amplification of the rounding error resulting 
from the SaO2 channel measurement resolution of 0.1%. 
4.4.2.  Validation experiment 
A representative example of the AIF acquired with the PDD plotted alongside 
the AIF calculated from pulse oximetry is depicted in Fig. 4.3. In this case, 
the slope and y-intercept of the regression between the two curves was 0.915 
and 0.1 mM, respectively. There was a −3.3% difference in the peak 
concentration, and a −10.2% and 5.5% percent difference in F and PS when 
the pulse oximeter AIF was used to extract the kinetic parameters from Ct(t) 
generated from the PDD-measured AIF.  
 
Figure 4.3: Arterial input functions measured by the two instruments 
The AIF recovered with the PO method (gray line) using the method presented in this 
Chapter, and the AIF directly recovered using the PDD (black line). 
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This analysis was performed for all measurements across the four 
rabbits used in the study, and group means were determined as well as the 
95% confidence intervals for each parameter. Figure 4.4 summarizes the 
regression results for the group analysis. The mean slope was 0.92, bound by 
a 95% confidence interval of 0.787 - 1.063. The mean y-intercept was 0.2 mM 
with a 95% confidence interval of –0.3 - 0.6 mM. 
 
 
Figure 4.4: Relationship between PO and PDD measured ICG concentration  
The regression plot comparing ICG concentration values obtained with the PO and the PDD 
simultaneously. The individual regression lines-of-best fit (n=8) were determine separately 
for the two ICG boli given to each of the four animals. The average line of best fit is indicated 
by the dashed line (slope =  0.92 ± 0.03, y-intercept = 0.18 ± 0.09 mM)  
Figure 4.5 shows the Bland-Altman plot comparing the ICG 
concentration values obtained with the PDD and PO techniques. Linear 
regression analysis revealed a significant relationship between difference and 
mean concentration (p < 0.05) suggesting a proportional bias. The bias was 
defined by the line with a slope = −0.052 and a y-intercept = 0.19 mM. The 
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95% confidence intervals for the slope and y-intercept were −0.13 - 0.2 and 
−0.28 - 0.66, respectively. 
 
Figure 4.5: ICG concentration Bland-Altman plot   
The Bland –Altman plot comparing the ICG concentration measurements obtained with the 
PDD and calculated from PO measurements of SaO2. As in Fig. 4.3, data are represented by 
lines-of-best fit of each ICG bolus (n=8). The mean difference between the two techniques is 
indicated by the solid line, and the 95% confidence interval is indicated by the dashed line. 
As suggested by the proportional bias in the Bland-Altman analysis, 
the pulse oximeter tended to underestimate the concentration of ICG at high 
concentrations. This could be in part due to the dynamic range of the 
detectors used by this specific oximeter, which may not be as sensitive to 
SaO2 below 60%. 
Table 4.2 summarizes the group mean and confidence intervals for the 
percent differences in peak concentration, F, PS, and Tc extracted from the 
theoretical ICG tissue concentration data using the AIF from the pulse 
oximeter AIF rather than the true AIF from PDD. In addition, the p values 
from a paired t-test comparisons of values obtained using the two AIFs are 
shown. While there was no significant difference in the parameters obtained 
with the two AIFs, blood flow measurements were most affected by the 
underestimation in high ICG concentrations previously mentioned. 
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Table 4.2: Percent difference in recovered parameters 
Parameter Mean 95% Confidence 
Interval 
p value 
Peak concentration −7.4%   −27.6 - 12.8% 0.23 
Blood flow, F −8.5% −23.3 - 6.3% 0.06 
Permeability-surface 
area product, PS 
1.7% −7.4 - 10.9% 0.45 
Capillary transit 
time, Tc  
1.5% −6.5 – 9.5% 0.40 
Percent difference in parameters recovered using the pulse oximeter AIF from the forward 
data generated using the DDG AIF. Results of the paired t-test between input and recovered 
values are shown in the fourth column. 
The results of this study suggest that the commonly used pulse 
oximeter can be readily converted to a PDD fairly easily, which provides an 
accessible means of acquiring an AIF for use in tracer kinetic studies. 
Advancements in dynamic contrast-enhanced optical techniques have 
resulted in the ability to assess cerebral hemodynamics in neonates (Arora et 
al 2012), stroke patients (Steinkellner et al 2010) and traumatic brain injury 
patients (Keller et al 2001), and to localize and assess tumors in breast 
cancer patients (Schneider et al 2011). In addition, dynamic contrast-
enhanced techniques have been described for a wide of range of applications 
including diagnosis of peripheral artery disease (Kang et al 2010) and 
monitoring muscle oxygenation (Boushel and Piantadosi 2000), and have 
been theoretically described for pre-clinical imaging methods such as 
fluorescence molecular tomography (Elliott et al 2012). In all cases, the 
ability to measure the AIF would enable the use of more sophisticated and 
more accurate kinetic models that would account for the between-subject 
variability in AIFs (Schneider et al 2011). For example, recent work by 
Schneider and colleagues demonstrated the ability of NIRx to detect breast 
cancer in a group of patients undergoing biopsy (Schneider et al 2011). In 
that study, relative metrics such as time-to-peak and relative peak 
concentration were used to discriminate between benign and malignant 
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tissues. The acquisition of the AIF would allow blood flow and vascular 
leakage of the regions of interest to be characterized, possibly providing 
additional sensitivity and specificity, and would also reduce intra-subject 
variability since measuring the AIF implicitly accounts for differences in 
blood circulation. Despite the benefit of characterizing the AIF, only a limited 
number of groups regularly employ a PDD because they are expensive and 
few units have been approved for patient use. The methodology described in 
this note enables clinicians and researchers to instead capitalize on pulse 
oximeters, which exist in virtually every advanced trauma center or intensive 
care unit around the world, and can be combined with current dynamic 
contrast-enhanced optical techniques at little additional cost. 
In small animal imaging, an additional challenge to measuring the AIF 
is that no PDD device has been developed that is compatible with the high 
heart rates of rodents. There are, however, several pulse oximeter devices, 
including the MouseOx device used in this study, which are suitable for heart 
rates up to 900 bpm and can therefore be used to measure the AIF. Doing so 
would enable more sophisticated tracer kinetic models that could determine 
key parameters in the study of cancer development and treatment. For 
example, plasma input two-tissue compartment models (Mintun et al 1984) 
could be used to quantify molecularly targeted optical probe binding.  
While the method described in this paper will be useful for a variety of 
applications, there are several limitations that will ultimately determine 
whether the use of a pulse dye densitometer is more appropriate. First, the 
accuracy of the recovered dye concentration will be affected by any errors in 
the extinction coefficients in Eq. 4.5, as well as the accuracy of the measured 
tHb concentration. The former can be minimized if the peak wavelength of 
the two channels can be obtained either from the manufacturer of the device, 
or by spectrometric measurement by the user. Careful consideration of Eq. 
4.5 reveals that an error in tHb concentration will result in an equal error in 
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recovered dye concentration. This could be important, for example, in the 
critical care setting, where trauma patients presenting lower initial 
haemoglobin concentration may receive a packed red blood cell (PRBC) 
transfusion to improve the oxygen carrying capacity of the blood. In this case, 
a PRBC-corrected value of tHb may be helpful, where tHb is incremented by 
1 g for every one unit of infused PRBC (Christy et al 2011). More 
significantly, the limited measurement resolution of this approach in certain 
circumstances may hinder its applications. As demonstrated in the error 
analysis, measurement resolution issues are addressed by using higher dye 
concentrations, constructing custom probes that use a “red channel” 
wavelength at the peak absorption of the dye-of-interest, and being aware of 
the potential tHb-related pitfall. In some cases, however, the measurement 
resolution may still be limited. For example, when performing a tracer 
kinetic binding study, only a limited concentration of dye can be injected to 
avoid receptor saturation. However, given that demand often drives 
technological advances, the adoption of this technique as a means of 
measuring the AIF may result in the development of pulse oximeters capable 
of 0.01% or better SaO2 measurement resolution.  
4.5. Conclusions 
The results of this study demonstrate that with a basic understanding of 
pulse oximetry, it is possible to convert an off-the-shelf pulse oximeter into a 
dye densitometer that can be used to approximate the arterial input function 
in dynamic contrast-enhanced studies. This finding has immediate 
applications in both clinical and preclinical contexts.  
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Chapter 5 
KINETIC DECONVOLUTION OPTICAL 
RECONSTRUCTION: THEORETICAL BASIS 
AND NUMERICAL SIMULATIONS 
This chapter highlights the kinetic deconvolution optical reconstruction 
(KDOR) methodology, which can be applied to a variety of dynamic contrast 
enhanced (DCE) biomedical optics problems. The theoretical basis for KDOR 
was published in “Model-independent dynamic constraint to improve the 
optical reconstruction of regional kinetic parameters” by Elliott JT, Diop M, 
Lee T-Y, and St. Lawrence K, in Optics Letters in 2012. This chapter is an 
expanded version of the Letter, providing additional details on the theory and 
numerical results. The original Letter from which this chapter is adapted can 
be found at http://www.opticsinfobase.org/ol/abstract.cfm?uri=ol-37-13-2571 
5.1. Introduction 
Chapters 2 and 3 highlighted the use of DCE near-infrared (NIR) methods to 
measure tissue hemodynamic parameters: blood flow (BF), blood volume (BV) 
and mean transit time (MTT). Analogous to DCE methods in computed 
tomography (CT) and magnetic resonance imaging (MRI), the methodology 
requires the injection of a bolus of contrast agent, the recording of the time-
dependent signal change, and then the reconstruction of time-dependent 
contrast concentration for each pixel or region-of-interest. As in CT and MRI, 
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the conventional approach is a two-step (TS) process that first involves 
reconstructing a time-series of DCE images or datapoints, followed by 
performing kinetic analysis on the data from individual regions or image 
pixels to recover the parameters of interest (Cenic et al 2000). For example, 
in Chapter 2, continuous-wave (CW) NIR measurements were collected at 
two source-detector distances, and separation of brain and extracerebral 
layer (ECL) information was achieved using subject-specific anatomical and 
spectral priors to estimate mean partial pathlength (MPP) values. In Chapter 
3, the variance of the time-resolved signal was used to increase sensitivity to 
cerebral blood flow (CBF), and was deconvolved with the arterial input 
function (AIF) to estimate change in CBF. These steps represent first steps 
towards the goal of a robust bedside tool to measure CBF in the neurocritical 
care unit. However, the first study used an animal model that was an 
imperfect representation of the clinical reality, and was likely a “best-case 
scenario.” The second study achieved partial separation of brain and ECL 
signal enabling the quantification of changes in CBF, but would require 
calibration with another imaging modality in order to provide absolute CBF. 
The principle challenge to addressing the limitations in the previous 
studies is that complete separation of DCE signal arising from different 
tissue regions is non-trivial. First, the volume of interrogation is optically 
heterogeneous, with each region exhibiting different scattering and 
absorption properties. The adult head is comprised of scalp, skull, 
cerebrospinal fluid (CSF) and brain (which can be further divided into grey 
and white matter), each of which interacts with light differently. Therefore, 
the sensitivity function (or Jacobian) in the reconstruction forward problem is 
likely to contain model errors since the exact optical properties of each region 
are not known. Furthermore, even if the exact optical environment is 
sufficiently characterized, the scattering nature of light means that 
information measured across multiple source-detector pairs is highly similar. 
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This degree of interrelatedness reflected in the Jacobian results in an ill-
posed system (Bonfert-Taylor et al 2012), which is a common theme in almost 
all biomedical optical reconstruction problems. 
 Subsequent kinetic analysis further complicates matters since 
nonparametric kinetic analysis (i.e., deconvolution) is an unstable 
mathematical problem, often requiring modeling constraints to achieve 
acceptable precision (Lee 2005; Wirestam et al 2000). An implicit assumption 
is that the image region-of-interest or region-specific tissue concentration 
curve contains information from only one homogeneous tissue region. 
Because of the problems with spatial reconstruction, this assumption is 
invalid in many optical applications where the medium is heterogeneous and, 
as a result, quantitative kinetic analysis has been elusive. 
 Combining spatial reconstruction and kinetic deconvolution into a 
single mathematical system improves both problems and enables the 
reconstruction of kinetic parameters from multiple regions. In this chapter, 
the theoretical basis for this “kinetic deconvolution optical reconstruction” 
(KDOR) approach will be provided and, as a proof-of-principle, numerical 
simulations of time-resolved NIR measurements on the adult head are 
described. The accuracy and precision of KDOR recovered parameters will 
also be compared with values calculated using the traditional TS approach. 
5.2. Theory 
The KDOR approach combines the traditionally distinct steps of image 
reconstruction and tracer kinetic modeling in order to improve accuracy and 
precision of the recovered kinetic parameters (BF, BV, and MTT). Recall that 
optical reconstruction is governed by the forward problem, which in matrix 
form is given by 
 .ACS   (5.1) 
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In this case, S is the optical signal data vector (usually defined for a finite set 
of spatial coordinates or source-detector distances), C is the concentration of 
tracer in tissue (defined on the spatial set of nodes, voxels, or regions 
representing the imaging domain, Ω), and A is the transformation between 
these two vectors (conventionally referred to as the “Jacobian”). The Jacobian 
is defined for the domains of S and C, and includes scaling factors such as ε, 
the extinction coefficient of the tracer. The exact domains of S and C will vary 
for different applications.  For example, in reflectance measurements on the 
head, C is typically defined for two regions (ECL and brain) and S is collected 
at various source-detector distances. Other ways of encoding S include: 
source-detector pair, i; moment order, k; and time-of-flight, t. 
Notwithstanding differences in the encoding of S, optical reconstruction 
involves solving 
   ,minarg 2SAC
C
  (5.2) 
either in the least-squares sense, or using an iterative solver such as the 
Levenberg-Marquardt algorithm (Dehghani et al 2008). The recovered C 
vector is equivalent to a concentration map when spatially oriented according 
to the coordinates of Ω.  
When S is characterized temporally with a resolution on the order of 
seconds to minutes, tracer kinetic theory can be used to describe the behavior 
of C as a function of time. The time-dependent change in dye concentration at 
any location in the medium is given by the convolution between a global AIF, 
Ca(t) (since the same circulatory system feeds all tissue regions) and a flow-
scaled impulse residue function FR(t) (Eq. 1.5). The KDOR algorithm is 
formulated by substituting this definition for C into Eq. 5.1, yielding: 
 ,FBRS   (5.3) 
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where B is the Kronecker product, , RF is the vector constructed by 
stacking all node-specific FR(t) functions, and S is the vector constructed by 
stacking all time-specific data vectors. Quantification of blood flow, F, along 
with other kinetic parameters is achieved by the recovery of RF through 
   0HR0GR FF   and subject tominarg 2SBRF  (5.4) 
Equality and inequality constraints G and H are block matrices with 
identical-sized partitions equal to the number of regions, constructed based 
on the physiological assumptions outlined in subsection 1.4.3 for a single 
kinetic region. For example, in the case where RF represents the 
hemodynamic functions of three regions, the constraints in Eq. 5.4 would be 
represented by: 
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where gj and hj are the inequality and equality constraint vectors for the jth 
region. Recall from Eqs. 1.10 and 1.11 in the first chapter, that constraints 
are defined for time-intervals given by the lag time, Lj, which is equal to the 
time between the injection and first appearance of dye, and the minimum 
transit time, Mj, which is the shortest time that an idealized bolus (i.e., a 
Dirac-delta function) can travel across the capillary bed within the region of 
interrogation, specific to the jth region. In this case, the compartment hj in the 
equality constraint presented in Eq. 5.5 is represented as: 
ACA
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where NT  is the number of columns in CA. Similarly, the compartment gj in 
the inequality constraint in Eq. 5.5 is represented as: 
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It is therefore necessary to determine L and M for all tissue regions before 
the minimization of Eq. 5.4. This is done iteratively by solving Eq. 5.4 for 
different Lj and Mj values, and then comparing the reconstructed signal, S, to 
the experimentally measured signal. To speed up the process, only the first 
145 
30 seconds of the signal was used in the optimization. Figure 5.1 shows a 
representative example of this fitting procedure, which is analogous to the 
procedure used in the single-region deconvolution except that an iterative 
search was used instead of an exhaustive search (Lee 2005).  
 
Figure 5.1: Iterative search of lag and minimum transit time. 
The implementation of equality and inequality constraints in the deconvolution method 
require that the lag time, L and minimum transit time, M, be defined. This was done 
iteratively: the initial guesses for L and M shown in (A) were adjusted so that (B) shows the 
optimized value for L and (C) shows the convergence of both L and M. 
Once the values of L and M are optimized, Eq. 5.4 is minimized for all 
time points to recover RF. Finally, hemodynamic parameters are recovered 
from the region-specific FR(t) functions: BF is recovered by determining the 
maximum of FR(t), since R(t) is a normalized function with a maximum of 
unity (Meier and Zierler 1954); BV is given by the area under FR(t), and MTT 
can be calculated by the central volume principle (Zierler 1965) where MTT = 
BV / BF. 
5.3. Methods 
5.3.1. Forward model of the adult head 
A segmented finite element mesh of an adult human head was obtained 
online from the mesh-based Monte Carlo (MMC) repository 
(http://mcx.sf.net/mmc/). The MMC program and related files were developed 
by Qianqian Fang and are available free to use (Fang 2010). The adult head 
model was segmented from an MRI into four tissue regions: scalp, skull, CSF, 
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and brain. For the purpose of the forward model, these were assigned the 
optical properties summarized in Table 5.1. 
Table 5.1: Optical properties used in the Monte Carlo simulations 
Medium µs' (mm−1) µa (mm−1) g 
Scalp 0.70 0.018 0.9 
Skull 0.80 0.013 0.9 
CSF 0.01 0.002 0.9 
Brain 1.10 0.015 0.9 
 Continuous-wave signals were simulated for source-detector distances 
of 10, 20, 30 and 40 mm. First, MMC was used to simulate photon 
propagation in the adult head mesh, and photons “detected” at the four 
source-detector distances were recorded. Then, the mean partial pathlengths 
were determined from the photon history files using a previously described 
method (Boas et al 2002). In this way, the Jacobian, A, was constructed to 
relate the change in absorption occurring in the brain and in the ECL 
(representing the scalp, skull, and CSF) to the change in signal for the four 
distances. Time-dependent absorption changes in the two regions were 
generated by first convolving a simulated Ca(t) with layer-specific FR(t) 
functions defined by a gamma variate model (Thompson et al 1964) to obtain 
region-specific C(t) curves.  These curves were then converted to change in 
absorption coefficient using the ICG specific absorption at 800 nm.  An 
example is shown in Fig. 5.2.  
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Figure 5.2: Change in tissue absorption coefficient 
The dye-induced change in tissue absorption coefficient in the scalp (gray line) and brain 
(black line) used in the forward model. Absorption curves are plotted along with the Ca(t) 
function (dashed line, secondary y-axis) used in the simulations. 
Gaussian noise of 10% was added to both the arterial input function and the 
signal data vector. Noise was generated independently for each simulation 
using a unique pseudorandom number seed.  
5.3.2. Data reconstruction 
The KDOR reconstruction method was performed by numerical optimization 
of Eq. 5.4 using the MATLAB function lsqlin. The TS method, on the other 
hand, involves first performing spatial reconstruction to recover the brain 
and ECL specific C(t) curves, and then deconvolving these curves with the 
Ca(t) function using the single-region method described in subsection 1.4.3. 
Spatial reconstruction was regularized with the truncated singular-value 
decomposition (TSVD) method which has been proposed elsewhere for this 
application (Liebert et al 2004) and is an example of a common regularization 
method to stabilize optical reconstruction. 
A reconstruction Jacobian, Arec, was used in both KDOR and TS 
reconstructions, which differed from the Jacobian used to generate the 
forward data to avoid committing an “inverse crime”. The reconstruction 
Jacobian was essentially a noisy version of the forward Jacobian to simulate 
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uncertainty in the sensitivity factors that occurs during experimental 
conditions. Two aspects of uncertainty were added to the reconstruction 
Jacobian: the total sensitivity factor for each channel was randomly varied 
between ± 10% of the original value, and the ratios between region-specific 
sensitivity factors and the total sensitivity factor for that channel were varied 
between ± 10%. These randomizations represent uncertainties that would be 
introduced if the bulk scattering coefficient was inaccurate, or if there were 
inaccuracies in the ECL thickness, respectively. For each iteration, Arec was 
uniquely randomized with a new pseudorandom number seed.  
5.3.3. Numerical experiments 
Numerical experiments were conducted to compare the accuracy and 
precision of the KDOR and TS methods. Hemodynamic input parameters 
used to generate the forward data were held constant for all iterations. For 
the ECL, BF = 5 ml min-1 100g-1, BV = 1 ml 100g-1, and MTT = 12 s and for 
the brain, BF = 50 ml min-1 100g-1, BV = 4 ml 100g-1 and MTT = 5 s. 
Reconstruction was repeated 100 times on the forward data to compare the 
precision of the KDOR and TS methods. 
5.4. Results and discussion 
Brain-specific absorption curves obtained from the TS and KDOR approaches 
are shown in Fig. 5.3. Note that the TS absorption curve is recovered in the 
first step of the procedure, and then subsequently analyzed to recover the 
hemodynamic function. The KDOR absorption curve is generated by 
convolving the recovered FR(t) function with the original arterial input 
function. Two important differences are observed when comparing these 
curves. First, the TS curve shows a bias in the peak absorption compared to 
the input curve, of about -10%, whereas, the KDOR curve shows no 
discernible bias. In addition, the variability in the TS curve was two times 
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greater than the KDOR curve around the absorption peak, and this 
variability increased to five times at all other time points. 
 
Figure 5.3: Brain tissue change in absorption coefficient recovered with KDOR  
and TS 
(A) The brain change in absorption coefficient recovered with the KDOR method (open 
circles), and (B) the change in absorption coefficient recovered with the TS method (open 
circles). Both are compared with the true input curves (black solid line). Data points are the 
mean of 100 iterations, and error bars are the standard deviation.  
Next, the average FR(t) curves recovered with the two approaches, which are 
shown in Fig. 5.4, were compared. Interestingly, the ECL curves are 
recovered well by both methods, suggesting that there is sufficient 
information present in the measured signal pertaining to this region to allow 
direct reconstruction with minimal regularization.  
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Figure 5.4: Impulse residue functions recovered with KDOR and TS 
(A) and (B) show the true (solid black line) and recovered (open circles) FR(t) curves for the 
ECL and brain tissue, respectively, calculated with the KDOR algorithm. (C) and (D) show 
the true and recovered curves for the ECL and brain tissue, respectively, obtained using the 
TS method. Data points are the mean of 100 iterations, and error bars are standard 
deviation. 
However, the reconstructed brain FR(t) curves show marked differences 
between the two methods, similar to the differences seen in the absorption 
curves. In particular, the TS approach seemed to do a poor job of capturing 
the shape of the top of the curve. Since the plateau is used to calculate BF, 
this resulted in an underestimation of BF by 11%. The precision of the 
recovered curves was higher for the scalp region, and higher when using 
KDOR compared to TS. Taken together, these results suggest that errors in 
the TS during spatial reconstruction propagate into the kinetic analysis, 
resulting in increased variability and an underestimation bias. 
The three hemodynamic parameters of interest (BF, BV and MTT) 
were calculated for the two tissue regions from the recovered FR(t) curves. 
Box-and-whisker plots shown in Fig. 5.5 summarize the results of the kinetic 
analysis.  
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Figure 5.5: Hemodynamic parameters recovered with the two methods 
Box-and-whisker plots of the blood flow (BF), blood volume (BV) and mean transit time 
(MTT) recovered with the KDOR and TS methods for scalp (top row) and brain (bottom row) 
regions. Boxes are bound by the 1st and 3rd quartiles, and the median is given by the centre 
line. Error bars are min and max, with outliers shown as crosses. Dashed lines show the true 
value of the parameter. 
In general, the KDOR method does a better job of recovering the 
hemodynamic parameters than the TS method. In particular, the mean error 
in recovered CBF was −1.4% using the KDOR approach, compared with 
−11.0% using the TS approach. Additionally, the precision of the CBF 
estimate derived from the KDOR method was about two times greater. 
The improvements that were observed by using the KDOR are most 
likely a result of the reduced loss-of-information when solving the inverse 
problem in Eq. 5.3. In particular, when compared to the spatial 
reconstruction problem in Eq. 5.1, the linear operator in Eq. 5.3 (i.e., the 
Kronecker product of A and CA) is of higher rank since its rank is equal to the 
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sum of the ranks of A and CA (Laub 2005). In signal processing, the 
numerical rank (also called the effective rank or pseudorank) is often more 
instructive than the algebraic rank, and is defined as the number of columns 
in the matrix that, with respect to some error tolerance, are practically 
linearly independent (Hansen 1998). Since measurement and modeling errors 
do not depend on the analytical method, the resulting effective rank is also 
higher in the KDOR inversion than in the TS inversions. Furthermore, the 
ability to constrain the KDOR inversion temporally, using rigid 
physiologically derived equality and inequality constrains is likely to add 
further stability to the inverse problem.  The exact degree to which these 
constraints improve reconstruction will depend on how different the FR(t) 
functions are for the different regions. For example, if two regions of very 
similar FR(t) functions are interrogated, there is likely to be crosstalk 
between the two regions as the amount of interrelated information in B is 
increased. However, in this case, since the regions are so similar to begin 
with, any crosstalk will have a negligible effect on overall accuracy. An 
additional benefit to using the KDOR approach is that it can be applied to 
data that is encoded across any number of different dimensions (e.g., spectral, 
spatial, as well as temporal in the case of time-resolved data). Because it is 
compatible with the use of other constraints (e.g., spectral and anatomical 
priors) it has the potential to improve optical—and potentially photoacoustic 
or optoacoustic—reconstruction across a wide range of applications. 
5.5. Conclusions 
Taken together, these numerical simulations suggest that KDOR enables the 
accurate and precise characterization of hemodynamics for a wide range of 
conditions. Based on these encouraging results, the next chapter will validate 
multi-distance, time-resolved NIR measurements of cerebral hemodynamics 
recovered using the KDOR method in an animal model of cerebral ischemia. 
This represents a final step in the development of instrumentation and 
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analytical methods presented in this thesis to monitor adult patients in the 
neurocritical care unit.  
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Chapter 6 
MEASURING CEREBRAL HEMODYNAMICS IN 
AN ADULT PIG MODEL OF ISCHEMIA WITH 
TIME-RESOLVED NEAR INFRARED AND 
KINETIC DECONVOLUTION OPTICAL 
RECONSTRUCTION 
This chapter presents the validation of cerebral hemodynamic parameters 
measured by time-resolved (TR) near-infrared (NIR) in combination with the 
kinetic deconvolution optical reconstruction (KDOR) analytical method in an 
adult pig model of ischemia. As such, this work extends the theoretical 
derivations presented in the previous chapter, establishing the outlined 
methodology as a robust technique capable of accurately quantifying cerebral 
blood flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT). 
This chapter is based on a manuscript entitled "Measurement of cerebral 
hemodynamics in an adult pig model of ischemia using a quantitative 
dynamic contrast-enhanced optical method" by Elliott JT, Diop M, Morrison 
LB, d'Esterre CD, Lee T-Y, and St. Lawrence K, which will be submitted to a 
peer-reviewed journal in the near future. 
6.1. Introduction 
In the previous chapter, the kinetic deconvolution optical reconstruction 
(KDOR) analytical method was introduced and, based on numerical 
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simulations, it was suggested that KDOR could be used to recover cerebral 
hemodynamics from multi-distance dynamic contrast-enhanced (DCE) NIR 
measurements, even in the presence of large extracerebral layer (ECL) signal 
contamination. By employing the KDOR approach, while at the same time 
leveraging improvements in optical instrumentation presented in Chapter 3 
(i.e., time-resolved NIR), it is hypothesized that resulting CBF measurements 
acquired in an adult pig during baseline, hypocapnia and ischemia will show 
strong agreement with CT perfusion measurements, similar to the 
continuous-wave, two-step approach in Chapter 2 demonstrated on a juvenile 
pig model with less ECL contamination. Furthermore, by validating this 
approach in a clinically relevant model, using anatomical and dynamic priors 
that are also available clinically, this study represents a final staging ground 
before deploying DCE-NIR in clinical trials. 
 With this goal in mind, this chapter will address three main objectives. 
First, the KDOR method will be used in combination with time-resolved NIR 
measurements acquired at four source-detector distances to evaluate the CBF 
and CBV in an adult pig under three physiological states: baseline, 
hypocapnia, and ischemia. Concomitant measurements will be acquired using 
CT perfusion, in similar fashion to the juvenile pig study presented in 
Chapter 2, and regression and Bland-Altman analysis will be used to 
determine the difference between the two techniques. Second, to induce 
ischemia in the adult pig, intracortical injections of endothelin-1 will be 
administered. The reproducibility of this method will be determined, and the 
resulting lesion will be described in terms of three abnormal tissue states: 
infarct core (defined as CBF < 10 ml min-1 100g-1), penumbra (defined as CBF 
between 10 ml min-1 100g-1 and 20 ml min-1 100g-1), benign oligemia (defined 
as CBF between 20 and 40 ml min-1 100g-1) and normal tissue state (defined 
as CBF > 40 ml min-1 100g-1). In particular, for the purpose of this 
experiment, it is important to understand how each tissue state is 
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contributing to the region interrogated by the NIR light. Finally, an error 
analysis will be conducted to investigate the effect of probe positioning errors 
(i.e., corregistration with CT or MRI anatomical information) and model 
dependent errors caused by inaccuracy in the ECL reduced scattering 
coefficient input value, which has a stronger influence on the sensitivity 
factors (e.g., mean partial pathlength) than absorption coefficient. In 
particular, the dependency of the method on correctly estimating the optical 
properties of the ECL provides insight into whether or not TR NIR 
instrumentation (which is more complex and expensive than CW 
instrumentation, but provides greater sensitivity) is needed in clinical 
applications. 
6.2. Materials and methods 
6.2.1.  Animal protocol 
Animal experiments were conducted according to the guidelines of the 
Canadian Council on Animal Care and approved by the Animal Use 
Committee at Western University (AUP #2007-050-06). Eight Duroc x 
Landrace crossbred pigs (Sus scrofa domesticus, weight = 15.4 ± 0.74 kg, 6 
females) were obtained from a local supplier on the day of the experiment. 
Following anesthetic induction with 1.75-3% isoflurane, the animals were 
tracheotomized and mechanically ventilated on a mixture of oxygen and 
medical air. A polychloroprene probe holder was constructed in-house and 
fixed on the head of the animal with tissue glue (Vetbond® (n-butyl 
cyanoacrylate), 3M, St. Paul, MN). The adult pig has thick temporalis 
muscles that originate at the temperoparietal region of the head are highly 
vascularized, resulting in a scalp blood flow of about 25 ml min-1 100g-1 
(Elliott et al 2013b)—much higher than is typical in the adult scalp, 
estimated to be 5-8 ml min-1 100g-1 (Friberg et al 1986). To improve the 
relevance of the animal model, three surgical incisions were made (caudial, 
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rostral, and lateral to the probe holder) to reduce the blood flow to about 10 
ml min-1 100g-1, measured with CT perfusion. Following the preparation and 
surgical procedures, the animals were moved to the CT imaging suite and 
allowed to stabilize for 1-hr before the experiment was continued.   
6.2.2. Study design 
The study consisted of collecting CT and DCE-NIR measurements at three 
different levels of CBF. Following stabilization, physiological parameters 
were recorded and a DCE-NIR measurement was acquired over a period of 
about 5 minutes. The optical probes were removed from the probe holder and 
a CT perfusion scan was performed. Following the CT scan, the probes were 
replaced in the probe holder, and a second DCE-NIR measurement was 
acquired. A period of at least 15 minutes was given between DCE-NIR 
measurements to allow for clearance of the dye. This process was repeated for 
the hypocapnia and ischemia conditions, resulting in a total of six optical 
datasets and three CT perfusion datasets for each animal. A total of five 
animals were subjected to all three conditions and a total of three animals 
were subjected to only baseline and hypocapnia conditions; for two animals, 
the experiments were conducted before a protocol modification was submitted 
to allow the ischemia procedure, and for one animal, endothelin-1 was 
unavailable. 
6.2.3. Modification of cerebral blood flow 
Hypocapnia was achieved by adjusting the ventilation rate on the mechanical 
ventilator to achieve a PCO2 of 25 mmHg. Blood gas levels were confirmed 
using a hemoximeter (ABL 80 FLEX CO-OX, Radiometer, Copenhagen, 
Denmark). Once the appropriate PCO2 level was achieved, the physiological 
parameters were allowed to stabilize before proceeding with the experiment. 
Ischemia was achieved by intracortical injection of endothelin-1 (Sigma-
Aldrich, St. Louis, MO), a potent vasoconstrictor. A burr hole was drilled 
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through the scalp and skull just lateral to the probe holder, half way between 
the source optode and the 40 mm detector optode. A 30-Ga needle was 
carefully inserted into the cortical tissue, angled towards midline, and a low-
dose CT scan was performed to confirm the location of the needle tip. The 
needle was connected to a catheter, which in turn was connected to a syringe 
containing approximately 1 μg/kg of endothelin-1 in 0.1 ml of sterile water. 
Using a syringe pump, the contents of the syringe were delivered to the 
cortical tissue over 10 minutes. Data collection proceeded 10 minutes after 
the endothelin-1 injection was finished. 
 The reproducibility of endothelin-induced blood flow change was 
reported as the standard deviation of mean CBF across the DCE NIR region 
of interrogation (determined from light propagation modeling). The 
reproducibility of infarct-size was determined tracing the infarct perimeter 
free-hand, and computing the corresponding area using image analysis 
software (ImageJ 1.46, National Institutes of Health, Bathsheba, MD). The 
area was determined on the eight blood flow maps, and the volume was 
calculated by multiplying the sum of the areas from each stack by the slice 
thickness (5 mm). 
6.2.4. Physiological measurements 
In addition to CT and DCE-NIR measurements, physiological parameters 
were monitored throughout the experiment, including: arterial oxygen 
saturation, heart rate, respiration rate, end-tidal CO2, mean arterial 
pressure, and rectal temperature. In addition, a hemoximeter was used to 
measure arterial blood pH, PCO2, PO2, and glucose. The main purpose of 
collecting these measurements was to ensure physiological stability at each of 
the three conditions, which was achieved by adjusting the respiration rate on 
the mechanical ventilator, and by maintaining temperature and glucose 
homeostasis via a heated blanket and dextrose administration, respectively. 
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6.2.5. Instrumentation 
Optical measurements were collected using a time-resolved NIR system that 
has been described previously (Diop et al 2010), and is depicted in Fig. 6.1. 
The system comprised of a picosecond diode laser light source that was used 
to emit 802 nm light pulses with a repetition rate of 80 MHz. A 1.5-m long 
multimode fiber was used to guide the light from the source to the surface of 
the animal head at a single position. Photons exciting the scalp were collected 
by four optodes configured linearly at distances of 6, 20, 30, and 40 mm from 
the source, which was guided through bandpass filters (FEB800-10, Thorlabs, 
NJ; to exclude fluorescence) to four photomultiplier tubes (PMC-100, Becker 
& Hickl Gmbh, Berlin, Germany). To perform DCE-NIR measurements, time-
of-flight histograms were collected every 0.4 seconds for a total of 320 seconds 
during the passage of indocyanine green (ICG), the optical dye used as a 
contrast agent. Baseline data of 12.8 s were collected before the bolus 
injection. Distributions of time-of-flight (DTOF) were measured at all four 
channels simultaneously. In addition, the arterial input function (AIF) was 
acquired using a pulse dye densitometer (DDM2000, Nihon-Koden, Japan).  
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Figure 6.1: Layout of the time-resolved NIR system 
The source fiber guides the pulsed light towards the sample, where it is collected by four 
fibers, and detected using four photomultiplier tubes (PMTs). The PMTs send constant 
fraction descriminator (CFD) signal to the four single-photon counting (SPC) boards located 
in the PC where the data is stored and displayed. The PMT data is synchronized to the laser 
driver via a sync cable. 
 Computed tomography anatomical images and CT perfusion maps 
were acquired using the LightSpeed QXi scanner (GE Healthcare, Waukesha, 
WI). Dynamic CT data was acquired during the bolus injection of an iodine-
based contrast agent (1.0 mL/kg of iopamidol [300-Isovue®], Bracco S.p.A., 
Milan, Italy) at a rate of 1 ml/s. CT data was used as anatomical information 
in the light propagation modeling, as previously described (Elliott et al 
2013a) Region-of-interest analysis was performed on CT perfusion 
parameteric maps to determine the mean value of CBF, CBV, and MTT 
within the volume of tissue interrogated by the DCE-NIR light. The region-of-
interrogation was estimated from Monte Carlo generated sensitivity maps 
(Fang and Boas 2009). In addition to DCE-NIR validation, CT perfusion maps 
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were also used to confirm the magnitude and volume of the ischemic lesion 
following endothelin-1 injection.    
6.2.6. Data analysis 
The DTOFs measured at the four source-detector distances were converted to 
the three statistical moments of attenuation, mean time-of-flight and 
variance (Liebert et al 2004), which were smoothed using a Savitzky-Golay 
filter (using a window size of 12 seconds and a 7th order polynomial) prior to 
being analyzed (Savitzky and Golay 1964). The KDOR method, which was 
developed in-house and has been described in detail previously (Elliott et al 
2013a; Elliott et al 2012b) was used to analyze the DCE-NIR moments. 
Briefly, CT anatomical images were segmented manually into scalp, skull, 
and brain, and Monte Carlo eXtreme (Fang and Boas 2009) was used to 
model light propagation at the source-detector positions used in the 
experiment. The transformation between the detected signal and the change 
in dye concentration in the tissue regions, known as the Jacobian, A, was 
calculated from the Monte Carlo results (Liebert et al 2004) using optical 
properties determined by fitting the baseline (pre-ICG) time-resolved data 
(Diop et al 2010) and anatomical information from the CT image. The 
Jacobian function, the DCE-NIR data and the AIF are input into the KDOR 
algorithm, which was used to recover BF, BV, and MTT for the ECL and 
brain regions. Specifically, these three parameters were calculated from 
region-specific impulse residue functions, based on the previously described 
method (Meier and Zierler 1954). A schematic of this process is provided in 
Fig. 6.2. 
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Figure 6.2: KDOR workflow 
Flow chart outlining the steps involved in recovering the hemodynamic parameters. The 
parallelograms indicate the measured data from the three devices. Rectangles represent the 
analytical processes used: fit, diffusion approximation (DA) fitting routine; seg, manual or 
automatic segmentation; and MC, Monte Carlo modeling of the Jacobian. Intermediary 
parameters are represented by ovals: μ, region-specific bulk optical properties, B, binary 
segmented CT volume; and A, Jacobian. Finally, the recovered hemodynamic parameters 
(BF, blood flow; BV, blood volume; and MTT, mean transit time) are indicated by triangles. 
 The ECL fitting step (fit) involved optimizing the difference norm of 
time-resolved data collected at the 6 mm source-detector distance and the 
time-resolved function generated with the reflectance model of the diffusion 
approximation (Kienle and Patterson 1997). This procedure is described in 
detail elsewhere (Diop et al 2010). Segmentation (seg) was performed 
manually, slice-by-slice, on CT anatomical data that was acquired with a slice 
thickness of 5 mm.  
6.2.7. Error analysis 
An error analysis was conducted to investigate the influence of errors in the 
anatomical information used in the KDOR procedure that might occur during 
the clinical implementation of this technique. If it is assumed that the CT 
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images can be accurately segmented from clinical-resolution scans, then a 
potential source of error when inputting the anatomical information into the 
KDOR algorithm is co-registration of the optical probe positions using either 
feducial markers or a landmarking system (such as SLM10-20; Custo et al 
2010). Errors in probe positioning could result in differences between the 
modeled and actual ECL geometry. This error was investigated by generating 
DCE-NIR forward data on a two-layer slab (ECL and brain) according to a 
previously described method (Elliott et al 2012). Following the addition of 5% 
Gaussian noise to the NIR and AIF signals, CBF was recovered with KDOR 
using a Jacobain modeled with four-layer slabs of varying thicknesses. The 
thickness of the ECL was varied between 14 and 17 mm, representing the 
variation in thickness measured from T2-weighted MRI images of 5 healthy 
subjects for positional changes of approximately 15 mm (data not published). 
6.2.8. Statistical analysis 
All data are presented as mean ± SEM unless otherwise indicated. An 
analysis of variance (ANOVA) was used to uncover any physiological 
condition effects on the physiological parameters, which were further 
investigated with Tukey's post hoc test when appropriate. 
 Linear regression analysis was performed on each hemodynamic 
parameter (CBF, CBV, and MTT) to examine correlations between the values 
obtained using the two techniques (DCE-NIR and CT perfusion). Since 
datasets included multiple measurements from the same animal, 
independence could not be assumed and therefore a variation of the 
generalized estimating equation was utilized (Zeger et al 1988). First, a 
linear fit was applied to the data from each animal separately. A t-test was 
used to compare the slope and intercept values obtained from each animal to 
a null hypothesis (i.e., a slope of zero). Upon rejection of the null hypothesis, 
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the distribution of slopes was compared with a slope of unity to determine if 
the mean regression line was significantly different from the line of identity.  
 For the CBF regression plot (Fig. 6.6), the 95% confidence bounds on 
the regression line-of-best fit (i.e., the region containing the 95% of the 
distribution of lines-of-best fit assuming a Gaussian random effect) were 
calculated.  Finally, the degree of similarity between CBF measurements 
acquired with the two techniques was evaluated using a Bland-Altman plot 
(Bland and Altman, 1986). Differences with p < 0.05 were considered 
significant. 
6.3. Results 
6.3.1. Physiological parameters 
Table 1 summarizes the physiological parameters of the eight pigs averaged 
for each condition. Respiration rate, which was artificially increased by 
adjusting the mechanical ventilator setting, was significantly higher during 
hypocapnia and ischemia conditions. This resulted in the intended decrease 
in pCO2 measured from arterial samples, which was significantly different 
during hypocapnia and ischemia compared with baseline. A significant 
decrease was also observed in end-tidal CO2 measurements. No significant 
differences were observed in SaO2, HR, MAP, pO2, glucose and temperature. 
The mean ECL thickness in these animals was 12.0 ± 0.6 mm (ranging from 
10.5 to 14 mm), measured from CT images. 
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Table 6.1: Physiological parameters at each condition 
 
SaO2 
(%) 
HR 
(min-1) 
RR 
(min-1) 
MAP 
(mmHg) 
pCO2 
(torr) 
pO2 
(torr) 
glucose 
(mM) 
temp 
(°C) 
Baseline 
100 ± 
0 
108 ± 2 
29 ± 
1* 
49± 2 37.3 ± 0.7 
168.6 ± 
29.4 
5.3 ± 
1.0 
37.3 
Hypocapnia 
99 ± 
1 
109 ± 4 
46 ± 
1* 
46 ± 2 
24.2 ± 
1.2* 
149.4 ± 10 
5.4 ± 
1.2 
37.4 
Ischemia 
99 ± 
0 
124 ± 
17 
41 ± 
2b 
47 ± 4 
26.0 ± 
2.4* 
138.4 ± 
15.2 
5.2 ± 
0.8 
37.3 
SaO2, arterial oxygen saturation; HR, heart rate; RR, respiration rate; MAP, mean arterial 
pressure; pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen. * p < 0.01 
compared to baseline 
6.3.2. Reproducibility of hypocapnia and ischemia 
Analysis of variance with physiological condition (i.e., baseline, hypocapnia, 
or ischemia) as a within-subject factor and modality (i.e., CT perfusion or 
DCE-NIR) as between-subject factors revealed a significant condition effect 
on CBF measurements acquired with the two modalities (F2,18 = 10.27, p < 
0.01) but no significant condition by modality interaction. Post-hoc analysis 
was performed with Tukey’s method to further elucidate this condition effect. 
Compared with baseline, hypocapnia induced by artificially increasing the 
ventilator respiration rate from an average of 29 min-1 to an average of 46 
min-1 resulted in a significant reduction in CBF measured with CT perfusion  
(43.0 ± 4.2 ml min-1 100g-1 during hypocapnia vs. 61.7 ± 3.1 ml min-1 100g-1 at 
baseline; p < 0.05) and with DCE-NIR (42.6 ± 3.7 ml min-1 100g-1 during 
hypocapnia vs. 62.2 ± 4.7 ml min-1 100g-1 at baseline; p < 0.05). A further 
reduction in blood flow was observed following intracortical injection of 
endothelin-1, which resulted in an average CBF value of 39.9 ± 3.1 and 32.7 ± 
3.6 ml min-1 100g-1, measured by CT perfusion and DCE-NIR, respectively.  
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Figure 6.3: Sensitivity of optical measurements to endothelin-1 lesion. 
(A) CT perfusion blood flow map with visible large lesion caused by endothelin-1 injection. 
(B) Map showing spatial sensitivity of optical signal measured at 40 mm source-detector 
distance (arrow represents source; arbitrary units). (C) Segmentation map showing regions 
identified as infarct (red), penumbra (orange), benign oligemia (green) based on thresholding 
of panel A. 
 A closer examination of the CT perfusion data acquired during 
ischemia identified the presence of four tissue states with clinical importance: 
infarct (< 10 ml min-1 100g-1), penumbra (10-20 ml min-1 100g-1), benign 
oligemia (20-40 ml min-1 100g-1) in addition to normal tissue (> 40 ml min-1 
100g-1). The reproducibility of endothelin-1 induced ischemia was 
investigated in terms of the change in CBF compared to baseline within the 
optical region of interrogation as well as the total volume of the ischemic 
lesion (i.e., infarct and penumbra regions). A mean percent decrease in CT 
perfusion-measured CBF of 36.5 ± 7.3% (S.D.) was observed during ischemia 
in the region interrogated by the NIR light, and the mean volume of the 
ischemic lesion was estimated to be 27.6 ± 10.4 ml (S.D.).  
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Figure 6.4: Average contribution of tissue states to the optical ROI 
The average contribution of these tissue states to the optical region-of-interrogation across 
five animals.  I, infarct (< 10 ml min-1 100g-1); P, penumbra (10-20 ml min-1 100g-1; BO, 
benign oligemia (20-35 ml min-1 100g-1); N, normal. 
 Figure 6.3 shows a representative example of a CT perfusion map 
acquired during ischemia, a corresponding Monte Carlo sensitivity map, and 
a threshold map of the abnormal tissue states. To further investigate the 
robustness of the ischemic model to produce clinically relevant lesions, the 
percentage of the region-of-interest (ROI) representing the four tissue states 
was measured across all animals subjected to ischemia. On average, the three 
abnormal tissue states represented 48.7% of the total optical ROI. In Figure 
6.4, a bar graph shows the mean percent contribution of the four tissue states 
within the region of interrogation. 
6.3.3. DCE-NIR signal and recovered ICG concentration curves 
Time-resolved data were collected before and during bolus injection 
enhancement at four source-detector distances. Changes in the statistical 
moments of time-of-flight distribution―attenuation, mean time-of-flight, and 
variance―were calculated for subsequent analysis by the KDOR method. 
Figure 6.5 shows a representative example of the change in attenuation and 
change in variance signals measured at two of the source-detector distances 
(40 and 6 mm) during DCE measurements acquired under the three 
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physiological conditions. The tissue concentration curves recovered from the 
same data for the scalp and brain regions, along with the arterial input 
functions measured with the dye densitometer, are also shown. In these three 
datasets, the CBF (determined using the KDOR method) was equal to 45 ml 
min-1 100g-1 at baseline, 32.5 ml min-1 100g-1 during hypocapnia, and 22.6 ml 
min-1 100g-1 during ischemia.  
 
Figure 6.5: Dynamic contrast-enhanced signals during the three conditions 
The attenuation (top row) and variance (middle row) signal measured at 40 mm (black line) 
and 6 mm (gray line) source-detector distances during baseline, hypocapnia and ischemia 
(left-to-right). The recovered tissue concentration curves for the brain (solid black line) and 
ECL (solid gray line), and the corresponding arterial input function (dashed line) for the 
same data are presented in the bottom row. 
6.3.4. Comparison of hemodynamic parameters calculated using 
DCE-NIR and CT perfusion 
As stated in the methods section, a simple linear regression approach could 
not be performed because both independent and within-subject data are 
represented. Therefore, regression analysis was performed on data from each 
animal, individually, and the average of the eight analyses was determined. 
This approach was used to determine the relationship between CT perfusion 
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and DCE-NIR measured CBF, and between CT perfusion and DCE-NIR 
values of BV. Figure 6.6 shows the regression plot of the CBF data; the line-
of-best fit averaged across the individual regression analyses had a slope of 
1.06 ± 0.08, and a y-intercept of −4.37 ± 4.33 ml min-1 100g-1. The average 
slope was significantly different from the null (p < 0.001) but not significantly 
different from the line of identity (p = 0.81). The average y-intercept was not 
significantly different from zero (p = 0.76). The average r value, calculated 
from the individual regression analyses was 0.86 ± 0.06. 
 
Figure 6.6: Cerebral blood flow regression plot   
Regression plot comparing CBF values calculated from DCE-NIR data and concomitant CT 
perfusion values of CBF. Data are grouped by animal (n=8) and represented with a unique 
symbol. Regression analysis was performed on each group individually, and the average line-
of-best fit is indicated by the dashed line (slope = 1.06 ± 0.08, y-intercept = -4.37 ± 4.33 ml 
min-1 100g-1). 
The regression analysis of BV measured with the two techniques yielded an 
average line-of-best fit with a slope of 2.49 ± 0.34 and a y-intercept of 0.14 ± 
1.60 ml 100g-1. The average slope was significantly different from the null (p 
< 0.01) and significantly different from the line of identity (p < 0.05). The y-
intercept was not significantly different from zero (p = 0.90). The average r 
value for the CBV regression analyses was 0.56 ± 0.13. The mean difference 
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between BV calculated with the two techniques was 6.53 ml 100g-1, and the 
data was bound by a 95% confidence interval of 3.12 – 9.95 ml 100g-1. Finally, 
the average difference between the two techniques was significantly different 
from the null (p < 0.001), suggesting the presence of a systemic bias that 
would allow one technique to be calibrated to the other. 
 Figure 6.7 shows the Bland-Altman plot comparing the CBF 
measurements from the two techniques. The mean difference between the 
two techniques was −1.7 ml min-1 100g-1, which was bound by a 95% 
confidence interval of −16.3 to 12.9 ml min-1 100g-1. In this case, the average 
difference between the two techniques was not significantly different from 
the null (p = 0.31). 
 
Figure 6.7: Cerebral blood flow Bland-Altman plot 
Bland-Altman plot comparing the CBF measurements obtained with the DCE-NIR method 
and the CT perfusion method. Data are grouped by animal using the same symbols as in 
Figure 6.6. The mean difference between the two methods is indicated by the solid line, and 
the 95% confidence interval is demarcated by the dashed line. No statistically significant 
CBF magnitude effect was detected. 
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6.3.5. Error analysis 
Two error analyses were conducted to investigate potential sources of model 
uncertainty that could occur within the context of the KDOR framework 
presented in Figure 6.2. Uncertainties in probe holder position, which was 
determined from segmented CT images corregistered to the optical imaging 
domain, were investigated by generating forward optical data (replicating the 
experimental data) for an ECL thickness of 15 mm, and then reconstructing 
the same optical data with light propagation models assuming ECL thickness 
values from 13 to 17 mm. No significant differences were observed across 
ECL thickness values (p = 0.83). The results of this error analysis are shown 
in Figure 6.8A. 
 
Figure 6.8: Probe position and scattering coefficient error analysis 
(A) The relationship between error in assumed ECL thickness and error in the recovered 
CBF, simulated for a range of ECL thicknesses between 13 and 17 mm. (B) The relationship 
between error in the ECL reduced scattering coefficient, μs', and the error in recovered CBF. 
The regression line-of-best fit (slope = -0.39, y-intercept = 4%) is also shown (dashed line). 
 The value of directly measuring the ECL reduced scattering coefficient 
was evaluated by generating forward optical data with an ECL reduced 
scattering coefficient of 0.8 mm-1, and then reconstructing the same data with 
light propagation models using ECL scattering coefficient values from 0.4 to 
1.2 mm-1. A significant correlation between the error in reduced scattering 
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coefficient and error in recovered CBF was observed (slope = -0.39, y-
intercept = 4%, r = 0.96, p < 0.001). These numerical results are shown in 
Figure 6.8B. 
6.4. Discussion 
Dynamic contrast-enhanced optical measurements of CBF have been 
proposed for over 25 years as an attractive modality for bedside clinical 
monitoring, especially within the context of critical care. In particular, 
because DII is a leading contributor to poor outcome in patients that have 
sustained severe traumatic brain injury (Bouma et al 1991), stroke (Dirnagl 
et al 1999), and subarachnoid hemorrhage (Hijdra et al 1988), the ability to 
measure CBF at the patient's bedside would be of great value. Currently, 
only surrogate markers of CBF (i.e., intracranial pressure and cerebral 
perfusion pressure) are available to assess neurological recovery, and 
considerable controversy surrounds the use of these indirect markers of CBF 
to guide patient management. Despite the significant clinical potential of 
bedside CBF measurements, it is only recently that optical techniques have 
shown promise in achieving the stated goal.  
 An early study by Owen-Reece and colleagues identified the problem of 
extracerebral signal contamination as a confounding factor in optical 
measurements of CBF, resulting in a large underestimation of CBF. To 
overcome this problem, they suggested the use of a correction factor to 
calibrate NIRS CBF measurements to measurements obtained with an 
alternate technique. This was, in part, based in the assumption that the 
extracerebral layer effect was primarily due to a partial volume error, and 
that this effect would show low intrasubject variability (Owen-Reece et al 
1996). The notion of a direct correlation between NIRS-CBF measurements 
and CBF measured by an alternate method was challenged by a later study. 
Schytz and colleagues showed an absence of any correlation between CBF 
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measured concomitantly with NIRS and SPECT in healthy subjects before 
and after administration of acetazolamide (Schytz et al 2009). In particular, 
this study highlighted the lack of a universal correction factor for NIRS 
measurements of CBF, underlining the importance of subject-specific 
modeling using anatomical priors (Elliott et al 2010). 
 The advent of more sophisticated optical methods—including time-
resolved and frequency-domain NIR techniques—resulted in an increase in 
sensitivity to deeper tissue structures, such as the brain. In particular, time-
resolved methods allowed the discrimination of photons based on the time-of-
flight (i.e., the time required for a photon to travel from the source fibre to the 
detector), providing additional improvements in brain tissue sensitivity on 
the basis that late-arriving photons are statistically more likely to 
interrogate deeper tissue (Steinbrink et al 2001; Liebert et al 2004). Several 
papers have been published demonstrating qualitative curve analysis 
(Liebert et al 2006, Liebert et al 2012) and within subject quantification 
(Steinkellner et al 2010) of ICG bolus measurements acquired in neurocritical 
care patients with time-resolved methods. While this work has established 
the sensitivity of DCE-NIR methods to CBF changes, measurements are 
typically relative blood flow indices calculated using methods such as time-to-
peak (TTP). In Chapter 3, it was demonstrated that TTP analysis is 
unreliable when perturbations in cerebral blood volume and the arterial 
input function occur (Elliott et al 2013b). An alternative method of analyzing 
DCE-NIR data was presented, in which nonparametric kinetic analysis 
(Elliott et al 2013b) was used to calculate a relative blood flow index that 
showed good agreement with CBF changes determined from CT perfusion. 
 It is likely that absolute CBF measurements will be more clinically 
useful than relative blood flow indices, since well-defined CBF thresholds for 
cell dysfunction and irreversible cell damage are known (Jones et al 1981; 
Astrup et al 1981; Schaefer et al 2006). Therefore, to provide absolute 
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measurements of CBF, time-resolved instrumentation was combined with 
subject-specific light propagation modeling, and subsequently incorporated 
into an analytical framework called kinetic deconvolution optical 
reconstruction (KDOR). The theoretical basis for the KDOR method was 
described in a recent Letter, and provides a more robust means of separating 
the ECL and brain contributions to the optical signal through the use of 
anatomical priors and physiological constraints (Elliott et al 2012b). The 
main objective of this study was to confirm these theoretical predictions by 
validating DCE-NIR CBF measurements against CT perfusion 
measurements acquired concomitantly in adult pigs.  
 The representative example of optical signals measured in a single 
animal at three different physiological conditions provided in Figure 6.5 
illustrates the features of DCE-NIR data. As expected from previous studies 
(Liebert et al 2004; Steinkellner et al 2010; Liebert et al 2006), including the 
study presented in Chapter 3, differences between attenuation and variance 
signals were observed. The subtle differences at baseline suggest increased 
sensitivity of variance to faster cerebral tracer kinetics. As CBF decreased 
due to hypocapnia and ischemia, greater differences between these three 
conditions were observed in the variance signal than in the attenuation 
signal—a trend observed in the Chapter 3 study. Improvements in sensitivity 
provided by the variance signal facilitated the recovery of tissue 
concentration curves, which appear to reflect the corresponding change in 
CBF, both in the peak concentration and the temporal dynamics. An 
interesting feature of the tissue concentration curves recovered for the 
ischemia condition is the apparent transient increase in concentration 
following the recirculation of dye. This is likely an artifact of the 
reconstruction process, as opposed to any real kinetic effect such as 
extravasation, and is an atypical feature. It is important to note that 
constraints implemented by the KDOR inversion have the greatest effect on 
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the first rise, and peak concentration, of the corresponding tissue 
concentration curves. Therefore, any small discrepancies in the shape of the 
reconstructed tissue curve is not indicative of a significant error in recovered 
CBF. 
 For all eight animals, values of CBF and CBV recovered with the DCE-
NIR method were compared to CT perfusion values—the most common 
method used to assess these parameters clinically (Koenig et al 1998; Mayer 
et al 2000). In general, an excellent agreement was observed between CBF 
measurements acquired with the two modalities with a precision comparable 
to previous studies published by our group for the neonatal pig model (Brown 
et al 2002), as well as the juvenile pig study presented in Chapter 2. It is 
likely that the improvements in instrumentation (time-resolved vs. 
continuous-wave) and the use of the KDOR method to mitigate optical 
reconstruction problems (Bonfert-Taylor et al 2012) contributed to the strong 
correlation with CT perfusion measurements, despite the use of animals with 
thicker ECLs and reduced scalp flow. While CBV values measured with the 
DCE-NIR method showed a strong correlation with CT perfusion 
measurements, the optical technique reported values that were on average 
2.5 times larger (baseline mean values of 4.7 ml 100g-1 and 11.39 ml 100g-1 
determined with CT perfusion and DCE-NIR, respectively). One explanation 
for this discrepancy is that the two methods utilize different kinetic modeling 
approaches to calculate hemodynamic parameters from DCE. The CT 
Perfusion 4 program utilizes a variation of the adiabatic approximation to the 
tissue homogeneity (AATH) model (Bisdas et al 2008) which is essentially a 
plug flow model. Plug flow models have been demonstrated to underestimate 
mean transit time (MTT) in many situations (Schabel 2012; St. Lawrence et 
al 2013), and since CBV is directly related to MTT by the central volume 
principle, it is also underestimated. On the other hand, the DCE-NIR method 
employs a nonparametric deconvolution method to recover an arbitrary 
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hemodynamic function. Since the NIR region-of-interrogation is larger, it is 
likely to contain a distribution of MTTs that contribute to an overall larger 
CBV than would be observed for a single CT voxel. In addition to the transit 
time distribution effect, because the DCE-NIR method does not truncate the 
recovered hemodynamic function, it is likely that any residual scalp 
contribution that remains in the brain signal would contribute 
disproportionately to CBV, without significantly affecting CBF values. 
Nevertheless, it is important to recognize that the discrepancy between CBV 
values attributed to these differences resulted in a consistent bias across all 
eight animals, suggesting that a simple calibration curve could be used to 
relate the two modalities if desirable. 
 Given the strong correlation between the DCE-NIR method and the 
clinical standard, a closer investigation of the analytical framework is 
pertinent. In particular, it is worthwhile investigating the relative 
importance of the priors incorporated into the workflow before the KDOR 
routine is executed. First, while the acquisition of anatomical imaging (i.e., 
CT or MRI) is ubiquitous in almost all neurotrauma centers, the 
segmentation and incorporation of this data into a subject-specific model may 
not be trivial within the context of acute care. In particular, it may be 
difficult to provide an accurate method of coregistering the anatomical data 
with the location of the optical probes, which was rather straightforward in 
these experiments given the visibility of the polychloroprene probe holder on 
the CT images. While the use of feducal markers has been explored 
elsewhere, it is likely that a landmark system such as the 10-20 international 
system (Custo et al 2010) used for electroencephalogram placement would be 
more clinically compatible. To this end, the effect of small errors in optical 
probe corregistration was investigated by varying the ECL thickness within a 
range typical of small but non-negligible positional changes on an average 
human head. No significant difference was found in the recovered blood flow 
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values across the range of ECL thicknesses, suggesting that the DCE-NIR 
method is insensitive to small perturbations in ECL thickness. As a result, it 
is reasonable to assume that a less accurate positioning system, such as the 
SLM 10-20, would provide acceptable accuracy. The importance of measuring 
the optical properties of the ECL using time-resolved data collected at the 6 
mm source-detector distance was also investigated. Across a range of values 
for the reduced scattering coefficient, a significant correlation between error 
in CBF and error in μs′ was determined. More specifically, an error of about 
40% in μs' resulted in a 20% error in CBF. Given that reported values of μs' 
for the scalp of the human head include 1.0 mm-1 (Boas et al 2002), 1.2 mm-1 
(Choi et al 2004), and 1.7 mm-1 (Okada and Delpy 2003), using an assumed 
value for μs' would introduce a large amount of uncertainty. In part, the 
results of this second error analysis provide a strong justification for the use 
of time-resolved instrumentation to directly measure the optical properties in 
the ECL, despite its relative sensitivity to stray light compared to 
continuous-wave systems. 
 In this study of cerebral ischemia, intracortical injection of endothelin-
1 was used to produce a large lesion containing infarct and penumbra tissue 
states, which persisted long enough to acquire the three measurements 
needed for this study. A limitation with this model is that only a portion of 
the lesion (14%) was reduced to ischemic levels, as defined by CBF less than 
10 ml min-1 100g-1, with penumbra (10 - 20 ml min-1 100g-1) and benign 
oligemia (20 - 35 ml min-1 100g-1) regions also contributing to 18 and 19%, 
respectively. Since the NIR region-of-interrogation encapsulated all of these 
components, the recovered CBF values by DCE-NIR and corresponding CT 
perfusion values averaged over a representative region-of-interest did not 
reach ischemic levels. However, given that the difference between the two 
techniques, as determined with the Bland-Altman method (Fig. 6.7) did not 
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depend on the blood flow level, it is reasonable to assume that DCE-NIR 
would quantify even lower levels of CBF with comparable precision.  
6.5. Conclusions 
The present study validated the DCE-NIR method of measuring CBF, which 
combines multi-distance time-resolved measurements, arterial input function 
characterization, and subject-specific light propagation modeling using the 
KDOR analytical framework. This work provides a convincing argument for 
using this robust optical method to measure CBF in the neurocritical care 
unit, where quantitative CBF measurements may provide a means of guiding 
patient management and intervention.   
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Chapter 7 
CONCLUSIONS AND FUTURE WORK 
The final chapter of this thesis provides a summary of the dynamic contrast 
enhanced (DCE) near-infrared (NIR) method developed to measure 
hemodynamic parameters in neurocritical care unit (NCU) patients. As the 
objectives of this thesis were advanced, improvements were made to the 
instrumentation and the analytical approach, beginning with the depth-
resolved continuous-wave (CW) near-infrared spectroscopy (NIRS) method in 
Chapter 2. Next, a blood flow index calculated from the variance of time-
resolved (TR) NIR distribution of time-of-flight (DTOF) measurements was 
described as a reliable technique to measure changes in cerebral blood flow 
(CBF) (Chapter 3). Finally, a multi-distance TR moments-based method 
using the kinetic deconvolution optical reconstruction (KDOR) approach was 
validated in an adult pig model of ischemia (Chapter 6). Each of these 
developments will be summarized within the context of the objectives 
presented in Chapter 1. Following this, the future work for this technology 
will be discussed and the principle conclusions of the thesis will be stated. 
7.1. Summary of stated objectives 
The four objectives of this thesis focused mainly on: (i) the design and 
optimization of clinically compatible instruments, (ii) the development of an 
analytical framework, (iii) the development of clinically relevant animal 
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model for NCU applications, and finally, (iv) the validation of the technique 
against CT perfusion. These will now be addressed in turn. 
7.1.1. Design and optimization of NIR instrumentation 
The design and optimization of the DCE-NIR system was accomplished in 
three main steps. First, a two-channel continuous-wave broadband system 
was developed, based on the previous work of our group in using CW NIRS to 
measure CBF in neonatal pigs (Brown et al 2002; Tichauer et al 2006) and 
more recently, in the neonatal intensive care unit (Arora et al 2013). In the 
subsequent study, a time-resolved system was introduced to improve brain 
sensitivity through the use of statistical moments of DTOF data. Chapter 3 
highlighted the results obtained using the variance signal measured at 30 
mm to calculate a relative blood flow index, dBF, which is capable of tracking 
changes in CBF. It was evident from the error analysis and the strong 
agreement with CBF changes measured by CT perfusion that a necessary 
precursor in proper kinetic analysis of DCE-NIR is the acquisition of the AIF. 
Therefore, in Chapter 4, an alternate method of capturing the AIF was 
described to eliminate the need of a specialized dye densitometer. The goal in 
developing this pulse oximeter (PO)-based method was to facilitate clinical 
implementation of DCE-NIR by leveraging the ubiquity of POs in the critical 
care setting. Finally, in Chapter 6, a multichannel TR-NIR system was 
presented that enabled the three statistical moments (A, <t>, and V) acquired 
at four source-detector distances (6, 20, 30, and 40 mm) to be measured 
simultaneously. This sophisticated instrumentation enabled accurate and 
precise characterization of CBF, even in the presence of substantial ECL 
contamination. In particular, an error analysis demonstrated the importance 
of direct determination of extracerebral layer (ECL) optical properties, which 
can be done effectively using TR-NIR. 
 
187 
7.1.2. Development of the analytical framework 
In parallel to the developments in instrumentation, improvements in 
analytical methodology were made. In the first pig study, the inter-subject 
variability in sensitivity factors (i.e., mean partial pathlengths (MPPs)) was 
identified as the likely cause of reported failure of DCE NIRS to measure or 
even track changes in CBF in adult subjects (Schytz et al 2009). Therefore, 
subject-specific Monte Carlo simulations were implemented and a lookup 
table of MPPs was generated using two-layer models with varying ECL 
thicknesses. For each animal, MPPs were selected from the library using an 
objective cost function that optimized two error norms: ECL thickness of the 
two-layer model compared to the value measured from the animal’s CT 
image, and the resulting brain water concentration compared with the 
assumed value of 80%. Compared to the simple subtraction method, in which 
a group averaged MPP set was used, the subject-specific approach 
significantly reduced the inter-subject variability and, as a result, NIRS CBF 
measurements showed good agreement with CT perfusion values. Time-
resolved NIR was implemented as a way to further improve depth sensitivity 
by measuring the DTOFs. The use of the change in statistical variance of the 
DTOF during ICG uptake and washout to calculate a deconvolution-based 
blood flow index (dBF) was investigated, avoiding the need for the subject-
specific modeling used in the previous study. A secondary goal of this study 
was to highlight the pitfalls of using the TTP as a surrogate of CBF changes: 
a commonly used approach in DCE optics. A more robust analytical approach 
based on the deconvolution method was developed, and it is arguably the 
most significant advancement of this doctoral work. The ill-posed nature of 
optical reconstruction impacts almost every field of biomedical optics and any 
additional unique information that can be included in the reconstruction 
problem will likely improve the results. The KDOR method, described in 
Chapter 5, is a novel reconstruction approach that uses dynamic priors. The 
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ability of this method to recover CBF accurately was demonstrated in 
Chapter 6. 
7.1.3. Development of the animal model 
Adult pigs were used in all three DCE NIR studies since they have similar 
ECL thickness to humans. Furthermore, the average CBF of an adult pig is 
similar to the human adult. The main limitations of the pig model are small 
size of the brain relative to the head and the higher scalp blood flow than in 
the humans due to the thicker temporalis muscles that have evolved to 
enable strong mastication. The former issue is not a problem because the 
farthest source-detector distance (40 mm) was well within the length of the 
brain. To overcome the second limitation, three incisions were made rostral, 
caudal and lateral to the optodes in the second and third pig studies to reduce 
scalp blood flow to less than 10 ml min-1 100g-1, as observed in humans. In all 
three animal studies, CBF was varied over a range of values by adjusting the 
PaCO2 (i.e., hypercapnia and hypocapnia). However, two limitations of this 
approach were identified within the context of DCE NIR validation. First, 
hypocapnia does not decrease CBF below the clinically important thresholds 
of either infarct or penumbra. Second, a vascular response to PaCO2 may 
occur in the ECL, as well as in the brain. The latter could confound the 
ability to assess whether depth-resolved NIRS is truly sensitive to only flow 
changes occurring in the brain. For these two reasons, we introduced the 
ischemic model in Chapter 6, which involves inducing a large ischemic lesion 
by intracortical injection of endothelin-1. Computed tomography maps were 
used to demonstrate the reproducibility of the model in causing a large 
volume (27.6 ± 10.4 ml) lesion with infarct, penumbra and benign oligemia 
tissue states. 
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7.1.4. Validation of the method against CT perfusion 
Finally, validation of the DCE-NIR method was accomplished at each stage of 
development through comparisons to CT perfusion, the current clinical 
standard for CBF measurements. In the first study, the DCE-NIR 
measurements of CBF showed strong agreement with CT perfusion values  
(r = 0.84, p < 0.001), and the mean difference between the two techniques was 
−2.83 ml min−1∙100 g−1 with a 95% confidence interval of −19.63 ml min−1 100 
g−1 to 14.00 ml min−1 100 g−1. In the second study, the specificity and 
sensitivity of the dBF index measured from the variance signal was 
investigated in four animals. First, extracerebral blood flow and composition 
was modulated to determine the effect of the ECL on the measured index: the 
average change in dBF during these manipulations was 0.2 ± 2.4%. Second, 
the ability of dBF to track changes in CBF was examined by inducing 
hypocapnia and performing concomitant measurements of CBF with CT 
perfusion. In this case, measurements of dBF acquired on the surface of the 
head showed a similar decrease compared with CT perfusion values of CBF. 
In the third pig study, DCE-NIR measurements of CBF analyzed using 
KDOR showed strong agreement with CT perfusion values (r = 0.86,  
p < 0.001) across a range of blood flow levels from about 25 to 75 ml min-1 
100g-1. The mean difference between the two techniques was -1.7 ml min-1 
100g-1, which was bound by a 95% confidence interval of −16.3 to 12.9 ml min-
1 100g-1. Furthermore, the validation was performed in animals with an ECL 
thickness similar to adults. This final validation study confirmed that 
accurate measurements of CBF can be obtained from DCE-NIR 
measurements acquired on the surface of the head, during normal, oligemic 
and ischemic blood flows. 
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7.2. Future work 
7.2.1. Improvements to DCE-NIR and KDOR analysis 
The analytical method described in this thesis can be advanced in two 
different directions, depending on the demands of the situation. In certain 
cases, a large amount of information might be sought from a large number of 
inputs—e.g., for imaging applications. To properly characterize the spatial 
distribution of a parameter, such as CBF, it is necessary to increase the 
number of channels of data so that the system is not underdetermined. For 
example, a recent study demonstrated the use of a CW-NIRS instrument for 
acquiring DCE data on the surface of the head, simultaneously, in 900 
channels (Habermehl et al 2013). Another large-scale problem arises when 
attempting to analyze the DTOFs directly, instead of reducing the problem to 
the three statistical moments A, <t>, and V.  
Since KDOR differs from traditional optical reconstruction methods, in 
that it uses the NNLS algorithm with equality and inequality constraints, its 
current implementation is computationally demanding, due to a need to 
perform a full pseudo-inverse calculation for each iteration (Chen and 
Plemmons 2009). This limitation can be somewhat mitigated by applying a 
dimension-reduction method. For example, principle component analysis 
(PCA) has been incorporated into FMT reconstruction schemes without 
significant performance cost (Cao et al 2012). It stands to reason that an 
analogous method could be applied to KDOR large-scale problems with 
similar results. One immediate application could be to distinguish flow in an 
infarct region from normal brain and ECL.  There are other applications in 
which DCE measurements could improve the clinical utility of NIRS such as 
characterizing the uptake of a tracer into a tumor. In such cases, the goal 
would be to reconstruct dynamic parameters on an image space defined by a 
set of arbitrary node coordinates. 
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Moving in the other direction, there are certain clinical settings where 
it would be desirable to obtain hemodynamic measurements, but where there 
is no a priori spatial information. Considering that the accuracy of the CBF 
measurements obtained with the KDOR method were fairly insensitive to 
uncertainties in the ECL thickness in the error analysis from Chapter 6, it 
may be possible to use a standard landmarking system to place one or two 
optodes on the head and estimate CBF using a population average head 
geometry (Custo et al 2010; Okamoto et al 2004). Removing the dependence 
of the KDOR workflow on anatomical priors from another imaging modality 
would enable its use in remote or hostile environments. The development of 
"field-unit" optical systems has been investigated by government defense and 
humanitarian organizations as a means of directly assessing brain injury in 
patients for whom access to NCU is not available. In particular, the 
portability of biomedical optics compared to traditional imaging methods is 
desirable in remote villages or on the battlefield. Near-infrared spectroscopy 
has shown promise in assessing severity of brain injury and presence of 
hematoma (Kessel et al 2007; Gopinath et al 1995). Unlike these studies, 
which used simple CW instrumentation and did not account for ECL 
contributions, time-resolved NIR in combination with the methods described 
in this thesis would significantly improve accuracy and precision, and 
therefore the predictive value of the recovered parameters. While TR NIR is 
considerably less compact than CW NIR, scaled-down versions have been 
developed (Wilmink et al 2011; Re et al 2010) and are therefore quite feasible. 
7.2.2. Clinical validation 
Clinical trials, including validation studies and randomized controlled trials, 
are ambitious, yet necessary next steps before DCE-NIR can be accepted as a 
clinically useful tool for the management of NCU patients. Three principle 
objectives should be addressed.  
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First, CBF measurements determined using the DCE-NIR method 
should be compared to a clinical standard such as CT perfusion to determine 
their accuracy and precision in NCU patients compared with the animal 
model. The comparisons could be made during routine CT imaging, adding 
the CT perfusion scan to the protocol with only a slight increase in dose to the 
patient (2.0-3.4 mSv compared to 1.5-2.5 mSv for a routine head CT (Hoeffner 
et al 2004)).  
Second, it is necessary to determine the predictive value of DCE-NIR 
measurements of CBF for identifying DII in susceptible patients. For 
example, along the same lines as a previous study (Pham et al 2007), CT 
perfusion and DCE-NIR measurements could be obtained in SAH patients 
during the first two weeks of admission to the NCU. The two modalities could 
be compared in their abilities to predict the development of DII, as defined by 
the presence of delayed infarction on CT.  
Finally, should the first two objectives be met, a randomized controlled 
trial should be conducted comparing clinically relevant endpoints (i.e., 
Glasgow outcome scale, survival, etc.) of two groups of patients: those in 
whom CBF values are calculated with DCE-NIR at regular intervals during 
the acute recovery stage to inform patient management, and a control group 
for whom management is determined using current clinical practices. This 
final objective will be necessary before DCE-NIR can be recommended as 
standard-of-care.       
7.2.3. Future applications 
In Appendix A, the results of a recent numerical simulation are presented to 
highlight the use of the KDOR method in a completely different application. 
In particular, we investigated the ability of KDOR to recover the rate 
constants and molecular binding potential of a targeted tracer using the dual-
tracer method (Tichauer et al 2012). These numerical experiments suggest 
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that the KDOR method improves the quantification of other dynamic 
parameters, compared with the traditional two-step method employed in 
FMT and DOT. Since commercially available solutions already exist for small 
animal preclinical imaging, KDOR can likely be incorporated into existing 
systems to improve the accuracy of these devices in evaluating molecular 
expression and drug binding. 
 In addition to small animal experiments, KDOR could be used in 
conjunction with targeted tracers to detect primary or metastatic cancer in 
vivo. In one potential application, the dual tracer method could be applied to 
breast cancer imaging targeting the HER2 receptor, which is expressed in the 
majority of primary tumors and lymph node metastasis (Carlsson et al 2004). 
In another application, a passive leaky tracer could be used to assess tissue 
permeability, a hallmark of cancer progression, in a variety of different 
cancers (St. Lawrence et al 2013). In both cases, accurate quantification of 
dynamic parameters is necessary to properly direct and monitor treatment. 
7.3. Principle conclusions 
The salient finding of this thesis is that DCE-NIR techniques have the 
potential to assess cerebral hemodynamics at the bedside of NCU patients, 
given that: 
(i)  CBF measurements obtained using a depth-resolved CW 
NIRS method showed strong agreement with CT perfusion 
measurements of CBF acquired in juvenile pigs. 
(ii)   Relative changes in CBF derived from statistical moments 
of TR-NIR data were in good agreement with percent 
change in CBF measured by CT perfusion. 
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(iii) Numerical simulations demonstrated that KDOR 
significantly improves the accuracy of flow measurements 
obtained from a heterogeneous medium (e.g., the adult 
head). 
(iv) Experimental multichannel TR-NIR data analyzed with the 
KDOR method provided accurate quantification of CBF in 
an adult pig model of ischemia. 
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APPENDIX A 
Applying KDOR to small animal fluorescence 
imaging of molecular binding 
A.1.  Background 
The kinetic deconvolution optical reconstruction (KDOR) approach can be 
extended to more complex tracer kinetic models to characterize the behaviour 
of targeted tracers which bind to receptors of interest. Targeted tracer 
methods have been extensively used in more established imaging modalities 
such as positron emission tomography (PET), and have recently been applied 
to planar fluorescence imaging to quantify molecular expression of epidermal 
growth factor receptor (EGFR) in tumors (Tichauer et al 2012). Similar to 
computed tomography (CT) perfusion, PET molecular imaging methodology 
involves two-steps: spatial reconstruction of tracer concentration and 
subsequent kinetic analysis. Spatial reconstruction in PET is a well-posed 
problem: the radioisotope undergoes positive beta decay, and subsequent 
postitron-electron annihilation, producing two 511 keV gamma photons that 
are emitted at  almost 180° and can be used to localize the source of the decay 
(i.e., a radiolabeled tracer) with sub-centimeter resolution. However, using a 
two-step (TS) reconstruction process in optical tomography will result in loss-
of-information that will decrease the accuracy of recovered kinetic 
parameters. An alternative approach is to use the kinetic deconvolution 
optical reconstruction (KDOR) algorithm to characterize the R(t) function for 
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each region directly, and then to obtain information from these recovered 
functions by fitting them with a kinetic model. This approach allows the 
kinetic information to be extracted from the imaging data in a single 
inversion, mitigating the loss-of-information from the spatial reconstruction 
step. 
 In molecular imaging with targeted and untargeted probes, the uptake 
of a tracer by the tissue can be described by the following convolution: 
     ),(1 tRtCKtC a   (A.1) 
where K1 is the rate constant governing the extraction of the tracer into the 
interstitial space, and K1 = F x E, where E is the extraction fraction, and F is 
the blood flow. Note that this notation differs slightly from applications 
involving vascular tracers such as ICG, since this model specifically 
characterizes the uptake of tracer into the tissue and does not attempt to 
model the vascular dynamics of the dye. To extract meaningful information 
from the impulse residue functions of targeted and untargeted tracers, 
mathematical models are derived through compartmental analysis (Goldberg 
et al 1980; Hine et al 1980; Tichauer et al 2012), assuming the targeted 
tracer can be in one of three “spaces”: the arterial space, Ca(t), unbound in the 
extracellular extravascular space (EES),Cf(t), or bound to its receptor in the 
EES, Cb(t). The untargeted tracer is assumed to only occupy the arterial 
space and the unbound EES.  The transport of each tracer from one 
compartment to the other is described by first order rate constants (e.g. K1 
and k2 describe transport between blood and the ESS, and k3 and k4 describe 
transport between the free and bound states), and is summarized in Figure 
A.1. 
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Figure A.1: The dual-tracer compartment model 
The targeted tracer, CT(t), characterizes the delivery, uptake and binding of a ligand to a 
receptor-of-interest. The untargeted tracer, CU(t), is designed to behave identical to the 
targeted tracer in terms of delivery and uptake, but does not have the ability to occupy the 
bound space. By the simultaneous injection of targeted and untargeted tracers, parameters 
K1, k2, and k3/k4 can be characterized. (Adapted from Tichauer et al 2012). 
If an untargeted tracer is selected that has the same arterial input function, 
Ca(t), as the targeted tracer, and the binding kinetics (k3 and k4) are much 
faster than the vascular leakage kinetics (k2), then the following set of 
equations describes the residue function in Eq. A.1 for the targeted, RT(t), 
and untargeted, RU(t), tracers:  
  
t
BP
k
T etR


 1
2
  (A.2a) 
   ,2tkU etR
   (A.2b) 
where BP is the binding potential and is equal to k3/k4 by definition (Tichauer 
et al 2012). Often, the measurement of Ca(t) is difficult, and is avoided by 
combining the targeted and untargeted model-specific versions of Eq A.1 
(Lammertsma and Hume 1996). However, pulse dye densitometers can 
quantify the Ca(t) of indocyanine green and its derivatives (Iijima et al 1997), 
and Ca(t) can be estimated for near-infrared and red dyes using widely 
available standard pulse oximeters (Elliott JT et al 2012b). Since both of 
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these approaches enable the Ca(t) to be measured independent of the FMT 
data at high temporal resolution, Ca(t) can be used as a time-reference for the 
FMT projection data. In this case, the KDOR method recovers the K1R(t) 
from each region, which is analogous to vector RF from Eq. 5.3. (see Chapter 
5) in the dual-tracer approach, and can be formulized as: 
 
  UAU RACS   (A.3a) 
 
  TAT RACS   (A.3b) 
where SU and ST represent the signal vector measured at the wavelengths 
corresponding to the untargeted and targeted tracers, respectively, and RU 
and RT represent the stacked RT(t) and RU(t) functions from each region. An 
implicit assumption in this technique is that CA, the Toeplitz matrix of the 
AIF, is the same for both tracers; this requires consideration when designing 
probe pairs, but has been demonstrated to be a valid assumption in 
applications using IRDye 700DX and IRDye 800CW-EGF (both by LI-COR 
Biosciences, Lincoln, NE) (Samkoe et al 2012). The kinetic parameters (i.e., 
K1, k2, BP) are recovered by optimizing the following expression: 
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Optimization was performed in MATLAB using the fminsearchbnd function 
(D’Errico 2005).  
A.2. Numerical experiment 
The numerical simulations presented in this subsection demonstrate the 
ability of KDOR to quantify the molecular expression of a targeted tracer in 
small animal imaging of cancer using FMT. Numerical simulations were 
performed with NIRFAST using the heterogenous optical digimouse (Dogdas 
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et al 2007) and the previously described fan-beam FMT configuration 
(Tichauer et al 2011). This configuration is shown in Fig. A.2. Fluorescence at 
the targeted (800 nm) and untargeted (700 nm) dye wavelengths was 
simulated in the digimouse head and signal was recorded in the five detectors 
simultaneously with an integration time of 12 seconds. This was repeated for 
32 source detector positions, with a rotation time (deadtime) between 
positions of 32 seconds.  A complete set of optical data (32 source-positions x 5 
detectors) was acquired every 23.5 minutes for 2.5 hours.  
 
 
Figure A.2: Fan beam FMT and digimouse mesh used in simulations 
(A) The FMT system, based on published work by the Optics in Medicine group at Dartmouth 
College, consists of one source position and five detector positions, which rotate around a 
gantry to collect tomography data. A cross section of the mouse head with a tumor region is 
shown in the centre of the system. (B) The digimous mesh used in the simulations, showing 
the tumor inclusion located in the head slice.  
 Targeted and untargeted tracer uptake in each tissue region was 
simulated using Eq. A.1. The true (input) values for the kinetic parameters 
are given in Table 1 and are from kinetic planar imaging data (Tichauer et al 
2012). An arterial input function was simulated using a biexponential model 
of the form tdtb ceae   , for which parameters a-d were defined as 0.15 uM, 
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3.6 min-1, 0.05 uM, and 44 min-1. This model was previously shown to fit 
experimental arterial input functions in mice with good agreement (Samkoe 
et al 2012). Gaussian white-noise of 20% was added to the FMT signal and to 
Ca(t). The targeted and untargeted uptake curves are shown in Figure A.3. 
 
Figure A.3: Simulated uptake curves 
The uptake curves used in the forward model for the background (grey solid line) and the 
tumor (black solid line) regions, for the targeted (A) and untargeted (B) tracers. The arterial 
input function is also shown (black dashed line). 
 Reconstruction of kinetic parameters was performed using the KDOR 
and TS methods. In the KDOR approach, the region-specific K1R(t) functions 
for the targeted and untargeted tracers were reconstructed from Eq. A.3, and 
kinetic parameters were extracted by minimizing Eq. A.4. In the TS 
approach, a time-series of targeted and untargeted concentration maps were 
reconstructed using a Levenberg-Marquardt approach (Dehghani et al 2008) 
with hard anatomical priors and these regions-of-interest were then used to 
define the tracer uptake curves. Kinetic parameters were extracted by fitting 
the tracer uptake curves with the convolution in Eq. A.1. In both cases, 
reconstruction was performed on a homogeneous mesh (μa = 0.01 mm-1, μs′ = 
1.0 mm-1) rather than the heterogeneous mesh used in the forward data, to 
avoid the inverse crime. To compare the precision and accuracy of the two 
approaches, the reconstruction procedure was repeated 100 times. 
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A.3.  Results and discussion 
For the tumor region, the KDOR-recovered K1R(t) functions and the tissue 
uptake curves recovered from the reconstructed fluorophore maps are shown 
in Fig. A.4. Both untargeted and targeted R(t) functions recovered with the 
KDOR approach show a strong agreement with input values—the percent 
difference in area under the fitted and input curves was less than 0.01% in 
all cases and were not significantly different. Whereas the values recovered 
using the TS method show marked deviations from the true values. 
 
Figure A.4: Functions recovered with KDOR and TS methods 
The mean KDOR-recovered K1R(t)  (open circles ± SD) for the 100 repetitions, along with the 
true (black line) and mean model-fitted (red line) K1R(t) functions for the targeted (A) and 
untargeted (B) tracers. The mean C(t) uptake curves recovered with the two-step approach 
(open squares  ± SD), along with the true (black line) and mean model-fitted (red line) uptake 
curves for the targeted (C) and untargeted (D) tracers. 
 Kinetic parameters were recovered by fitting the corresponding dual-
tracer model functions to these curves. Figure A.5 presents box-and-whisker 
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plots for the three kinetic parameters recovered for the two regions 
(background and tumor) with KDOR and TS methods. In general, KDOR is 
more accurate and precise in recovering the kinetic parameters. In fact, the 
TS method is only capable of accurately recovering the background K1 
parameter, and in even in this case, exhibits high variability.  
 
Figure A.5: Kinetic parameters recovered with the two approaches 
Box-and-whisker plots of K1, k2 and binding potential recovered with the KDOR and TS 
method for the background (top row) and tumor (bottom row) regions. Boxes are bound by the 
1st and 3rd quartiles, and the median is given by the centre line. Error bars are min and max, 
with outliers shown as crosses. Dashed lines show the true value of the parameter. 
 The most important parameter in preclinical cancer imaging 
applications is BP, which can be used to assess molecular expression of a 
particular receptor, and evaluate the affinity of a particular ligand (e.g., a 
prospective drug) for its receptor. Both methods exhibited different levels of 
BP underestimation, likely owing to spatial blurring causing contamination 
from the low-BP background. However, this underestimation was five times 
less pronounced when KDOR was used. Also contributing to this 
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improvement, the temporal resolution of the functions recovered with KDOR 
show significant improvement over the uptake curves characterized from the 
reconstruction fluorophore maps. This is a direct result of using the 
independently-measured AIF to time-stamp each data projection. Of 
particular interest, the mean error and 95% confidence interval in the tumor 
BP recovered by KDOR was −5.86% (−25.0 - 13.3%), whereas the with the TS 
approach, the error was −32.6% (−49.0 - −16.5%). The improved accuracy in 
the KDOR-recovered values of K1 and k2 are also notable, since these 
parameters could indicate enhanced vascular permeability, which is a 
hallmark of tumor angiogenesis. Surprisingly, the errors in all KDOR-derived 
parameters were comparable to reported results using more robust planar 
imaging techniques (Tichauer et al 2012). This finding can be explained by 
the negative monotonicity temporal constraint on the R(t) reconstructions 
(see Chapter 5), which is valid irrespective of the kinetic model used since all 
compartment models decay exponentially. Further studies are ongoing to 
investigate the accuracy of this KDOR approach in animal studies. 
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